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Abstract 
The Draize eye irritation test has been widely adopted as the "gold standard" to 
evaluate the potential eye irritation of a wide range of chemicals and formulations, 
including; pharmaceuticals, cosmetics, and their raw ingredients. The rationale for 
pursuing the development of human ocular based in vitro alternatives is to provide 
greater confidence in the prediction of human reactions to mild and moderate 
chemicals. This is particularly important with the implementation of the EC White 
Paper, "Strategy for a future chemicals policy" (2001) that is estimated to require the 
testing of approximately 30,000 'existing' chemicals by 2012. 
The development of in vitro alternatives for toxicity testing has mainly focused upon 
tests for quantitative measurement of acute toxicity following a single high-dose 
exposure. However, the degree of toxicity of any exposure is a function of; the dose 
which target cells receive, the duration of the exposure and the ability of the exposed 
cells to recover from the exposure. However, little account is taken of the potential 
role of long-term effects in modulating the toxic response. This study aims to generate 
an in vitro model utilizing a human corneal cell line monolayer to investigate the 
effects chronic exposure to exogenous chemicals has upon toxicity of a subsequent 
acute challenge. 
Surfactants are ubiquitous within our daily environment, being significant active 
components In both household and personal care products, cosmetics and 
pharmaceuticals. Initially the effects of four representative surfactants (sodium dodecyl 
sulphate; anionic, tween 20; non-ionic, cocamidopropylbetaine; amphoteric and 
benzalkonium chloride; cationic) were examined following chronic exposure. 
11 
Although the measured endpoints (neutral red uptake, resazurin reduction, fluorescein 
leakage and total protein content) revealed no alterations in J-HCET morphology, 
barrier function or biochemistry as a consequence of chronic exposure, it was 
determined that pre-exposure modulated the toxicity of subsequent acute exposures. 
The observed modulation in toxicity could have significant health implications for 
personal care products, cosmetics and pharmaceuticals intended for use near or within 
the eye. However, the mechanism(s) by which the toxicity of subsequent surfactant 
exposures was modulated remains to be elucidated. 
Whilst standard surfactants are good indicators of the effects following chronic 
exposure, there are pharmaceuticals designed for repeat use in the eye that have been 
associated with long term ocular irritancy, and a discontinuation of use i.e. timolol 
maleate. J-HCET cultures exposed to BSO in vitro confirm that the toxicity of timolol 
to the human corneal cells line was enhanced by suppressing the activity of y-
glutamylcysteine synthetase through irreversible inhibition, resulting in a decrease in 
intracellular glutathione (GSH) levels. In addition, chronic exposures to timolol 
maleate were also associated with an increase in toxicity of subsequent acute 
challenges. The long term use of Timolol maleate in the treatment of glaucoma in vivo 
may result in similar alterations in the intracellular GSH concentrations, resulting in 
discontinuation of treatment as consequence of ocular irritation through the generation 
of reactive oxidation species beyond the threshold that depleted intracellular GSH can 
respond. 
Since in vitro methods have been, and are being developed as alternatives to animal 
experiments, the use of bovine serum as a source of growth factors can seem to be 
contradictory to the purposes of the Three R's concept of Russell and Burch (1959). 
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This study was conducted using culture media that contain animal derived growth 
supplements and a media where these had been substituted for plant derived materials. 
Comparisons were made between the effects these two supplements had upon a number 
of biological factors including morphology, biochemistry, barrier function and the 
response to exogenous chemicals. No alterations were observed in these parameters as 
a consequence of using culture medium containing plant derived materials compared to 
those containing animal derived growth supplements. 
This study has demonstrated that the development of a reliable and reproducible in 
vitro assay in keeping with the principles of the Three R's for modeling chronic - repeat 
ocular irritation is possible. However, the mechanistic relevance of the endpoints 
chosen and cell layer ultrastructure is considered to be an essential component. The 
further development of cell based in vitro systems to predict human responses to 
chronic/repeat ocular irritation is required. 
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Chapter 1 
Introduction 
Introduction 
1.1 The Scientific Procedures Act (1986) and acute toxicity testing 
The need for alternatives to animal experimentation is increasingly recognised 
particularly with the advent of the registration, evaluation and authorization of 
chemicals (REACH) programme (Worth and Balls, 2002a), even though total 
eradication of animal use is not possible at the moment, for example if valuable 
medical research is to continue. The use of animals in scientific procedures is 
regulated by the Animals (Scientific Procedures) Act 1986, which is widely viewed 
as the most rigorous piece of legislation of its type in the world (Van der Valk et al., 
2004). It acknowledges the requirements of European Union Directive 86/6091EEC 
and offers a high level of protection to animals whilst recognising the need to use 
animals in determining chemical safety, human risk assessment, medical research, 
the development of new medicines and "blue skies" scientific research. The Act 
regulates scientific procedures which may cause pain, suffering, distress or lasting 
harm to "protected a n i m a l s " ~ ~ it refers to these as "regulated procedures". "Protected 
animals" are defined in the Act as all living vertebrate animals, except humans, as 
well as one invertebrate species, the common octopus. This Act recognises that 
scientific procedures can only be permitted when the benefits that the work is likely 
to bring (to humans, other animals or the environment) outweigh any pain or distress 
that the animals may experience. The Animal (Scientific Procedures) Act 1986, 
which was a total revision of the 1886 act and was itself amended in 1988, requires 
any persons planning to undertake animal testing to consider alternatives prior to 
beginning their research. Researchers must carry out a thorough search of the 
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relevant literature and report both their findings and the databases used for these 
searches to the Institutional Animal Care and Use Committee (IACUC). If no 
alternatives are available, a personal and project license application must be made to 
the Animal Procedures Committee before animal work will be considered. The 1986 
Act has a three-level licensing system; those carrying out procedures must hold 
personal licences, the programme of work must be authorised in a project licence, 
and work must also normally take place at a designated user establishment. In 
addition to controlling scientific procedures the Act also covers the breeding of 
animals with harmful genetic defects, the breeding of genetically manipulated 
animals, the production of antisera and other blood products and the maintenance of 
tumours and parasites. Of the animals bred for experimental research, one of the 
major consumers is that of the chemical and pharmaceutical industries for 
toxicological studies. The assessment of the in vivo toxicity of products and their 
constituents has conventionally been based on four elements; hazard identification, 
hazard characterisation, exposure assessment and risk characterisation. 
Hazard identification 
The identification of the inherent capacity of a chemical to cause one or more 
adverse effects, without regard to the likelihood or severity of such effects. 
Hazard characterisation 
The (semi-) quantitative evaluation of the nature of the adverse effects following the 
exposure to a chemical, including the assessment of toxic potency (the relative 
toxicity of a chemical) and, where possible, a dose response assessment. 
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Exposure assessment 
The (semi-) quantitative evaluation of the likely exposure of humans and/or the 
environment to a chemical. 
Risk characterisation 
The (semi-) quantitative estimation of the probability that an adverse effect will 
occur, and of its severity and duration in a given population under defined exposure 
conditions, based on the previous three elements. 
The various elements of the risk assessment paradigm encompass a variety of 
experimental activities, animal experimentation, chemical analysis, biomonitoring on 
animals or humans and computer modelling. Animal based studies generally lead to 
observations on the clinical, histological and/or functional changes in the animals 
caused by a single or repeat exposure to a defined dose of the chemical under study. 
The adverse effects can be defined as a change in the morphology, physiology, 
growth, development or life-span of an organism that results in an impairment of its 
functional capacity or ability to compensate for additional stress, or an increased 
susceptibility to the harmful effects of other environmental influences (IPeS, 1978). 
Acute local toxicity studies are performed to determine the local toxic effects that 
may result from a single exposure to a chemical or product, by way of the oral, 
dermal, ocular or inhalation routes. The exposure may be incidental, accidental or 
deliberate (for example, in the case of pharmaceuticals and certain cosmetics). 
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Of the toxic effects this project will concentrate on those related to ocular irritation 
that can result in corrosion. Essentially four different approaches to the evaluation of 
ocular hazard have been adopted, some of which have been used in the international 
regulation of chemical products Kay and Calandra (1962), FHSA (1974), NAS 
(1977), WHMIS (1987), EEC (1992). The classification procedures are similar since 
they all are based on the Draize rabbit eye model and utilize the Draize scoring 
system for ranking ocular responses. 
1.2 The Draize eye irritation test (determination of ocular irritancy in 
vivo) 
Most people do not consider the vulnerability of their eyes. Loss of eyesight can 
happen at work or at home by accidental exposure to products ranging from 
manufacturing solvents to residential cleaners. Yet few people think about how the 
use or misuse of preparations could have life changing effects (Wilhelmus, 2001). 
Ocular toxicology testing developed during the 20th century as the pharmaceutical 
industry grew (Green, 1992) and as their products were found to have effects upon 
the eye. The Draize eye irritation test (Draize test) (Draize et al., 1944) has been 
widely adopted as the "gold standard" to evaluate the potential eye irritation of a 
wide range of chemicals and formulations including pharmaceuticals, cosmetics, and 
their raw ingredients. It was originally conceived to asses the safety of products 
intended to go onto skin (Draize et al., 1944). The Draize test has been applied 
conventionally to investigate the safety of cosmetic and pharmaceutical products and 
their ingredients because it directly represents eye irritation due to chemical insult. 
The assay generates a score that is based on observations of irritant response by the 
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cornea, conjunctiva, lflS and/or nictating membrane after exposure to test 
compounds, including an evaluation or reversibility of injury (table 1.01). 
Table 1.01 : The Draize eye irritation assay scoring system (maximum of 110) for 
ranking responses. 
Ocular Structure 
Cornea 
Iris 
Conju nctivae 
Lids and/or nictating membranes 
Observation 
A No ulceration or opacity 
Scattered or diffuse area of opacity 
Easily discernible translucent area, details of iris slightly obscured 
Nectrotic area, no details of iris visible, size of pupA barely discernible 
Opaque cornea, Iris not discernible through the opacity 
B One Quarter (or less) but not zero 
Greater than one quarter, less than one half 
Greater than one half, less than three quarters 
Greater than three quarters. upto whole area 
Score 
o 
1 
2 
3 
4 
1 
2 
3 
4 
Score· A X B X 5 (range, 0 to 80) 
A Normal 
Iris still reacting to light (sluggish reaction is positive 
No reaction to light, haemorrhage, gross destruction (any or all of these) 
o 
1 
2 
Score • A X 5 (range, 0 to 10) 
A Blood vessels normal 
Some blood vessels definitely hyperaemic Qnjected) 
Diffuse. crimson colour, individual vessels not easily discernible 
Diffuse beefy red 
B Any sweUing above normat 
o 
1 
2 
3 
Obvious swelling with partial eversion of the lids 2 
Swelling with Hds about half closed 3 
Swelling with lids about half closed to completely closed 4 
C Discharge above normal 1 
Discharge with moistening of the lids and hairs just adjacent to the Uds 2 
Discharge with moistening of the lids and considerable area around the eye 3 
Score • (A + B + C) X 2 (range, 0 to 20) 
No swelling 
Any swelling above normal (includes nictating membranes) 
Obvious swelling with partial eversion of lids 
Swelling with Uds about half closed 
Swelling with Uds more than half closed 
o 
1 
2 
3 
4 
The separate scores for each ocular tissue are then weighted, combined and the 
maximum of these average scores is then taken as the modified maximum average 
score (MMAS) which is then used to determine the irritancy potential (table 1.02). 
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For most purposes the MMAS scores between 15 and 50 are the most clinically 
relevant. 
Table 1.02 : Classification of chemicals according to the Draize rabbit eye test 
(adapted from Vi an et al., 1995) 
MMAS 
s 15 
> 15 to s 30 
> 30 to s 50 
> 50 to s 110 
Irritant Potential 
Mild irritant 
Moderate irritant 
Irritant 
Corrosive 
Although an organisation for economic co-operation and development (DEeD) 
guideline exists for the Draize eye irritation assay. The specific protocols for testing 
the ocular toxicity of compounds vary among countries. Testers must ensure that 
flaws in the conduct and analysis are minimal, that sources of bias have been 
considered and controlled, and that adequate precision have been assured by study 
design (Wilhelmus, 2001). Typical components of Draize eye irritation testing are 
listed in table 1.03. Key parameters are; the type and number of model system, the 
dose and duration of exposure, and the spectrum and timing of outcome measures. 
7 
Table 1.03 : Test parameters of the Draize eye irritation assay (adapted from 
Wilhelmus, 2001) 
Albino rabbits (e.g., New Zealand white rabbits) are the usual test species; animals should be acclimated to th 
Animals are evaluated before exposure to ensure normal eyes; cages should be designed to prevent accident 
3 to 6 animals are generally used per test dose, although a single animal may serve as a sentinel before furthl 
One eye (e.g., right eye) is designated to the t e s ~ ~ the contralateral eye serves as a matched control and is USI 
A dose volume of approximately 1001-11 per eye was formally used, but low-volume doses (e.g., 101-11) may be n 
Topical anaesthetics are not usually recommended 
Instillation is made into the lower conjunctiva cul-de-sac; blinking is allowed although the eyelids may be held, 
Sterile saline of balanced salt solution may be used to irrigate the ocular surface 
Pre- and post-exposure evaluation is performed by external observation under proper illumination 
Evaluations are generally made at 1, 24, 48 and 72 hours after exposure, and if necessary at 7 and 21 days 
OCular changes are graded by a scoring system that includes rating any alterations to the eyelids, conjunctiva 
The evaluation of ocular lesions is subjective and susceptible to variability between 
observers and laboratories (Wilhelmus, 2001). The focus of eye irritation testing is 
on assessing observable mucosal and epithelial adverse effects. Systemic toxicity is 
not usually an outcome measure. However, any nonocular reaction resulting from 
drug absorption by the blood vessels and lymphatics of the conjunctiva or 
nasolachrymal outflow system should be noted. Even with this safeguard, there 
remains a considerable risk of overestimation of hazard when utilising the Draize 
test, and this was demonstrated by the early work of Beckley (Beckley, 1965; 
Beckley et al., 1969). They observed that when performed with a liquid detergent, 
the effects of 100J,l1 of the undiluted product in rabbits and humans, the effects in 
rabbit were significantly greater than seen in human volunteers, suggesting that the 
rabbit Draize test does not reflect the eye irritation in humans (Roggeband et al., 
2000). There is an increasing realisation of the limitations of animal models in 
relation to human ocular toxicology, as fundamental differences between species are 
identified (Wilson, 2000; Putnman et al., 2002). For example, the rabbit possesses a 
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nictitating membrane, the primary role of which is to protect the eye against injury 
and further moisturize the cornea (Chan and Hayes, 1994) essentially absent in 
humans. In addition the rabbit demonstrates a thinner cornea, a less effective tear 
film, looser palpebrae, slower blink reflex and a higher pH (8.2 - 8.5) (Chan and 
Hayes, 1994; Kajima et al., 1995; Sina et al., 1995). All of which contribute to a 
generalised increased sensitivity to chemical insult (Swanston, 1993; Chan and 
Hayes, 1994) in the rabbit eye. It can be argued that over sensitivity increases the 
safety margin, and hence is a desirable feature of the in vivo test. 
1.3 Limitations of the Draize test for predicting irritation potential 
Social and scientific criticism (table 1.04) of the Draize test and the reticence to test 
directly on humans, has stimulated researchers to develop in vitro alternatives that 
provide a quantitative and mechanistic evaluation of cellular damage. Given the 
complexity of the mechanisms involved in ocular response to irritants, it is especially 
challenging to develop in vitro models that are predictive of ocular irritation in vivo, 
and meet the validation criteria for in vitro assays (Brantom et al., 1997). 
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Table 1.04 Benefits and limitations of the Draize eye irritation assay (adapted from 
Wilhelmus, 2001). 
Criterta 
Training 
Exposure 
Severity rating 
Observations 
Scoring 
Endpoints 
Statistics 
Advantagn Drawbacks 
Ease of learning and performing the teGt Variable consistency among multiple examiners 
Allows complex mixtures and specific ingredients to be tested at Reflex bUnking, tearing, and other responses may affect results 
various concentrations 
Aids in comparing relative effects of different compounds 
Offers ability to observe h e a ~ n g g and recovery 
Ordered effects are not Unear; range of scores is not unfform for 
different ocular tissues 
Scored components are often limited to visible conjunctival, 
corneal, and iris changes 
Provides overview of the o n s e ~ ~ duration, severity, and resolution Weighting of test components ia a r b ~ r a r y ; ; summary score mask 
of adverse effects of a substance on the eye tissue specific effects 
Aasesses a full complement of toxic and inflammatory responses May fail to detect subtle effects or may find effects (e.g., 
haemorrhage or neovascularisation) not included in scoring 
Enables summary table and graphs Precision of individual scores is not often stated 
Gives good predictive accuracy with few false negatives; Interspacies differences can limit generalizability 
Extemal validity provides protective margin by overestimating human r e a c t i v ~ y y
Data uses Can be incorporated into regulatory requirements Databases listing different compounds are not necessarily comparable 
1.4 Organisations researching in vitro alternatives to the Draize test 
Many organisations are striving to develop and validate alternatives to animal tests. 
The European Centre for the Validation of Alternative Methods (ECV AM) was 
established by the European Commission (EC) with the aim of consolidating 
European efforts towards the development and validation of alternatives. The 
Interagency Co-ordinating Committee on the Validation of Alternative Methods 
(lCCV AM) co-ordinates activities on the validation of alternatives in the United 
States, and the Fund for the Replacement of Animals in Medical Experiments 
(FRAME) implements the Three R's, of Russell and Burch (1959), research strategy 
and encourage realistic consideration of ethical and scientific issues involved in the 
use of laboratory animals, 
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1.5 Reduction, refinement and replacement (The Three R's) 
There is an increasing realisation of the limitations of animal models in relating and 
predicting human adverse reaction and/or toxicology, as fundamental differences 
between species are identified (Wilson, 2000; Putnman et al., 2002). Social and 
scientific criticism of in vivo experimentation is beginning to exert pressure on 
governments to introduce tighter legislation to limit the number of animals used in 
scientific research. One approach that is widely accepted, is the Three R's (Russell 
and Burch, 1959), in their book 'Principles of Humane Experimental Technique' as 
reduction, refinement and replacement. 
• Reduction : the most immediate prospects for improving the current situation 
are to reduce the number of animals used e.g. improved experimental design 
and the use of in vitro pilot studies to assess the need for animal 
experimentation (Russell and Burch 1959). 
• Refinement : amending procedures already in use so that long-term animal 
suffering is minimised (Russell and Burch 1959). 
• Replacement : replacing of animal experiments as and when suitable 
alternatives are developed. Validated according to certain criteria outlined in 
EeV AM reports (Balls et al., 1995; Spielmann et al., 1997; Spielmann et al., 
1998; Spielmann et al., 2000) is now an integral part of acceptance within the 
scientific community and by the regulating bodies involved. 
11 
1.6 Current in vitro alternatives to the Draize eye irritation test 
Before the Draize test can be totally replaced in acute local ocular irritancy testing, in 
vitro assays need to be validated. This involves the establishment of a common 
protocol and a prediction model (required to convert in vitro results into 
measurement of irritancy related to the Draize results or known human effects), and 
to assess their interlaboratory reproducibility. For full validation a multi-laboratory 
trial where coded substances are assessed by the in vitro methods and compared to 
reliable in vivo data to evaluate their suitability for safety assessments is required 
(Balls and Karcher 1995). The alternative methods to the Draize eye irritation test 
comprise organotypic models such as isolated eyes or components thereof (Taliana et 
al., 2001), tissue (Harbell et al., 1991) and cell culture systems (Chiba et al., 1999) 
and physicochemical tests (Naughton et al., 1989). Success in developing and 
validating alternative tests to replace the Draize rabbit eye irritation test has remained 
elusive despite major efforts by the European Centre for the Validation of 
Alternatives (ECV AM), industry trade associations, individual companies and 
academia. Five major validation studies took place between 1991 and 1997. These 
were the ECIHO study (Balls et al., 1995), CTFA study (Gettings et al., 1996), 
COLIP A study (Brantom et al., 1997), IRAG study (Bradlaw et al., 1997) and the 
MHW/JCIA study (Ohno et aI., 1999). These studies focused on a small number of 
alterative methods including; the hen's egg-chorioallantoic membrane method (HET-
CAM) (Leupke, 1985), chorioallantoic membrane-trypan blue staining method 
(CAM-TB) (Hagino et al., 1999), red blood cell haemolysis method (RBC) 
(Okamoto et al., 1990), haemoglobin denaturation method (HD) (Hayashi et al., 
1993), Skin2™ (ZKl100 model) (Harbell et aI., 1991), MATREXTM (Gay et al., 
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1992), CornePack (Torishima et al., 1990), SIRC cells using crystal violet as an 
endpoint of cytotoxicity (SIRC-CVS) (Itagaki et al., 1991), SIRC cells using neutral 
red uptake (SIRC-NRU) (Okamoto et al., 1990), HeLa cells using MTT reduction 
(HeLa-MTT) (Mosmann, 1983), CHL cells using crystal violet staining (CHL-CVS) 
(Ishidate and Odashima, 1977; Gordon and Bergman, 1987), the MDCK cells using 
fluorescein leakage (FLA; Tchao, 1988; Shaw et al., 1990), using a specific set of 
test chemicals, usually cosmetic ingredients as employed by the MHW/JCIA study 
(table 1.05). Draize tests were conducted according to the OECD guidelines using 
the same test substances as were evaluated in the alternative in vitro assays tests 
(Ohno et al., 1999). 
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Table 1.05 : Range of test substances with corresponding Draize data used in the 
multilaboratory validation study (adapted from Ohno et al., 1999). 
Substance Compound Name Class Maximal Average No. Score (MAS) 
1 Isotonic sodium chloride solution 0 
2 Polyoxyethylene hydrogenated castor oil Surfactant (nonionic) 0 
3 Tween 20 Surfactant (non ionic) 0.7 
4 Polyethyleneglycol monolaurate Surfactant (non ionic) 3.3 
5 Sodium N-Iauroyl sacosinaye (30% solution) Surfactant (anionic) 10.3 
6 Sodium hydrogenated tallow-L-glutarnate Surfactant (anionic) 26.7 
7 Sodium dodecyl sulphate Surfactant (anionic) 16 
8 Sodium polyoxyethylene laurylether sulphate (27% solution) Surfactant (anionic) 10 
9 Polyoxyethylene octylphenylether Surfactant (non ionic) 41.3 
10 Benzalkonium chloride Surfactant (cationic) 78 
11 Sucrose fatty acid ester Surfactant (non ionic) 11 
12 Glycerin Polyols 0 
13 Acid Red 92 Colour additives 25 
14 Polyoxyethylene s o r b ~ a n n monooleate Surfactant (nonionic) 0 
15 Calcium thioglycolate Organic saks 4 
16 Oistearyldimethylammonium chloride Surfactant (cationic) NO· 
17 2-Ethylhexyl-p-dirnethylamino benzoate PABA derivatives 0 
18 Cetylpyridinium chloride Surfactant (cationic) NO 
19 Methyl p-hydroxybenzoate Esters NO 
20 Isopropyl rnyristate Esters 0.7 
21 Polyethylene glycol 400 Polyols 0 
22 Silicic anhydride Inorganics NO 
23 Benzyl alcohol Alcohols 23 
24 Sodium salicylate Organic saks 0 
25 rn-Phenylenediamine Amines 4.3 
26 Ethanol Alcohols 0 
27 Monoethanolamine Alkanolamines 23.3 
28 Triethanolamine Alkanolamines 0 
29 Stearyltrimethylammonium chloride Surfactant (cationic) 91.3 
30 Oiisopropanolamine Amines 23 
31 Potassium laurate Surfactant (anionic) 38 
32 Cethyltrimethylammonium bromide Surfactant (cationic) 76.7 
33 Acetic acid Carboxylic acids 68 
34 Butanol Alcohols 34 
35 Chlorhexidine gluconate solution (20% solution) Organic saks 28.3 
36 Domiphen bromide Surfactant (cationic) 96.3 
37 Lactic acid carboxylic acids 9.7 
38 Glycolic acid carboxylic acids 25 
39 Oi(2-ethylhexyl) sodium sulfosuccinate Surfactant (anionic) 57 
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1.6.1 Chorioallantoic membrane (CAM) test 
The Hens egg test-chorioallantoic membrane (HET -CAM) method first described by 
Leupke (1985), has been extensively studied and is considered validated in various 
research facilities (Hagino et al., 1999). This method is designed to examine the 
microscopic changes in the chorioallantoic membrane (CAM), such as hyperaemia, 
haemorrhage and coagulation, following treatment with test substances (Leupke 
1985; Hagino et al., 1999). It has been demonstrated (Hagino et al., 1999) that the 
HET -CAM assay shows a useful correlation between in vitro results and the Draize 
irritation assay. However, Reinhardt et al., (1987) reported that the HET-CAM test 
was not fully predictive for eye irritation. Hagino et al., (1999) concluded that the 
HET -CAM tests may be useful for predicting and evaluating eye irritation despite 
problems of inter-laboratory reproducibility. 
1.6.2 Red blood cell (RBC) haemolysis test 
The standard haemolysis test evaluates membrane injury using erythrocytes as a 
model biological membrane and measures the amount of haemoglobin that leaks 
from the erythrocyte. The Okamoto et al., (1999) concluded that the haemolysis 
method was useful as an alternative to the Draize eye irritation assay for the 
prediction and evaluation of severe (MMAS ~ 5 0 ) ) irritation based on damage to the 
cell membrane (Okamoto et al., 1999). 
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1.6.3 Skin2™ ZK1100 and tissue equivalent assay 
Skin2™ ZKl100 (ZKllOO) and Tissue Equivalent (TEA) assays are human dermal 
models constructed with cultured human cells to model the tissue structure relevant 
to the human eye or dermal tissue (Harbell et al., 1991) evaluated as alternatives to 
the Draize eye irritation assay. Naughton et al., (1989) reported that human dermal 
fibroblasts were grown in a three dimensional nylon mesh matrix. This model is 
referred to as Skin2 ™ ZK 11 00 cultures. Triglia et al., (1991) reported the 
application of another artificial skin model for detecting skin irritation. In contrast to 
the previous model, this model contains co-cultured stratified squamous epithelium 
and stromal fibroblasts, derived from skin and grown on nylon mesh. The stratified 
squamous epithelium is air-interfaced to promote epithelial layering but is non-
cornified. Hence, the cells in the model are cultured in a manner that stimulates 
mucosal epithelium, such as the cornea. This model was referred to as the tissue 
equivalents model during the validation study that concluded that both the ZK 11 00 
and TEA may be developed as valid alternatives to the Draize test (Kurishita et al., 
1999). Kurishita et al., (1999) concluded that both assays have the capacity to 
predict the eye irritation of test substances, however, further analysis would be 
required to define the utility of the ZK 11 00 and TEA assays. When employed with 
cosmetic ingredients (Brantom et al., 1997) in the COLIPAlEU validation study such 
models were considered highly predictive. 
16 
1.6.4 MATREXTM 
MATREXTM is a test system for evaluating eye irritation potential, using the living 
dermal model (LDM). The LDM consists or normal human fibroblast in a contracted 
collagen lattice, which eventually forms a three-dimensional structure (Ohuchi et al., 
1999). Ohuchi et al., (1999) concluded that the MATREXTM assay could be useful 
as part of a battery of tests in predicting the eye irritation potential of exogenous 
compounds. 
1.6.5 CornePack 
The cytotoxicity test of neutral red uptake (NRU) in normal rabbit corneal epithelial 
cells (CornePack) was evaluated as a potential alternative method to the Draize 
rabbit eye irritation test. Uchiyama et al., (1999) demonstrated several characteristic 
limitations of the CornePack assay. Although CornePack appears to be useful for the 
preliminary screening for cytotoxicity of substances due to its high sensitivity and 
ease of operation, Uchiyama et al., (1999) concluded this technique demonstrated 
difficulties in evaluating substances such as anionic detergents, acids, alkanolamines 
or alcohols. 
1.6.6 Rabbit cornea (SIRC) cell cytotoxicity 
Two common assays, the neutral red uptake assay (SIRC-NRU) and the crystal violet 
staining assay (SIRC-CVS), were evaluated by Tani et al., (1999) as an alternative to 
the Draize eye irritation assay. Tani et al., (1999) concluded: the intra- and 
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interlaboratory reproducibility of the SIRC-NRU/CVS method was relatively good 
for most test substances including dyes and water-insoluble substances; the results of 
the study demonstrated a good correlation with in vivo results; accurate evaluation of 
strong acids, alkanolamines and alcohols is difficult; SIRC-NRU and SIRC-CVS 
show similar efficacy in predicting irritancy potential. 
1.S.7 Cervical epitheloid carcinoma (HeLa) cell cytotoxicity 
The cytotoxicity test usmg the MTT (3-( 4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay on HeLa cells (MTT-HeLa) demonstrated 
several limitations, particularly for acids, amines and alcohol. However, overall the 
results of MTT -HeLa showed good reproducibility and strong correlation with in 
vivo data (Chiba et al., 1999). 
1.S.8 Chinese hamster lung (CHL) cell cytotoxicity 
The CHL cell line cell toxicity test employs crystal violet staining as a measurement 
of cell toxicity. Among the cells used in this validation study, SIRC cells were the 
only established cell line derived from rabbit corneal cells (Ohno et al., 1999). Tani 
et al., (1999) indicated that the SIRC cell method did not show any significant 
differences from methods employing other cell types e.g. HeLa (Chiba et al., 1999) 
or CHL (Okumura et al., 1999). The validation study concluded that cytotoxicity 
tests utilising CHL gave almost the same results as those using the other cell types 
(Ohno et al., 1999). Okumura et al., (1999) reported that although the assay could 
18 
accurately predict the toxicity of exogenous irritants, definitive criteria were required 
to establish the compounds that could be applied to the model. 
1.6.9 Fluorescein leakage assay 
The method employed was based upon that of Tchao (l988). The loss of trans-
epithelial impermeability of a confluent layer of MDCK cells was measured 
following a 1 minute exposure to the test chemical. One of the greatest difficulties 
was the removal of viscous, non-toxic chemicals due to the problems associated with 
their removal following the exposure period (Balls et al., 1995). In addition Balls et 
al., (1995) reported a number of limitations with the fluorescein leakage assay, 
including; only materials which are in solution or suspension may be tested, 
incompatibilities between test chemicals and the insert material resulting in leakage 
due to insert damage rather effects on the MOCK monolayer (Balls et al., 1995) and 
chemical interaction with the insert membrane prolonging exposure times (Ward et 
al., 1997a). Although the COLIP AlEU validation study evaluated the performance 
of the fluorescein leakage assay and demonstrated good interlaboratory 
reproducibility between the laboratories and a reasonable statistical fit within its 
prediction model, there was insufficient data to assess its reliability (Brantom et al., 
1997). 
1.7 Limitations of in vitro alternatives to the Draize test 
Generally the accuracy of an in vitro model is assessed by identifying a number of 
materials that have previously been tested for irritation in vivo and then retesting the 
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same materials in an in vitro assay (Eun and Suh, 2000). Data is conventionally 
analyzed by plotting the in vitro data on one axis and the animal data on the other. 
The mathematical relationship between the in vitro and in vivo scores, i.e., the 
algorithm that allows one to predict an in vivo score from an in vitro score, is then 
used to generate the prediction model, i.e. how the in vitro results from a new 
material could be used to derive a Draize equivalent score. The Draize eye irritation 
test, does demonstrates a high degree of variation for individual test compounds 
across multiple laboratories (figure 1.01). This affects the ability of an in vitro assay 
to correlate with in vivo data. None of the assays (HET-CAM, CAM-TB, RBC, HO, 
Skin2TM (ZKllOO model), MATREXTM, CornePack, SIRC-CVS, HeLa-MTT or 
CHL-CVS) of the MHW/JCIA study were found capable of replacing the Draize test, 
but some of the assays demonstrated considerable promise as screens for ocular 
irritancy. In the COLIPAlEU study the conclusion was that the 3D skin model and 
the fluorescein leakage were worthy of further investigation and refinement, whilst 
there were reservations about the other tests included (Brantom et al., 1997). The 
main reason for this is the difficulty of comparing in vitro test results with historical 
animal data where the subjective scoring of tissue lesions in the eye in the Draize test 
provides variable estimates of eye irritancy. 
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Figure 1.01 : Representation of the mean±S.D of the most reliable Draize eye 
irritation MMAS scores of the 60 chemicals used in the ECIHO validation trial 
(adapted from Balls et al., 1995). 
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Other possible contributing reasons for the failure of recently completed validation 
studies are: a) the in vitro tests only partially modelled the complex in vivo eye 
irritation response, b) the protocols were insufficiently developed, and c) the choice 
of statistical approaches for analysing the data was not appropriate (Balls et al. , 
1999). It was clear that the use of a cell line to model basal cell toxicity could 
accurately predict the more potent eye irritancy verging on corrosion (MMAS 80 -
120), in that this cell death is the endpoint regardless of compounds or chemicals. 
Several techniques to replace the Draize eye test in the mild to moderate band 
(MMAS 0 - 30) relying on the use of cells that express tight junctions and control of 
paracellular penetration pathways (e.g. the Madin-Derby canine kidney (MDCK) or 
corneal epithelial cells) and including specific non-lethal endpoint assays (e.g. 
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fluorescein leakage alone or including the resazurin reduction or neutral red uptake 
assays) to evaluate both the functionality and activity/viability of these cells 
subsequent to chemical exposure (Hubbard et al., 1994; Clothier and Samson, 1996; 
Grant and Acosta, 1996; Kruszewski et al., 1997; Clothier et al., 1999; Clothier et 
al., 2000). Whilst the major application of in vitro cultures is the analysis of acute 
toxicity, the existence of adequate culture systems would also improve the prospects 
of chronic toxicity testing (Wilson, 2000). Yet when this reductionist monolayer 
system is exposed to cosmetic formulations with known irritancy, assays such as the 
resazurin reduction and fluorescein leakage enabled them to be ranked in the order of 
their irritancy (Hubbard et al., 1994; Clothier et al., 2000). Though not formally 
validated, the usefulness of these in vitro methods is well established within some 
national regulatory agencies and within industry for specific and limited purposes 
(Cottin and Zanvit, 1999; Worth and Balls, 2002b). Confidence for such in-house 
use of some of the currently available in vitro methods is dependent on the 
availability of appropriate benchmark chemicals, historical information on similar 
materials, an understanding of the limitations of the assay(s) and the technical 
expertise of the user. In addition this historical information for cosmetic companies 
is based on human experience of the action of formulations or the relating of human 
skin irritancy with chemicals to predict levels that can be incorporated into cosmetic 
formulations that may encroach the eye. For these reasons, such use of in vitro 
methods is often company-specific, e.g. L'Oreal and Boots Plc have now 
incorporated the fluorescein leakage assay into their pre-clinical safety assessments 
(Cottin and Zanvit 1997; Zanvit et al., 1999). The rationale for pursuing the 
development of a human ocular based in vitro alternatives is to provide greater 
confidence in the prediction of human reactions to mild and moderate chemicals and 
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formulations, in particular with respect to babies and those with "sensitivities" to 
certain ingredients. In addition to provide a species specific model it is desirable that 
these assays afford the potential to express mechanistically relevant responses that 
can be used for predicting human ocular toxicity and recovery potential. These 
objectives address the recently stated needs for mechanism-based (Balls and 
Clothier, 1992; Frazier, 1994; Technical Committee on Alternatives to Animal 
Testing, ILSI, 1996) and human cell-based tests (Kruszewski et al., 1995) for 
supporting in vitro toxicology and human risk assessment. 
1.8 Chronic repeat exposure in vitro 
The development of alternatives to the use of animals for toxicity testing have mainly 
focused upon developing in vitro tests for quantitative measurement of acute local 
toxicity (Fentem and Balls, 1992) following a single high-dose exposure (ECIHO 
(Balls et al., 1995), CTFA (Gettings et al., 1996), COLIPAlEU (Brantom et al., 
1997), IRAG (Bradlaw et al., 1997), MHW/JCIA (Ohno et al., 1999». A substantial 
proportion of the studies have been carried out using undifferentiated secondary cell 
lines grown in a monolayer in flask culture. In these cases, a range of general and 
some specific indicators of toxic effects can be measured (Hanley et al., 1999). 
While cell culture cannot adequately mimic whole body responses to toxin challenge, 
there are a number of advantages with such approaches including ease of use, cost, 
the numbers of experiments which are feasible, the range of ~ o n c e n t r a t i o n s s that can 
be tested and complexity of the test substances (Soto et al., 1998). The degree of 
toxicity of any exposure is a function of; the dose which target cells receive, the 
duration of the exposure and the ability of the exposed cells to recover from the 
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exposure (Combes, 1999). However, little account is taken of the potential role of 
long-term effects in modulating the toxic response (Combes, 1999). Thus, it would 
seem logical to develop in vitro chronic exposure assays that will allow the 
monitoring of changing responses during the exposure period, and which also permit 
the measurement of recovery levels. Repeat dosing to obtain chronic exposures can 
lead to increased resistance to toxicity due to induction of repair processes and 
detoxification enzymes, as well as saturation of intracellular targets (Soto et al., 
1998; Combes, 1999). On the other hand, decreased resistance could result as a 
consequence of the induction of activating thereby increasing the concentration of 
reactive chemical species at target sites (Soto et al., 1998; Combes, 1999). 
Numerous chemicals exert toxic effects, at concentrations that in an acute assay 
would be non-cytotoxic, following chronic low-dose treatments. There are several 
different ways in which humans are exposed chronically or repeatedly e.g. dietary 
intake of foodstuffs and washing formulations, as well as splashings in the eye, 
involve exposing populations of cells, which could be in different stages of recovery 
from earlier responses (Combes, 1999). 
1.9 Development of chronic exposure models 
The limited published data on in vitro chronic toxicity models is mainly due to 
technical problems which must be overcome to develop such systems, including; 
effects on cell maintenance (e.g. trypsinisation, detachment from supporting matrix, 
reattachment, stabilization and regrowth (Hanley et al., 1999», attachment matrix, 
culture senescence and non-lethal cytotoxicity assays (Combes, 1999). Several 
advances have been made in protocols for studying cellular recovery from toxic 
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injury, and also for long-term culturing and repeat dosing. These advances include; 
the availability of improved methods for culturing and exposing cells, such as 
synthetic porous membranes (Combes, 1999) and the development of both non-lethal 
viability and function assays e.g. resazurin reduction and fluorescein leakage assays 
respectively (Clothier and Samson, 1996; Clothier et aI., 1999). Other important 
advances include better methods for retention of cell differentiation status and 
stability in culture to enhance longevity, delaying culture senescence using 
continuous and immortalized cell lines, by applying different culture conditions 
(MacDonald, 1993; Tateno and Yoshizato, 1996; Barile, 1997). ECV AM reviewed 
the use of long term toxicity methods in a report (Balls et al., 1999). Many of the 
problems associated with chronic toxicity modelling of epithelial barriers in vitro 
were addressed by the study of Clothier and Samson (1996) using a continuous cell 
line that expressed tight junctions grown on a synthetic porous membrane. It is also 
important that epithelial cells, with an inherent polarity express this in vitro. The 
advantage of the porous membrane is that they facilitate topical or systemic 
application of a variety of test materials for toxicity studies, since the epithelial cells 
have distinct basal and apical compartments. The use of membrane inserts 
effectively provides a means whereby the culture system can be divided into an 
upper and lower compartment that can mimic topical or systems exposure. 
Employing assays using non-cytotoxic endpoints, effects at times before and after 
initiation of treatment can be monitored (e.g. combined fluorescein leakage-
resazurin reduction assay), and repeat exposure of the cells to fresh test material can 
be undertaken (Clothier and Samson 1996; Combes, 1999). Using such a model 
Clothier and Samson (1996) observed that repeat treatment of monolayer cultures of 
MDCK cells, with surfactants lead to cumulative, dose dependent effects on barrier 
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function that was related to effects on zona-occulden adhesion molecules lost and 
restitution. However, the study of Clothier and Samson (1996) was restricted to 
measuring the effects on MDCK viability and barrier function of an acute 1 minute 
exposure with subsequent measurements made over 96 hours to ascertain recovery. 
In vitro chronic exposure assays need to be designed with the ability to monitor 
changing responses during the exposure period. Techniques should be adaptable, 
since the mechanisms of toxicity could change with the dose, cell target and number 
of exposures (Clothier et al., 1997). Assays could adopt different treatment 
regimens, for example ranging from daily re-exposure for a fixed time, as is adopted 
in vivo with human patch testing of cosmetics, to repeat exposure once recovery has 
occurred from the previous insult as described for the evaluation of repeat exposure 
to mild surfactants (Clothier and Samson, 1996). It is also important to relate what 
happens in vivo in terms of the initial and recovery effects to those in vitro 
mechanisms. Thus knowledge of the structure of the human eye is important as it 
does differ from the rabbit eye. 
1.10 Anatomical structure of the human eye 
The eye is a highly specialised organ of photoreception, a process which involves the 
conversion of different quanta of light energy into nerve action potentials. The adult 
human eyeball measures approximately 2.5cm in diameter and of its total surface 
area, only the anterior one-sixth is exposed, the remainder is recessed and is 
protected by the orbit into which it fits. Anatomically, the wall of the eyeball can be 
divided into three distinct layers: vascular tunic, retina tunic and fibrous tunic 
(Totora and Grabowski 1996) (figure 1.02). The fibrous tunic is the superficial coat 
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of the eyeball. It consists of the anterior cornea and posterior sclera. The cornea is 
an avascular, transparent coat that is separated from the coloured iris by the anterior 
chamber. Its outer surface consists of nonkeratinised stratified squamous epithelium. 
The middle coat of the cornea consists of collagen fibres and fibroblasts, and the 
inner surface is simple squamous epithelium (Totora and Grabowski, 1996). 
Figure 1.02 : Representation of the right eye demonstrating the relationship between 
the sclera, choroid and retina with enlargement demonstrating the layers of the 
corneal epithelium. 
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1.10.1 The cornea 
The cornea is comprised of five layers: the multilayered epithelium, Bowmans layer, 
the thick stroma consisting of keratinocytes and orthogonally arranged collagen 
lamellae, Descemets membrane, and the endothelium. The corneal epithelium has 5-
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8 layers of cells continuous with the bulbar (ocular) conjunctiva and is 7 0 ~ m m thick 
(figure 1.02). The basal layer secretes an irregular basal lamina to which it attaches 
by hemidesmosomes. Basal layer integrity is essential for re-epithelialisation after 
corneal damage (Klyce and Beuerman, 1988). The periphery of the basal layer is 
attached to a thicker basal lamina by basal villi, and is more mitotically active than 
the rest of the epithelium (Fone and Yanoff, 1972). Epithelial cells in the cornea are 
continuously in motion (Ladage et al., 2002) in two principle directions: centripetal 
and vertical. It has been demonstrated (Auran et al., 1995; Ladage et al., 2002) 
under normal conditions basal cells migrate centripetally at a speed of 1.7 to 3 2 ~ m m a 
day. In contrast, vertical movement occurs when basal cells leave the basal lamina 
and move toward the surface of the corneal epithelium. The cells then move 
anterioriy into the winged cell layers, where their metabolism decreases. The cells 
flatten and there is an increase in keratin and tonofibrils (figure 1.03). 
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Figure 1.03 : Schematic representation of the adhesion complex of human corneal 
epithelium (adapted from Zagon et al., 2001). 
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The corneal epithelium provides the eye with a smooth wettable anterior surface 
covered by the tear film (Sugrue and Zieske, 1997). This in part is achieved through 
the actions of the lachrymal apparatus producing the tear film . 
1.10.2 The tear film and the lachrymal apparatus 
When a foreign substance enters the eye from the external environment, it will first 
reach the pre-corneal tear film. This thin film covers the conjunctiva and cornea and 
has many vital functions. It corrects faults in the cornea to provide a smooth 
refractive surface and acts as a lubricant to reduce friction during eye movements and 
blinking. It also holds some oxygen and nutritional molecules for the cornea, has an 
antibacterial action and helps flush out surface debris. Immediately after blinking, 
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the tear film is around 91lm thick, this reduces to a minimum of 41lm after around 30 
seconds, after which the film will break up unless a blink occurs. Blinking normally 
occurs about 15-20 times a minute in humans, with tears draining away, via the 
lachrymal duct into the nose. Blinking also assists in the renewal of the tear film 
from the lachrymal gland. Ineffective or reduced blinking causes delayed tear 
clearance, which may lead to ocular irritation. This is especially true of certain 
topical medications, designed to adhere to the epithelium, giving a longer transit time 
on the corneal epithelium. The tear film is composed of three layers; an outer lipid 
layer (produced by the meibomian gland), a middle aqueous layer (produced by the 
lachrymal apparatus) and a deeper mucin layer (secreted by goblet cells). The 
lachrymal apparatus is a group of structures that produces and drains lachrymal fluid 
(pH 7.4), which drains into 6-12 excretory lachrymal ducts that empty fluid onto the 
surface of the conjunctiva of the upper eyelid. From here the fluid passes medially 
over the anterior surface of the eyeball to enter the lachrymal puncta. Tears then 
pass into two ducts, the lachrymal canals, which lead into the nasolachrymal sac and 
then into the nasolachrymal duct. Lachrymal fluid is a watery solution containing 
salts, some mucus, and a bactericidal enzyme called lysozyme. The fluid cleans, 
lubricates, and moistens the eyeball. Normally tears are cleared away as fast as they 
are produced by evaporation or by passing into the lachrymal canals and 
subsequently into the navel cavity. If an irritating substance contacts the 
conjunctiva, however, the lachrymal glands are stimulated to oversecrete and fluid 
can accumulate, leading the eyes to "water". This is a protective mechanism, since 
tears dilute and wash away the irritating substance. The lachrymal gland secretion 
rate is partly controlled by its parasympathetic and sensory innervation. The space 
behind the cornea and surrounding the lens is filled with a clear fluid called the 
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aqueous humor which supplies the lens and cornea with nutrients. This fluid is 
secreted by the processes of the ciliary body which is a component of the vascular 
tunic. Although the aqueous humor is isotonic with the blood, it is not a simple 
ultrafiltrate of plasma as it is relatively rich in bicarbonate. Moreover, inhibitors of 
the enzyme carbonic anhydrase decrease its rate of production. The aqueous humor 
drains through a fibrous mesh situated at the junction between the cornea and the 
sclera into the canal of Schlemm and from there into the venous blood. The pressure 
within the eyeball is about 2kPa (lSmmHg). This is known as the intraocular 
pressure and it serves to maintain the rigidity of the eye, which is essential for 
keeping the focal plane and distance constant for sharp image formation. This 
pressure is sustained by keeping the balance between production and drainage of 
aqueous humor constant. If the drainage is obstructed, the pressure rises and a 
condition known as glaucoma results. In glaucoma, the retinal circulation can 
become occluded, leading to retinal damage and defective vision. In glaucoma, the 
excessive production of aqueous humor cannot be vented through the front of the eye 
due to the histological structure of the cornea. The cornea acts as a barrier to the 
outflow of water from the interior of the eye and the passage of pathogens into the 
internal structures of the eye, via tightly adherence of the cells to one another as well 
as the underlying matrix. 
1.10.3 Barrier function of the human cornea 
In order to accomplish their barrier functions, epithelial must demonstrate a 
structural and functional polarity characterised by a distinctive organisation of the 
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cytoskeleton and by an asymmetric distribution of the membrane protein between the 
apical and basolateral domains (Chifflet et al., 2004). 
Figure 1.04: Schematic illustration of intercellular junctions found in various tissue 
of the body (adapted from Suzuki et al., 2003). 
c-AMP, cyclic adenosine monophosphate; Cid, claudin; Oc, occludin; 20-1 and 20-2, zonula 
occludens-l and -2; 7H6, 7H6 antigen; AF, actin filament ; Dsg, desmoglein; Dsc, desmocollin; DP, 
desmoplakin; PG, plakoglobin; KF, keratin filament. 
During morphogenesis, mechanical forces generated by the dynamic rearrangements 
of cell-cell contacts and the cytoskeleton modulate changes in cell shape and motility 
(Jamora and Fuch, 2002). Cell contraction is directly associated with 
phosphorylation of myosin light chains (MLC) by the calcium/calmodulin (CaM)-
dependent myosin light chain kinases (MLCK) (Garcia et al., 1995). MLCK 
activation which modify the fibrous actin (f-actin) cytoskeleton have been shown to 
be strongly linked to permeability increase (Haselton 1992; Yu and Gotlieb, 1992; 
Garcia et al., 1995). Transmembrane members of the cadherin superfamily of 
intercellular adhesion proteins have a pivotal function in these processes. E-cadherin 
forms cell-cell contacts through homotypic interactions, which results in the 
formation of stable junctions. The extracellular domains ofE-Cadherin dimerise and 
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cluster in a calcium-dependent manner, triggering an association of the cytoplasmic 
tails of cadherin to the actin cytoskeleton network (Jamora and Fuch, 2002). The 
recruitment of 0.- and ~ - c a t e n i n n is required for this cytoskeleton linkage, which in 
turn is essential for the stabilization and formation of E-cadherin-mediated cell-cell 
junctions referred to as adherens junctions (AJ's) (Yap et al., 1997; Jamora and 
Fuch, 2002). This interaction with the actin cytoskeleton initiates a complex cascade 
of signalling events that lead to the formation of tight junctions (TJ's) (figure 1.04) 
and the acquisition of the polarized cell phenotype (Jamora and Fuchs, 2002; Chimet 
et al., 2004). Multicellular organisms contain various composition ally distinct fluid 
compartments, which are established by epithelial and endothelial cell sheets 
(Tsukita and Furuse, 1999). For example, the corneal epithelium functions as a 
barrier that isolates the eye from the outside environment (Ban et al., 2003). For 
these cell sheets to function as barriers maintaining the distinct internal environment 
of each compartment the paracellular pathway between adjacent cells in the sheet 
must be tightly sealed or controlled to prevent the unwanted diffusion of solute and 
solvents, whilst the apical and basolateral domains must be differentiated to allow 
active transport across the confluent sheet of selected materials (Tsukita and Furuse, 
1999). Tight junctions are directly involved in paracellular sealing (barrier function) 
providing a continuous seal around the apical aspect of adjoining epithelial cells, 
thereby, preventing the free passage of molecules between adjacent epithelial cells 
(paracellular pathway). Recent studies reveal that the TJ complex includes two 
integral transmembrane proteins: claudin; and occludin and membrane associated 
proteins such as zonula occludins-l (ZO-I), ZO-2 and ZO-3 (Tsukita et al., 2001). 
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1.10.3.1 Zonula Occludins 1 (ZO-1) 
ZO-1 with a molecular mass of 220kDa (Stevenson et al., 1986; Lapierre 2000) was 
one of the first proteins identified and localized to the TJ where in conjunction with 
ZO-2, -3 (Lapierre 2000) acts as a scaffolding or plaque protein responsible for 
connecting the proteins occludin and the claudins to the f-actin cytoskeleton (figure 
1.04) (Citi, 1993; Anderson, 2001). The f-actin cytoskeleton is a highly dynamic 
network, changing structure during the cell cycle and in response to extra- and 
intracellular signals (Hall, 1994). It has been demonstrated (Sugrue and Zieske, 
1997) that the expression and localization to the interior surface of the plasma 
membrane of ZO-1 is largely influenced by calcium dependent interactions with the 
cytoskeleton. There is accumulating evidence that some unique proteins constitute 
TJ's. Collectively these membrane associated proteins are thought to interconnect 
the tight junction to the sub membraneous cytoskeleton network (Stevenson et al., 
1986; Anderson et al., 1993; Citi, 1993; Tsukita and Furuse, 1999). In now appears 
that ZO-l is a ubiquitous component of the tight junction in all epithelia and 
endothelia (Sugrue and Zieske, 1996) interacting with occludin (Stevenson et al., 
1986; Citi, 1993; Tsukita and Furuse, 1999) an integral membrane protein involved 
in the permeability barrier function of the tight junction. However, it has been 
shown that ZO-1 may be found at non-tight junctional locations (Schnabel et al., 
1990; Howarth et al., 1992; Miragall et al., 1994) leading to the unfortunate 
misinterpretation that the presence of ZO-1 immunoreactivity equates to the presence 
of tight junctions (Sugrue and Zieske, 1996). 
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1.10.3.2 Occludin 
Occludin was the first transmembrane protein of tight junctions to be identified 
(Furuse et al., 1993; Balda and Matter 2000). Occludin is a 60 - 65kDa protein with 
four transmembrane domains (Furuse et al., 1993; Balda and Matter 2000; Ban et al., 
2003) with both N- and C- termini oriented into the cytoplasm (Balda and Matter 
2000). Occludin appears to be the most important and relatively well characterized 
transmembrane protein of the tight junction (Kale et al., 2003) with the C-terminal 
interacting in vitro with several intracellular scaffolding proteins including ZO-I, 
ZO-2, ZO-3 (Furuse et al., 1993; Balda and Matter 2000; Ban et al., 2003) and f-
actin (Goodenough, 1999; Wittchen et al., 1999). To date there have been no 
reports of occludin isoforms - that is occludin-related genes - although two forms of 
occludin are generated by alternate splicing (Morita et al., 1999; Tsukita and Furuse, 
1999). The level of occludin expression in various cell types correlates well with the 
number of tight junction strands (Saitou et al., 1997; Tsukita and Furuse, 1999). 
1.10.3.3 Claudin-1 
Claudins, 23kDa integral membrane proteins bearing four transmembrane domains, 
have been identified as components of TJ strands (Furuse et al., 1998; Tsukita and 
Furuse, 2002), and to be directly involved in intercellular sealing in simple epithelia 
(Balda and Matter, 2000; Anderson 2001; Tsukita et al., 2001; Furuse et al., 2002; 
Ban et al., 2003). Claudin-l and -2 were originally identified because they 
cofractionated with occludin from sonicated fractions (Furuse et al., 1998). There is 
no evidence for a distinct interaction between occludin and claudin (Balda and 
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Matter, 2000), and claudins do not copurify with occludin from detergent solubilised 
membranes (Balda and Matter, 2000). At least 24 members of the claudin family 
have been identified (Furuse et al., 1998; Gow et al., 1999; Tsukita and Furuse, 
2002). In contrast to occludin, individual claudins are generally expressed in only a 
restricted number of specific cell types, suggesting that they are associated with 
tissue-specific functions of tight junctions (Balda and Matter, 2000) but the level of 
claudin expression does not correlate with the number of tight junction strands 
(Saitou et al., 1997; Tsukita and Furuse, 1999). Besides their membrane topology, 
different claudin members share other structural features, suggested by the 
observation that eight different claudins can bind to the three submembrane proteins 
ZO-l, ZO-2 and ZO-3 by interaction involving the claudins C-terminal cytosolic 
domain and the PDZ domain of the sub membrane plaque proteins (Simon, 1999). 
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Figure 1.05 : Interactions between molecular components of the tight and adherens 
junctions. 
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1.1 0.4 Innervation of the cornea in repair mechanism 
The cornea is one of the most densely innervated tissues in the body and is richly 
supplied with sensory and autonomic nerve fibres (Muller et al., 2003). The subject 
of corneal innervation has taken heightened importance in recent years due to the 
observation that corneal nerves are routinely injured following modern refractive 
surgical diseases or following certain corneal diseases (Muller et al., 2003). This 
damage can lead to transient or chronic neurotrophic deficits. In addition, in the past 
several years neuropeptides synthesised by corneal nerve fibres have been used 
successfully to promote corneal wound healing of corneas resistant to conventional 
therapy (Muller et al., 2003). Despite the numerous studies published in recent years 
that have indicated that cytokines, growth factors, and neuropeptides can influence 
epithelial proliferation and differentiation in vitro (Lambiase et al., 2000), a precise 
therapeutic approach to modulate the healing process has not yet been identified. 
1.10.5 The corneal endothelium and wound healing 
The corneal endothelium, a monolayer of cells at the posterior side of the cornea, is 
crucial for maintaining the transparency of the cornea. It consists of a single layer of 
cells forming a boundary between the corneal stroma and the anterior chamber 
(Joyce, 2003). It regulates the ion composition of the whole cornea, permitting 
optimal hydration of the cornea, and thus constant thickness and transparency. 
Consequently a disturbance of endothelial functions can provoke cornea oedema 
followed by partial or complete loss of transparency (Hoppenreijs et al., 1996). 
Apart from loss of endothelial cells during aging, other factors such as contact lens 
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wear, ultraviolet radiation, accidental trauma (physical and chemical), inflammation 
or dystrophy (Doughty, 1989; Nucci et al., 1990; Williams et al., 1992) can lead to a 
decrease in endothelial cell density and to an abnormal cell mosaic which can 
compromise the functional integrity of the endothelial monolayer (Hoppenreijs et al., 
1996). Many cellular events occur during corneal wound healing to ensure that the 
tissue can resume its normal function of light refraction (Taliana et al., 2001). When 
both the epithelium and the underlying stroma are wounded, epithelial cells and 
corneal fibroblasts (CF's) are directly involved in the repair process (Taliana et al., 
2002; Joyce 2003). In the wounded stromal tissue CF's are activated and transform 
the into myofibroblast (MF) phenotype (Taliana et al., 2001) to effect wound closure 
by contraction of the stroma under repair. In severe injury, if the endothelial cell 
layer is penetrated or damaged the clinical outcome may be in doubt. Both cell 
proliferation and migration contribute to the formation of the endothelium from 
neural crest-derived mesenchymal cells (Joyce, 2003). There is evidence to indicate 
that once the mature endothelial monolayer has formed, proliferation ceases and cells 
remain non-replicative throughout the normal lifespan (Taliana et al., 2001; Joyce, 
2003) and recovery from damage is achieved through cell enlargement and migration 
rather than division (figure 1.06). 
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Figure 1.06 : Endothelial cell enlargement and migration as a response to severe 
injury to the primate corneal endothelium. 
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During the first stage of wound healing, drastic changes in morphometric parameters 
of corneal endothelial cells take place: pleomorphism (variation in cell shape) and 
polymegethism (variation in cell size). After initial coverage of the wound areas, a 
period of cell transformation and rearrangement occurs (Hoppenreijs et al .. 1996). 
Cell transformation continues to take place for many years after recovery from a 
wound area damaged during surgery such as keratoplasty or lens extraction 
(Mishima, 1982). In other species such as rodents and rabbits, the wounded corneal 
endothelium is regenerated by cell replication in addition to enlargement and 
migration (Hoppenreijs et al. , 1996). Due to the tremendous regenerative capacity in 
these species, the endothelial layer is restored almost to its normal state (Landshman 
et al. , 1988; Ling et al., 1988). However, the low mitotic capacity of the primate 
corneal endothelium precludes complete regeneration of the endothelial layer after 
surgical intervention or trauma (Haung et al., 1989; Hoppenreijs et al., 1994). 
40 
1.11 Selection of a specific cell type for an in vitro model 
The selection of a cell line for in vitro toxicity testing depends upon a number of 
important considerations; does the cell line display the correct phenotype, i.e. barrier 
function studies must utilise cell line that express functional tight junctions, can the 
cell line be cultured under the required environmental conditions, e.g. does the cell 
adhere to synthetic supporting matrices, and is there a readily available supply of 
cells for high throughput screens, e.g. continuous cell line or a reliable source of 
primary human cells. To replace the Draize eye test an in vitro system must include 
a model of the barrier function of the corneal epithelium. A widely utilized rabbit 
corneal cell line, SIRC (Statens Seruminstitut rabbit cornea cells), was characterized 
ultrastructurally and immunohistologically (Niederkorn et al., 1990). SIRC cells 
lack desmosomes, cytoplasmic filaments, and cytokeratin-structures that are 
characteristic of human corneal epithelial cells. By contrast, the dendritic 
morphology, presence of vimentin, and the extensive dense accumulations of 
ribosomes and rough endoplasmic reticulum are consistent with a fibroblastic 
phenotype. Although SIRC cells are often described as being of epithelial origin 
collectively, the morphology, ultrastructural features, and antigenic composition 
favour the hypothesis that SIRC cells are fibroblastic cells (keratocytes) and not 
corneal epithelial cells (Niederkorn et al., 1990). In contrast Madin-Derby canine 
kidney (MOCK) cells grown to confluency as a monolayer have been used in vitro to 
model epithelial barrier function (e.g. Tchao, 1988; Shaw et al., 1990; Hubbard et 
al., 1994; Zanvit et al., 1999) in conjunction with the combined fluorescein leakage-
resazurin reduction assay (Clothier and Samson, 1996). 
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One problem with the in vitro alternatives to the Draize test is that many do not 
reflect the multi layer nature of the corneal epithelium in both humans and animals 
(Clothier et al., 2000). The extent to which this precise nature of the barrier in the 
human corneal epithelial layer is required in vitro is not yet fully defined, but a true 
physiological model should be multilayered as is the in vivo cornea. Two continuous 
corneal cells lines, the Japanese human corneal epithelium (J-HCET) cells and 
Gillette human corneal epithelial cells (HCE-T) can grow and form a four- to six-
layer epithelium permeable supports given the correct stimulus (Kahn et al., 1993; 
Kruszewski et al., 1995; Ward et al., 1997b; Clothier et al., 2000) allowing for the 
development of both a monolayer and three dimensional (3D) model of the human 
cornea in vitro. The HCE-T or J-HCET cell line are considered as the preferred basis 
of an in vitro corneal model. However, it is essential to ensure that the phenotype of 
a transformed corneal cell line remains unaltered, and whilst the HCE-T cell line is 
stable to passage 20, the J-HCET is considerably more stable up to 100 passages 
(Araki-Sasaki et al., 1995) and has been genetically typed by LGC for the FRAME 
laboratory. 
1.11.1 Transfected human corneal epithelial cells 
Many protocols exist for the isolation and limited in vitro propagation of primary 
mammalian cells, including those of the corneal origin (Baum et al., 1979; Kahn et 
al., 1993; Engelmann and Friedl 1989; Araki-Sasaki et ai, 1995; Bednarz et al., 
1998). Primary cultures of human corneal epithelial cells, especially from adult 
donors undergo upto 20 cumulative population doublings before entering senescence 
(figure 1.07). Furthermore, the characteristic morphology is often lost during 
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prolonged culturing (Albert et al. , 1972; Turksen et al. , 1989; Engelmann and 
Bohnke, 1990) when a cell line becomes transformed. The limited volume of 
material and the variability between cell cultures from different donor eyes makes it 
very difficult to perform routine biochemical and physiological investigations on 
primary human corneal epithelial cells (Bednarz et al. , 2000). To overcome this 
problem primary cell cultures may be transfected in vitro to increase cell 
proliferation and longevity. 
Figure 1.07 : Evolution of a cell line. The vertical axis represents total cell growth 
for a hypothetical cell culture. Total cell number is represented on the y-axis on a 
log scale and time in culture, on the x-axis on a linear scale. Although a continuous 
cell line is depicted as arising at 13 weeks it could arise at any time. Likewise 
senescence could arise at any time (adapted from Freshney 1994). 
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The most common method for immortalisation of human cells whilst retaining a 
specific phenotype is transfection with the Simian virus 40 (SV40) genome which 
encodes the large T-antigen (Bednarz et al., 2000; Ozdarendeli et al., 2003). Simian 
virus (SV40) originated in Asian rhesus monkeys and is closely related to the human 
polyomaviruses. SV40 can induce tumours in rodents and can transform human cells 
in vitro. The transforming ability of SV40 is dependent on the expression of the 
early region of the viral genome, coding for the T antigen (Tag), a nuclear 
phosphoprotein with multiple biological and biochemical properties (Sladek and 
Jacobberger, 1992; Ozdarendeli et al., 2003). The effect of SV40 transfection is to 
decrease the duration of G 1 whilst increasing G2 and M phases with a net increase in 
cell proliferation (figure 1.06). Araki-Sasaki et ai, (1995) isolated human corneal 
epithelial cells which were subsequently transfected with SV 40 to obtain a 
continuous growing cell line (J-HCET). This cell line was reported to grow for more 
than 400 generations exhibiting a cobblestone-like appearance similar to normal 
corneal epithelia in culture (Araki-Sasaki et al., 1995). When cultured at the air-
liquid interface the transformed corneal cells differentiated in multilayer fashion 
(Araki-Sasaki et al., 1995). Biochemical analysis reveals the expression of cornea-
specific, 64kDa cytokeratin in addition to five major insoluble proteins and 
aldehydedehydrogenase (8.71IUmg-1) (Araki-Sasaki et al., 1995). Araki-Sasaki (et 
ai, 1995) appears to have established an immortalised human corneal epithelial cell 
line (J-HCET) with properties similar to primary corneal epithelial cells. Many of 
the properties which can be used to differentiate a transfected cell from a non-
transfected control are also observed when tumour cells are compared with their 
normal in vivo counterparts. According to the European Centre for the Validation of 
Alternative Methods (Eev AM) review of in vitro methods (Worth and Balls, 
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2002b), models need to match human in vivo expression of differentiated function 
with the relevant highly differentiated cell phenotypes. Therefore, in order to assess 
the potential use the J-HCET cell line has in modelling in vitro chronic corneal 
toxicity it is necessary to establish the growth rate, phenotypic stability during 
prolonged culture and presence and correct localisation of proteins associated with 
the adherens and tight junctions, particularly since different media have been used in 
their culture with or without serum (Araki-Sasaki et al., 1995; Combes et al., 1999; 
Araki-Sasaki et al., 2000; Moore et al., 2005). 
1.12 Growth media to culture human corneal epithelial cells 
The validity of the cultured cell as a model of physiological function in vivo has 
frequently been criticised (Freshney, 1994). There are problems of characterisation 
due to the altered cellular environment; cells proliferate in vitro that would not 
normally in vivo, cell-cell and cell matrix interactions are reduced because purified 
cell lines lack the heterogenicity and the three dimensional architecture found in vivo, 
and the hormonal and nutritional milieu is altered. The provision of the appropriate 
environment, nutrients, hormones and substrate is fundamental to the expression of 
specialised function (Engelmann and Friedl, 1989; Freshney, 1994). In vitro cell, 
tissue and organ cultures play an important role in science, medicine and industry 
(Van der Valk et al., 2004). The growth of many cell types in culture requires serum 
in the medium (Castro-Munozledo and Hernandez-Quintero, 1997) as a source of 
hormones, cytokines, vitamins, attachment, spreading and growth factors (Tezel and 
Del Priore, 1998) the absence of which can have profound effects upon in vitro 
cultures (Tezel and Del Priore, 1998). There are disadvantages to the use of animal 
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derived materials such as serum, including the potential contamination with 
infectious agents such as mycoplasma, viruses (e.g. Hepatitis, HIY) and prions 
(Scrapie, Bovine Spongiform Encephalopathy) which may prove detrimental to the 
viability of cell cultures and pose a health risk to individuals exposed to the 
contaminated medium or supplements. In addition animal derived materials are ill 
defined supplements, and thus are ambiguous factors in cell culture (Bames et al., 
1987) since it has been demonstrated that batches display quantitative and qualitative 
variations in their composition (Price and Gregory 1982). Since in vitro methods 
have been, and are being developed as alternatives to animal experiments, the use of 
bovine serum can seem to be contradictory in some ways to the purposes of the 
Three R's concept (Russell and Burch, 1959). With the identification, cloning and 
recombinant production of essential growth factors several very effective chemically 
defined, serum free media have been formulated. Thus the development of serum 
free cell culture medium has been stimulated (Taub, 1 9 9 0 ~ ~ Bjare, 1 9 9 2 ~ ~ Ranaldi et ai, 
2 0 0 3 ~ ~ Fitzsimmons et al., 2 0 0 3 ~ ~ Van der Valk et al., 2004) and increasing numbers 
of formulations for the culture of primary isolates and continuous cell lines are been 
developed (Taub, 1 9 9 0 ~ ~ Bjare, 1992; Fitzsimmons et al., 2003) although serum free 
media are generally more cell type specific (Tezel and Del Priore, 1998). 
1.13 In vitro cell viability and function assays 
The rationale behind using in vitro cytotoxicity assays to predict in vivo toxicity 
stems from the concept of 'basal cell cytotoxicity' proposed by Ekwall (1983). It 
was suggested that for most chemicals, toxicity is a consequence of non-specific 
alterations in cellular functions (Ekwall, 1 9 8 3 ~ ~ Evans et al., 2001). Evaluating the 
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cytotoxic potential of compounds may, therefore, give an indication of their toxic 
potential in vivo (Evans et al., 2001). To this end a number of international studies 
have been performed previously to assess the correlation between cytotoxicity and in 
vivo toxicity in a wide range of cell lines with varying degrees of success (Knox et 
al., 1986; Clothier et al., 1988; Fry et al., 1990; Garle et al., 1994). In vitro 
cytotoxicity assays must fulfil a number of criteria, they must be simple, rapid, 
efficient, reliable, sensitive, reproducible, safe, and allow a cost effective 
measurement of cell viability. Importantly, the in vitro assay selected must not 
interfere with the compound to be tested (O'Brien et al., 2000) and have a clearly 
defined end-point. To validate (i.e. to establish the scientific validity of (Balls et al., 
1995» an alternative test, it is necessary to demonstrate that for its stated purpose: 
the test system has a sound scientific basis; the predictions made by the prediction 
model are sufficiently accurate; and the results generated by the test system are 
sufficiently reproducible within and between laboratories, and over time. These 
conditions can be referred to as the criteria for scientific relevance, predictive 
relevance, and reliability, respectively (Worth and Balls, 2002a). 
1.13.1 Cell viability assays 
1.13.1.1 The Resazurin reduction (Alamar Blue™) assay 
The Alamar Blue™ (Resazurin Reduction) assay (Page et al., 1993) has been 
compared to other viability assays and demonstrated a good correlation in predicting 
cytotoxicity, e.g. with the trypan blue exclusion-(Gazzano-Santoro et al., 1997), and 
the 3-( 4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide salt (MTT)- assay 
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(Black et al., 1999) whilst allowing for repeated or continuous measurements 
(Goegan et al., 1994; Vian et al. , 1994; Clothier and Samson, 1996; O'Brien et al. , 
2000) which cannot be achieved with some assays such as the MTT assay due to its 
inhibition of metabolic processes and final solubilisation step. Recent studies 
(Rasmussen, 1999; O'Brien et al. , 2000) comparing the Alamar Blue™ and resazurin 
(7-Hydroxy-3H-phenoxazin-3-one-l0-oxide) assays concluded that Alamar Blue™ is 
essentially resazurin dye (figure 1.08) supplemented with stabilizing agents. 
Figure 1.08 : Non-reduced Alamar Blue™ corresponds to resazurin. 
OH 
Resazurin is a tetrazolium-based dye incorporating resazunn and resorufin as 
oxidation-reduction indicators that yield colorimetric changes and a fluorescent 
signal (when excited at a specific wavelength of 530nm) in response to metabolic 
activity. In an irreversible reaction, the blue non-fluorescent oxidised form 
(resazurin) becomes pink and fluorescent (resorufin, figure 1.09) upon reduction 
(O'Brien et al., 2000; Byth et al., 2001). 
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Figure 1.09 : Reduced Alamar Blue™ corresponds to resorufin. 
OH 
It has been arbitrarily postulated (De Fries and Mistuhashi, 1995) that resazurin is 
reduced by mitochondrial activity, although uncertainty as to whether resazurin 
reduction actually occurs intracellularly, at the plasma membrane surface or just in 
the medium as a chemical reaction (De Fries and Mistuhashi, 1995). This was 
settled when observations of the change in the cells cytoplasm were reported in a 
confocal microscopic study of live MDCK cells (Cereijido et ai., 1980). In studies 
conducted by Andrew et al., (1997) and O'Brien et at (2000) it was demonstrated 
that resazurin reacted to the reduction-oxidation (redox) status of its environment. In 
the absence of living cells, resazurin in CO2 buffered medium was not converted to 
resorufin, however, in the presence of primary rat hepatocytes fluorescence, and 
therefore resorufin was clearly produced (Andrews et ai., 1997). Further 
intracellular reduction (two-electron reduction) of resorufin yields a colourless 
product dihydroresorufin (figure 1.10), which, if the fluorescence based assay was 
employed, would be suggestive of a lower resazurin reduction i.e. measurements and 
subsequent interpretation of fluorescence would imply that the cells were less active. 
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Figure 1.10 : Further intracellular reduction of resorufin yields a colourless product, 
dihydroresorufin. 
H 
I 
HO OH 
This phenomenon has been known for a long time as being due to the extensive 
reduction of resazurin (blue) into resorufin (pink) and then to dihydroresorufin 
(colourless) (figure 1.11) (Erb and EhJers 1950; O'Brien et al., 2000). 
Figure 1.11 : Further metabolic activity is responsible for the reversible reduction of 
resorufin to dihydroresorufin. 
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The lower the concentration of resazurin within the assay solution the more rapidly it 
is completely reduced and becomes colourless i.e. resazurin concentration is a 
limiting factor. Hence, being aware of this possible problem and the possible effects 
of proteins on the resazurin reduction (Page et ai. , 1993) the assay is normally 
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conducted in excess resazurin. The non-cytotoxic nature of this assay makes it an 
attractive candidate for the repeat assessment of cell activity. However, other 
detoxification pathways need to be included to encompass the possible mechanisms 
of adverse corneal epithelium reactions 
1.13.1.2 Glutathione assay 
The reduction-oxidation (redox) state of the cell is a consequence of the balance 
between the levels of oxidising reactive oxygen species (ROS) and reducing 
equivalents. Elevation of ROS in excess of the butTering capacity and enzymatic 
activities designed to modulate ROS levels result in potentially cytotoxic "oxidative 
stress" (Pastore et al., 2003) a situation in which the cellular redox homeostasis is 
altered because of excessive production of ROS and/or and impairment of cellular 
antioxidant mechanisms. To prevent oxidative damage and allow survival in an 
oxygen environment mammalian cells have developed two important defence 
mechanisms: a thiol reducing butTer consisting of proteins with redox active 
sulphydryl moieties (e.g., glutathione (GSH) and thioredoxin (TRX)) and enzymatic 
systems (e.g., superoxide dismutase (SOD), catalase and glutathione peroxidase) 
(Klatt and Lamas, 2000). These are supported by secondary protective defences, 
including DNA repair enzymes, proteolytic enzymes (which degrade oxidised 
proteins) and the radical scavenging vitamins E and C (Klatt and Lamas, 2000). The 
antioxidant mechanisms present within mammalian cells provide protection from a 
specific range of ROS e.g. catalase and glutathione peroxidase convert hydrogen 
peroxide into harmless products, SOD acts upon superoxide anions and glutathione-
S-transferase detoxifies DNA hydroperoxides (Chandra et aI., 2000). Glutathione 
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(figure 1.12) (L-y-glutamyl-Lcysteinylglycine) is the principle non-protein thiol (-
SH) involved in the antioxidant cellular defence (Pastore et ai., 2003). It is a 
tripeptide composed of glutamic acid bound to cysteine through its y-C02H group 
and glycine. 
Figure 1.12 : Reduced Glutathione is a tripeptide consisting of glutamic acid , 
cysteine and glycine (Adapted from Pastore et ai. , 2003). 
Glutathione is a ubiquitous molecule that is produced in all organs, especially the 
liver. Glutathione exists in two forms, the antioxidant "reduced glutathione" (GSH) 
and oxidized glutathione known as glutathione disulphide (GSSG). 
1.13.1.2.1 Chemistry of GSHEQ assay 
In the presence of nitrous acid, the free thiol group (R-SH) found on the amino acid 
cysteine is converted to its s-nitrosothiol derivative (R-SNO) (figure 1.13). 
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Figure 1.13 : Conversion of thiol groups to their s-nitroso derivatives (i) in the 
presence of nitrous acid. Ammonium sulphamate is used to remove excess nitrous 
acid (ii) adapted from (Saville, 1958). 
R-SH + HON=O - ~ - ~ - ~ - - ...... - R-SNO + H20 (i) 
(ii) 
In a reversal of the reaction, s-nitrosothiols (R-SNO) undergo hydrolysis to form 
nitrous acid and thiol. This reaction is slow in acidic conditions as indicated by the 
broken arrow in figure 1.13. If a slight excess of mercuric chloride is added to the 
reaction mixture, there is an immediate liberation of nitrogen and the red colour of 
the s-nitrosothiol compound is rapidly destroyed. This is due to the coordination of 
the metal cation with the nitrosothiol (figure 1.14) weakening the N-S bond (iii) 
increasing its susceptibility to nucleophilic attack by water molecules (iv) 
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Figure 1.14 : An excess of mercuric chloride results in an immediate liberation of 
nitrogen and the destruction of the red colour of the compound adapted from 
(Saville, 1958). 
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During these reactions the liberated nitrous acid reacts with the ammonium 
sulphamate to form gaseous nitrogen. If sulphanilamide is mixed with the mercuric 
salt before addition to the s-nitrosothiol solution, the amine competes favourably 
with the sulphamate for the nitrous acid equivalent and gives a high yield of the 
corresponding diazonium salt (figure 1.15). 
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Figure 1.15 : Sulphanilamide mixed with the mercuric salt before addition to the s-
nitrosothiol solution gives a high yield of the corresponding diazonium salt. 
R-SH + 
As the production of the diazonium salt is in direct proportion to the initial levels of 
free thiol groups, when coupled to an appropriate chromophore (e.g. n-(1-
napthyl)ethylenediamine) it can be used as a colorimetric scheme for the 
determination ofthiols within a specimen (figure 1.16). 
Figure 1.16 : The diazonium salt is coupled to n-(I-napthyl)ethylenediamine to yield 
an intensely coloured dye. 
H 
I 
NHCH2CH2N [ArN=N] 
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Whilst changes in redox potential as measured via the resazurin and GSH assays are 
important, they need to be related to cell number and a total cell protein assay was 
employed. 
1.13.1.3 The Kenacid Blue assay 
With the ever increasing ability to accurately measure minute quantities of specific 
molecules of interest through the use of enzyme linked immunosorbant assay 
(ELISA), radiological immunoassay (RIA) and various molecular biology tools, a 
limiting factor can be a common denominator for comparison of samples (Starcher, 
2001). Total protein has been one of the most universal denominators and several 
methods have been devised to measure protein in the microgram quantities (Lowry et 
al., 1951; Bradford, 1976). The kenacid blue total protein assay utilises a dye 
(Coomassie blue or Kenacid blue) that reversibly binds to cellular protein 
components, which is proportional to the total number of cells present within a 
culture (Knox et al., 1986; Balls and Clothier, 1992; Clothier et al., 1992). The basis 
of the assay for use in cytotoxicity testing is that any effects, for example, on protein 
production or maintenance of membrane integrity following chemical treatment will 
result is altered growth rate and therefore cell number. Kenacid blue or Coomassie 
blue dye detects protein by binding to the NH3 + terminal end of the protein molecule 
in a non-specific manner allowing detection of both active and non-active proteins 
(Fazekas de St Groth et al., 1963). Fixed cells exposed to the dye will bind the dye 
in proportion to the amount of protein present within the culture. This relates to the 
total cell number (Knox et al., 1986) and the total protein content of the culture may 
then be calculated from the standard curve (Gray et al., 1999). Cell distribution 
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within a well can be viewed macroscopically prior to desorbing the dye giving an 
instant indication of the assays success. If necessary measurements can also be 
repeated on the same cultures, by retaining the cultures, following dye desorption. 
The chemical nature of a substance may place constraints on this technique. Other 
problems which may arise include false indications of the amount of cell protein 
present if culture media is not aspirated sufficiently; resulting in the formation of a 
ring of dried protein around the well at the air/liquid interface. It is also possible for 
the dye to precipitate out, producing an uneven distribution, constant gently shaking 
and less handling time minimises this. It is also important to consider that the 
toxicity of a chemical may be underestimated by this technique as apoptotic cells 
remain attached to the well can be detected. If run too soon after exposure to the test 
substance the necrotic cells may not have been detached and so would be included 
with the live cells. Also the chemical may bind to the dye as well, but a no cell blank 
control treated with the top concentration of chemical can be used to check this. 
Hence the total protein assay has been used in conjunction with a cell viability assay 
e.g. neutral red uptake assay (Riddell et al., 1986). 
1.13.1.4 The neutral red uptake assay 
The neutral red uptake (NRU) assay (Borenfreund and Puerner, 1985) is a 
cytotoxicity assay based upon the inability of dead and damaged cells to actively take 
up the dye neutral red. Neutral red is selectively retained in the cytoplasm, in 
particular the lysosomes of living cells, by differential pH of the lysosome and 
surrounding cytoplasm. The amount of neutral red taken up is directly proportional 
to the number of viable cells in the culture as long as the chemical under 
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investigation does not directly affect the pH of the lysosomes e.g. as with the 
antimalaria drug Chloroquinine (Riddell et al., 1986). 
1.13.2 Cell function assays 
1.13.2.1 Combined fluorescein leakage- resazurin reduction assay 
The deterioration of intercellular junctions (figure l.04) may be demonstrated by the 
use of the fluorescein leakage assay (FLA) (Tchao, 1988; Shaw et al., 1990; Zanvit 
et al., 1999). The FLA was originally conceived by Tchao (1988) as an alternative to 
the Draize rabbit eye irritation assay and has since been used in a variety of forms 
(Tchao, 1988; Shaw et al., 1990; Balls and Clothier, 1992; Martin and Stott, 1992). 
The rationale underlying the approach is the assumption that irritancy potential is 
related, in part, to the ability of the applied chemical to breach the epithelial barrier 
(Botham et al., 1997). The barrier normally prevents the movement of substances 
from the exterior environment into the intercellular spaces between the epithelial 
cells and through to the deeper corneal layers, and is dependent on the existence of 
tight junctional complexes between the superficial cells of the epithelium (Tchao, 
1988; Ward et al., 1997b). The FLA is dependent upon two aspects of epithelial cell 
barrier function: tight junctions/desmosome and plasma membrane integrity (Tchao 
1988; Botham et al., 1997). Compromising either or both of these cellular structures 
through chemical or ionising radiation insult, causes an increase in permeability 
(Botham et al., 1997). Several protocols have been published for the fluorescein 
leakage assay. In all cases either a monolayer or multilayer of epithelial cells is 
grown on a microporous membrane cell culture insert that provides a two-chamber 
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system (figure l.17) to keep apical and basal culture media separated by the 
epithelial cell layer (Tchao, 1988; Shaw et al. , 1990; Balls and Clothier, 1992; 
Martin and Stott, 1992; Botham et al., 1997; Ward et al. , 1997b). 
Figure 1.17 : A microporous membrane provides a two-chamber culture system, 
damage to the plasma membrane and/or interepithelial junctions is detected by 
fluorescein leaking through to the basal chamber. 
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Chemically induced loss of transepithelial impermeability may be determined by 
colorimetric measurements of the levels of fluorescein which have passed from the 
apical to the basolateral side of the mono- or multilayer (Tchao, 1988; Cottin and 
Zanvit, 1997; Zanvit et al., 1999). If both the plasma membrane and epithelial 
junctions remain intact, only the limited fluorescein that has passed through the cells 
themselves is present in the basolateral chamber (figure 1.17). As the FLA is non-
cytotoxic, it is possible to study both the ability of cells to recover from chemical 
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challenge, and the damage produced by chemicals that do not exhibit an immediate 
effect (Cottin and Zanvit 1997). Results are expressed as either fluorescein leakage 
as a percentage of that leaking through the membrane support alone. The FL20 or 
FL50 values, representing the dose of a test reagent causing either a 20% or 50% 
leakage, respectively, of fluorescein through the cell monolayer (Pitt et al., 1987; 
Tchao, 1988; Shaw et al., 1990; Balls and Clothier, 1992; Cook et al., 1992; Martin 
and Stott, 1992; Botham et al., 1997; Ward et al., 1997a). The standard non-treated 
monolayer should show 6% or less leakage for the assay to qualify. Barrier function 
may also be measured by determining the transepithelial resistance (TER) of the 
epithelial sheet. This technique however, cannot distinguish between transcellular 
and paracellular permeability and alterations in cell volume as a consequent of 
chemical exposure may also significantly affect TER measurements whilst not 
significantly modulating barrier function. Although TER is routinely used to asses 
barrier integrity the assay measures ion flux in kidney models, neither water or solute 
flux are not and so is not necessarily an accurate measure of the barrier function 
(Ward et al., 1995). The complexity of the procedure means that it is unsuitable for 
high throughput screening of potential irritants, although new multiple measuring 
devices are now available (Ryan et al., 2005). 
1.14 Test Chemicals 
Test chemicals were selected upon the basis of their correlation with in vivo data. In 
addition, timolol maleate was selected as a clinically relevant pharmaceutical known 
to cause ocular irritancy as a result of prolonged use in the treatment of glaucoma 
(Baudouin et al., 1998; Burgalassi et al., 2000) . 
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1.14.1 Sodium dodecyl sulphate 
Anionic surfactants demonstrate a marked biological activity either by binding to 
various bioactive macromolecules such as starch (Merta and Stenius, 1999), proteins 
(Nielsen et al., 2000), peptides and DNA (Marques et al., 2000) or by inserting into 
v a r i o ~ s s cell fragments (i.e. phospholipids membranes) causing malfunction (Cserhati 
et aI., 2002). Sodium dodecyl sulphate (SDS) (figure l.18) is an important 
component of many dental cleansing products, emulsifying plaque deposits 
(Newbrun, 1983) and solubilising lipophilic substances whilst also acting as a 
foaming agent. In Europe and North America, its concentration in toothpastes ranges 
from 0.5% to 2.0010 (Barkvoll and Rolla, 1994). It is well established that SDS is an 
irritant to skin, its application resulting in a dose-dependent contact dermatitis 
(Berardesca and Maibach, 1988; Ponec and Kempenaar, 1995). Its use in toothpaste 
may, by chronic exposure, damage the integrity of the oral mucosa (Heriofson and 
Barkvoll, 1996) and exaggerated use models have been shown to induce mucosal 
desquamation (Herlofson and Barkvoll, 1996). This indicates that prolonged 
exposure to SDS impairs the function of the oral mucosa, which as a result of similar 
morphology to that of the cornea, could apply to this tissue. Draize eye irritation 
studies reveal that sodium dodecyl sulphate is a moderate irritant with a MAS of 16 
(Ohno et al., 1999), and a MMAS of 16 at 3% , 59.2 at 15% and 60.5 at 30% 
(ECETOC Technical report 48 (2), 1998) 
Figure 1.18 : Structural formulae of sodium dodecyl sulphate 
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Tween 20 sorbitanpolyoxyethylene monolaurate (figure 1.19) is a nonionic surfactant 
which has been demonstrated (ECETOC, 1998) to be one of the mildest forms of 
cleaning agents. Nonionic surfactants are most frequently found in infant cleansing 
products due to their mild cleansing action and low irritancy potential, as 
demonstrated by a Draize MMAS of 4 at a 100% concentration (ECETOC Technical 
report 48 (2), 1998). 
Figure 1.19 : Structural formulae oftween 20 CSsH1l4026 (W+X+Y+Z=20) 
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1.14.3 Cocamidopropylbetaine 
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Cocamidopropylbetaine (CAPB) (figure 1.20) is the most widely used amphoteric 
surfactant in the cosmetic industry (McFadden et ai., 2001) especially in shampoos 
and bath products. A number of studies have demonstrated that CAPB induces less 
degree of irritation both in skin and oral personal products compared to BAK and 
SDS (Herlofson and Barkvoll, 1996; Barany et ai. , 1999). However, some studies 
indicate that CAPB in rare cases may be responsible for allergic reactions (Fowler, 
1993; McFadden et ai, 2001) and this can be dependent on its purity (Foti et al., 
2003). 
Figure 1.20 : Structural formulae of cocamidopropylbetaine 
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Benzalkonium chloride (BAK) is a quaternary ammonium compound (figure 1.21) 
and is the most common antimicrobial preservative used in topical ophthalmic 
preparations (Berdy et al. , 1992; Pisella et ai. , 2000). BAK is highly efficacious 
against numerous microbes and acts by denaturing proteins and causing the lysis of 
cytoplasmic membranes. The surfactant abilities of BAK enable it to solubilise the 
extracellular matrix (ECM) of the corneal epithelium, thereby, increasing the 
penetration of BAK (Gasset et ai., 1974; Kreine, 1979). BAK can accumulate in 
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ocular tissue (Cha et al., 2004), remaining for relatively lengthy periods (Gas set et 
al. , 1974) and as a result, BAK can induce different types of cell death (De Saint 
Jean et al. , 2000) in a dose-dependent manner; apoptosis at very low concentrations 
(0.0001%) and necrosis at higher concentrations (0.05-0.1%) (De Saint Jean et al., 
2000). Draize eye irritation studies reveal that benzalkonium chloride is a severe 
irritant with a MAS of 78 (Ohno et al., 1999) and a MMAS of 34.3 to 56.3 at 1%, 
83 .8 at 5% and 108 at 10% (ECETOC Technical report 48 (2), 1998), 
Figure 1.21 : Structural formulae of benzalkonium chloride 
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1.14.5 Timolol Maleate 
Topical p-adrenergic blockers are usually the first line of medical therapy prescribed 
to reduce the intraocular pressure in glaucoma and ocular hypertensive patients 
(Stewart et al., 2000). Timolol maleate (figure 1.22) is a salt of an organic acid that 
has been demonstrated to have several types of cellular effects. First, it is used as an 
animal model in rats for the Fanconi syndrome, which is a renal disease affecting 
proximal renal tubule re-absorption of amino acids and electrolytes (Verani et al., 
1982). In addition, in vitro studies have demonstrated that maleate reduces 
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glutathione (GSH), a free radical scavenger, in both corneal epithelial and endothelial 
cells specifically. (Megaw, 1984; Riley, 1990; Stewart et al., 2000). Prolonged use 
of timolol maleate (required for the treatment of glaucoma and ocular hypertension) 
is associated with irritation of both the cornea and conjunctiva (Stewart et al. , 2000). 
This may be the explanation to why many patients prescribed timolol maleate for 
glaucoma often discontinue their treatment compared to individuals prescribed 
alternatives (Baudouin et aI., 1998; Burgalassi et al., 2000) 
Figure 1.22 : Structural formula oftimolol maleate 
HC-COOH 
11 
He-eOOH 
1.15 Aims of the current study 
The main aims of the current study are; 
• Evaluate the Japanese human corneal epithelial cell line (J-HCET) for use in 
an in vitro model of chronic ocular irritancy. 
• Determine if a monolayer of J-HCET cells can correctly predict ocular 
irritancy of four representative surfactants using a range of biological 
endpoints when compared to the Draize eye irritation assay. 
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• Evaluate the effects of a sub cytotoxic surfactant concentration over a 21 day 
exposure period in terms of viability and function subsequently to an acute 
surfactant exposure utilising the J-HCET cell line. 
• Evaluate the effects growth medium composition has upon the differentiation 
and barrier function of the J-HCET cell line. 
• To assess the use of commercially available animal product free growth 
supplement in conjunction with a defined culture medium, in terms of growth 
rate and modulation of responses to exogenously applied chemicals of a 
human corneal cell line. 
• Employ the in vitro chronic toxicity model to evaluate the effects timolol 
maleate has upon the corneal epithelium, can one mimic known in vivo 
corneal epithelial adverse affects in vitro? 
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Chapter 2 
Materials and Methods 
Materials & Methods 
The procedures commonly used during this study have been described in this 
chapter. Techniques specific to particular investigations are described in the 
appropriate chapters. 
2.1 MATERIALS 
2.1.1 Chemicals 
Heat inactivated foetal bovine serum (FBS) was obtained from Autogene Bioclear 
(Wiltshire, V.K). Ammonium sulphamate, benzalkonium chloride (BAK), 
buthionine sulphoxamine (BSO), cocamidopropylbetaine (CAPB), 
dimethylsulphoxide (DMSO), ethanol, glacial acetic acid, Hanks balance salt 
solution (HBSS with calcium and magnesium), hydrochloric acid, L-glutathione 
(GSH), mercury (11) chloride, methanol, n-(l-napthyl)ethylenediamine 
dihydrochloride, neutral red (CI50040), paraformaldehyde, penicillin (10000 IV mrl) 
/streptomycin (IOmgmrl) solution in 0.8% sodium chloride, fluorescein 
isothiocyanate (FITC) labeled phalloidin, resazurin, resorufin, sodium bicarbonate, 
sodium fluorescein, sodium nitrite, sodium dodecyl sulphate (SOS), sulphanilamide, 
sulpho salicylic acid dehydrate, triton X-lOO, TrypsinfEOTA (porcine, Imgmr l in 
O.4mgmr l EOTA) Coomassie®brilliant blue R 250, milling blue 2BR (Kenacid 
Blue) and tween 20 (T20) was obtained from Sigma-Aldrich Co Ltd (Poole, U.K). 
Phosphate buffered saline tablets (with calcium and magnesium) from Oxoid 
(Basingstoke, UK). Anhydrous calcium chloride and citric acid obtained from 
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Fischer Scientific Ltd (Loughborough, UK). Carbon dioxide and liquid nitrogen 
obtained from British Oxygen Company (BOC) (Surrey, UK). Epilife keratinocyte 
calcium free growth media, collagen coating kit (containing an undisclosed 
concentration of human recombinant type I collagen), human keratinocyte growth 
supplements (HKGS) and human keratinocyte growth supplements V2 (HKGS-V2) 
from Cascade Biologics (Mansfield, U.K). KBM keratinocyte growth media and 
KGM Singlequots™ from Cambrex Bioscience Wokingham, Ltd (Wokingham, UK). 
Fibronectin-collagen (FNC) (containing l0J..1gmr1 bovine fibronectin, 3SJ..1gmr1 
bovine type I collagen) coating kit was obtained from AthenaES (Baltimore, USA). 
Haychlor Industrial, Trigene 11 and liquid detergent ES@7X was purchased from 
Scientific Laboratory Supplies (Nottingham, UK). Transmit™ resin was obtained 
from T AAB laboratories Equipment Ltd (Berkshire, UK). Chemicals were stored as 
recommended by the manufacturer. 
2.1.2 Consumables 
Bijoux (7ml), and 30ml universal bottles were purchased from Bibby Sterilin Ltd 
(Staffordshire, UK). Coming Costar disposable serological pipettes (Sml, IOml, 
2Sml) and disposable reservoir liners (8 channel) were purchased from Coming 
Incorporated (Loughborough, UK). Autoclave bags, indicator tape, yellow 
biohazard bags and sterile plastic packaging were obtained from NHS supplies. 
Cryopreservation vials and pipette tips (2001l1 and lOOOIlI) were purchased from 
Starstedt (Leicester, UK). Biological hazard tape was purchased from Sellotape. 
Hand towels were obtained from Kimberley-Clark® Corporation. Cellstar tubes 
(SOml) were purchased from Greiner Labortechnik (poitiers, France). Long form 
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unplugged glass pasteur pipettes were purchased from Mexcel. Minisart high flow 
aerodisc filters (pore size 0.2J..1.m) were purchased from Sartorius A.G (Goettingen, 
Germany). Powder free non-sterile vinyl gloves were obtained from Labsales Co 
(Cambridge, UK). Universal graduated glass bottles, chamber slides (8 well), 
coverslips, culture flasks (125cm2, 80cm2 and 25cm2), 24 and 96 well flat base 
culture plates and polycarbonate (lOmm diameter, O.4J,1m pore size) culture inserts 
were purchased from Scientific Laboratory Supplies (suppliers of Nunc Brand 
Products) (Nottingham, UK). 
2.1.3 Equipment 
Medical Centaur 2 MSE centrifuge obtained from Thermolife Sciences (Paisley, 
UK). LEEC MKII proportional temperature controlled C02 incubator was purchased 
from LEEC (Cardiff, UK). Laboratory microscope obtained from Nikon (Japan). 
Confocal microscope TCS4D obtained from Leica (Heidelberg, Germany). Power 
pipette gun purchased from Jencons-PLS (Leighton Buzzard, UK). Waterbaths 
(models WB14 and Y14) obtained from CamLab Ltd (Cambridge, UK). Class 11 
culture cabinets (ICN Biomedicals and MDH) were purchased from Walker Safety 
Cabinets (Derby, UK). FLUORstar Galaxy plate reader obtained from BMG, Lab 
Technologies (Buckinghamshire, UK). Analytical balance, ASYS HITEC Expert 96 
plate reader, Mr. FrostyTM, surgical forceps, Neuerbaur improved haemocytometer, 
pipettes (50-300J..l.l) and scalpels obtained from Scientific Laboratory Supplies 
(Nottingham, UK). Dymax 30 aspirator vacuum pumps obtained from Charles 
Austen Pumps. Autoclave obtained from Denley (Colchester, UK). Rotatest plate 
shaker was purchased from Luckham Ltd (Essex, UK). Microscope slides and 22 x 
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64mm glass coverslips obtained from Chance Propper Ltd (West Midlands, UK). 
mM compatible PC running Microsoft Windows xpTM Professional, Microsoft 
Office xpTM Professional and GraphPad Prism 4.0 was purchased from Fujitsu-
Siemens (Nottingham, UK). 
2.1.4 Immunostaining reagents 
Vectashield™ mounting medium containing propidium iodide (50llgmr1) was 
obtained from Vector Laboratories (California, U.S.A). Normal goat serum and 
bovine serum albumin ( B S A ~ ~ heat and alcohol fractionated) obtained from Sigma-
Aldrich Company Ltd (Poole, U.K). Phosphate buffered saline (PBS) (calcium- and 
magnesium- free) was prepared, as directed by the manufacturer from pre-weighed 
tablets added to distilled water, autoclaved in 500ml or 50ml aliquots (as required) 
and stored at room temperature. Primary and secondary antibodies were obtained as 
outlined in tables 2.0 and 2.1 respectively. 
Table 2.0 : Primary antibodies used for immunochemical staining. 
Antigen Specltlclty Host Form Reactivity Working Dilution Source 
Claudin-1 (C Terminus) Rabbit Polyclonal Human 25119mr' Zymed (San Fransisco, USA) 
E-Cadherin (C Terminus) Mouse Monoclonal Human, Dog, Rat, Mouse 251l11mr' BD Biosciences (Oxford, UK) 
Occludin (C Terminus) Mouse Monoclonal Human, Mouse, Rat, Dog 10119mr' BD Biosciences (Oxford, UK) 
Occludin (C Terminus) RabbM Polyclonal Human, Mouse, Dog, Rat 101lllmr' Zymed (San Fransisco, USA) 
Z0-1 (C Terminus) Mouse Monoclonal Human,Dog 1Ol19mr' Zymed (San Fransisco, USA) 
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Table 2.1 : Secondary antibodies used during immunostaining. 
Antigen Specificity Host Form Reactivity Label Working Dilution Source 
Rabbit IgG Goat Monoclonal Rabbit Fe FITC 251Jgml-1 Sigma-Aldrieh (Poole. UK) 
Mouse IgG Goat Monoelonal Mouse Fe FITC 25IJgml-' Sigma-Aldrieh (Poole. UK) 
Antibodies were aliquoted into cryovials and stored and -20°C until required. 
2.1.5 Immortalised human corneal epithelial (J-HCET) cell line 
The SV40 transfected human corneal epithelial cell line (J-HCET) was a kind gift 
from Professor Araki-Sasaki (Institute of Ophthalmology, Tane Memorial Eye 
Hospital, Sakaigawa, Osaka, Japan). 
2.1.6 Reagents and stock solutions 
2.1.6.1 Fluorescein leakage assay 
a.) Resazurin solution 
Resazurin stock (Sml, Imgmr1 in HBSS) was filter sterilized into a SOml universal 
container. HBSS (4Sml) with calcium (as required) and magnesium was added to 
create a stock dilution of 1001lgmr1. The resazurin stock was subsequently diluted 
1: 10 in HBSS and wrapped in aluminium foil to prevent photoreduction. Resazurin 
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solution ( 1 0 ~ g m r l ) ) was stored at 40 C and used within 2 weeks. Where possible, for 
a given series of experiments the same prepared resazurin solution was employed. 
b.) Resazurin- sodium fluorescein (RlSF) solution 
Sodium fluorescein (0.05g) was completely dissolved in 500ml of l O ~ g m r l l
resazurin solution (section 2.1.6.5) to give a final concentration of 0.01% fluorescein 
in l O ~ g m r l l resazurin. RlSF solution was wrapped in aluminium foil to prevent 
photoreduction, stored at 4°C and used within 4 weeks. Where possible, for a given 
series of experiments the same RlSF solution was employed. 
2.6.1.2 Glutathione equivalents assay 
a.) Acidified mercury (11) chloride - sulphanilamide solution 
Mercury (11) chloride (0.2g) and sulphanilamide (0.68g) were completely dissolved 
in 100ml 0.32M hydrochloric acid (HCl) and stored at 4°C. 
b.) Acidified n-1-naphthylethylenediamine solution (0.1 % w/v) 
N-l-naphthylethylenediamine (lOmg) was completely dissolved in 10ml of O.4M 
hydrochloric acid (HCl), immediately prior to use. 
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Co) Ammonium sulphamate (005% w/v) 
Ammonium sulphamate (1g) was completely dissolved in 200ml of distilled water. 
The solution was stored at 4°C. 
do) Acidified sodium nitrite (1mM) solution 
Sodium Nitrite (NaN02) (ImM) was dissolved in O.5M hydrochloric acid (HCI) and 
stored at 4°C. 
eo) Glutathione (1mM) solution 
Glutathione (3.07mg) was completely dissolved in lOml of aqueous sulphosalicyclic 
acid (5% w/v). 
fo) HydrochlOriC acid (005, 004 & 0032M) 
Hydrochloric acid (HCI) (lM) stock was produced by dilution of concentrated acid 
with distilled water (dH20). Stock solution was diluted using distilled water to 
produce O.5M, D.4M and O.32M working dilutions. Working dilutions were stored at 
room temperature. 
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g.) Sulphosalicylic acid (5% w/v) 
Sulpho salicylic acid (5g) was completely dissolved in 100ml distilled water and 
stored at 4°C in the dark. 
2.1.6.3 Kenacid blue (total protein) assay 
a.) Kenacid Blue fixative solution. 
Neutral red desorb solution was made by the addition of 10ml glacial acetic acid and 
490ml distilled water to 500ml ethanol. The solution was stored at room temperature 
until required. 
b.) Kenacid blue staining solution 
Kenacid Blue (KB) stock solution was prepared by adding O.4g Coomassie®brilliant 
blue R 250 (Kenacid Blue) to 250ml ethanol and 630ml distilled water. The solution 
was mixed thoroughly and stored at room temperature. Kenacid Blue working 
solution was prepared by addition of 12ml glacial acetic acid to 88ml Kenacid Blue 
stock solution immediately prior to use. 
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c.} Kenacid blue wash solution 
Washing solution was prepared by the addition of IOOml ethanol and 50ml glacial 
acetic acid to 850ml distilled water. The solution was stored at room temperature 
until required. 
d.) Kenacid Blue desorb solution 
Kenacid Blue desorb solution was prepared by completely dissolving 98.15g 
potassium acetate (equivalent to IM) to 700ml ethanol and 300ml distilled water. 
The solution was stored at room temperature. 
2.1.6.4 Imaging techniques 
a.) Normal goat serum (NGS) (5% v/v) 
Heat inactivated normal goat serum (500,.d) was added to 9.5ml phosphate buffered 
saline immediately prior to use. 
b.) Paraformaldehyde solution (4% w/v) 
Paraformaldehyde (4g) was added to lOOml PBS and heated to 60°C with continuous 
agitation until completely dissolved. The solution was filtered and stored at -20°C 
until required. 
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c.) Triton X-100 solution (0.1% v/v) 
Triton X-lOO (lOJ,1l) was suspended in 9.99ml phosphate buffered saline (PBS) 
immediately prior to use. 
2.1.7 Preparation of Epilife cell culture media 
2.1.7.1 Cascade Biologies Epilife TM culture media 
Cascade Biologics Epilife™ growth media (500ml) was prepared as directed by the 
manufacturer with either HKGS [bovine pituitary extract (0.2% v/v), bovine insulin 
(5J,1gmr1), hydrocortisone (0. 1 8 J,1gmr l), bovine transferring (5J,1gmrl), human 
epidermal growth factor (0.2ngmrl)] or HKGS-V2 [human recombinant insulin-like 
growth factor type-I, prostaglandin E-2, human recombinant epidermal growth 
factor, hydrocortisone and a proprietary plant extract at undisclosed concentrations] 
supplements, penicillin (10,000 ill mrl) streptomycin (lOmgmrl) solution (Sml) and 
calcium chloride to give a final concentration of 1 mM calcium in 500ml of complete 
medium. Anhydrous calcium chloride (4.41g) was dissolved in 100ml distilled water 
and filter sterilized. The solution was stored at 40 C and used within 1 month. 
Medium was stored at 40 C in the dark and used within 4 weeks of preparation. 
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2.1.7.2 Chronic surfactant exposure culture media 
An appropriate mass of test surfactant (SDS, T20, CAPB or BAK), was suspended in 
cell culture medium to create concentrations as outlined in table 2.2. Medium was 
filter sterilised, stored at 4°C and used within 4 weeks. 
Table 2.2: Chronic surfactant exposure cell culture media concentrations. 
Surfactant 
Tween 20 
Sodium dodecyl sulphate 
Cocamidopropyl bentaine 
Benzalkonium chloride 
Concentration (pgmr1) 
25 
4 
3 
0.0025 
2.1.7.3 Chronic surfactant exposure culture media with neutral red dye 
Immediately prior to use neutral red dye (3.3mgmr l ; Sigma, Poole, UK) (125J.ll) was 
added to llml media to give a final concentration of 37.51lgmr1 and filter sterilized. 
This was kept at 37°C and used within 1 hour of preparation to avoid problems 
associated with neutral red crystals, that can occasional occur. 
2.1.7.4 Culture media quality control 
Prior to use, a bijoux containing 5ml of prepared media (sections 2.1.7.1/2) was 
incubated for 2-3 days at 37°C, 5% (v/v) CO2 in air and inspected microscopically 
for micro-organism contamination. If contamination was present, the media was 
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discarded. 
2.2 METHODS 
2.2.1 Sterilization 
2.2.1.1 Autoclaving 
Sterilization by autoclaving was carried out in an autoclave at lSlb/sq inch for 20 
minutes at 120°C. Autoclave indicator tape was employed to confirm heating. 
2.2.1.2 Glassware 
All items of glassware were washed in liquid detergent ES®7X, rinsed in distilled 
de-ionized water, air dried and autoclaved (section 2.2.1.1). 
2.2.2 Microscopy 
2.2.2.1 Light Microscopy 
All microscopic observations were carried out using a Nikon inverted microscope 
with 10 times eye piece, 2.5, 4 or 10 times objective. 
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2.2.2.2 Confocal Microscopy 
Fluorescein isothiocyanate (FITC) immunofluorescence was detected using a Leica 
TCS4D confocal microscope with an excitation filter of 485nm, and an emission of 
530nm. 
2.2.3 Routine maintenance of J-HCET cell line 
2.2.3.1 Culture conditions 
All experimental work and tissue culture manipulations were conducted in a sterile 
class 2 laminar flow cabinet using sterile techniques. When required both 
plasticware and glassware were coated using coating kits as directed by the 
manufacturer. 
2.2.3.2 Calculation of cell number 
A haemocytometer was used to determine the number of cells usmg a light 
microscope. Cells that crossed the triple line at the side and bottom of the square 
were excluded from the count. The volume of cell suspension required to give the 
required seeding density was then calculated using equation 2.0. 
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Equation 2.0 : Determining the volume of cell suspension and media required for 
the appropriate experimental seeding density. 
-
-
Where Vl denotes total ml of cell stock required, Cl denotes total number of cells in 
stock, V2 denotes final volume of cell suspension needed and C2 is final cell 
suspension concentration. 
2.2.3.3 Serial propagation of J-HCET cell line 
Growth medium was warmed to 37°C immediately prior to cell harvesting. Medium 
was a ~ p i r a t e d d from large (125cm2) culture flasks, and J-HCET cells washed with 
20ml of sterile PBS (pre-warmed to 37°C). PBS was aspirated and a second wash 
performed. The cells were incubated with 10ml EDT A/trypsin for 5 minutes at 
37°C, 5% (v/v) C02 in air. Foetal bovine serum (FBS) (lOml, 10% v/v in PBS) was 
applied to stop the action of the trypsin and the suspension transferred to sterile 20ml 
containers and centrifuged at 1000 rpm for 5 minutes at room temperature. The 
supernatant was aspirated and the cellular pellet re-suspended in 10ml of cell culture 
medium. A sample of the the cell suspension was counted using a haemocytometer, 
and a large culture flask seeded with 5xl05 cells in 20ml of medium i.e. 2.5 x 104 cell 
mrl . Cultures were maintained at 37°C, 5% (v/v) C02 in air, re-fed with fresh 
culture medium every 72 hours and sub-cultured once cells were 70-80% confluent. 
Cells were monitored on a daily basis at low magnification (xlO objective) to 
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ascertain the level of cell growth, the morphology of the cells and check that micro-
organism contamination had not occurred. 
2.2.3.4 Cryopreservation of J-HCET cell line 
J-HCET were harvested, pelleted and re-suspended in FBS containing 10% 
dimethylsulphoxide (DMSO). Cryovials were seeded at a density of Ixl06 cells per 
ml and frozen to _80°C over 24 hours in Mr. FrostyTM. Cryovials were placed in 
liquid nitrogen for long term storage. 
2.2.3.5 Retrieval of cryopreserved J-HCET cell line 
Growth media were warmed to 37°C immediately prior to cell retrieval. Cryovials 
were retrieved from liquid nitrogen storage and rapidly thawed to room temperature. 
The contents of the vial were transferred to 9ml of medium and centrifuged for 5 
minutes at 1000rpm. The supematant was aspirated and the pellet re suspended in 
10ml medium. Large (125cm2) flasks were seeded with the 10mls of suspension, and 
maintained at 37°C, 5% (v/v) CO2 in air, re-fed with fresh culture medium every 72 
hours and sub-cultured once cells were 70-80% confluent. 
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2.2.4 Cytotoxicity assays 
2.2.4.1 Kenacid blue total protein assay 
The kenacid blue protein assay was used to detennine the total protein content in the 
fixed cells in wells containing mono layers, by the previously described method 
routinely used in the laboratory (INVITTOX protocol 3B; Knox et al., 1986; 
Clothier, 1995). The Kenacid blue fixative solution (200,.11) was added and allowed 
to evaporate over 48 hours at 37°C. The acidified kenacid blue solution (100J.ll) was 
applied. Plates were agitated on a rotatest shaker for 2 hours. Wells were aspirated 
and unbound dye removed by washing twice with kenacid blue wash solution for 20 
minutes. Kenacid blue desorb (section 2.1.6.3), lOOJ.lI was added and the plates 
agitated for 60 minutes. The optical density of each well was then read using an 
ASYS HITECH Expert plate reader at 570±10nm. A standard protein curve was 
produced using concentrations of BSA ( 0 - 1 6 0 ~ g m r l ) ) in 70% ethanol (Gray et aI., 
2004). Total cell protein was calculated from the concentration curve which gave a 
linear increase in optical with increasing standard protein concentrations (figure 2.0). 
Total protein was expressed as ~ g m r l l of protein. 
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Figure 2.0 : Kenacid blue assay standard curve (mean±S.D, n=12). 
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For linear section; y =O.0283x where y is absorbance at 570nm and x is protein 
content (pgmri). At protein concentrations above 80pgmri the standard curves 
exhibits non-linear behaviour. 
2.2.4.2 Resazurin reduction assay 
Resazurin is a tetrazolium-based dye (O'Brien et al., 2000), incorporating resazurin 
and resorufin as oxidation-reduction indicators that yield colorimetric changes and a 
fluorescent signal (when excited at a specific wavelength of 530nm) in response to 
cell metabolic activity. In an irreversible reaction, the blue non-fluorescent oxidised 
form (resazurin) becomes pink and fluorescent (resorufin) upon reduction (Andrew 
et al., 1997; O'Brien et aI, 2000; Byth et ai., 2001). The possibility that the resorufin 
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produced would be further reduced to dihydroresorufin was minimized by using 
resazurin in excess (lOllgmr1 in HBSS). Measurements were made on J-HCET 
cultures at 1,2,4, and 8 hour intervals (figure 2.1), to determine production (llgmr1) 
(table 2.3) using a standard curve resorufin in SIlgmr1 resazurin (figure 2.2). The 
resorufin concentration continued to increase throughout the duration of the 
experiment, although the increase per hour decreased as time progressed. Between 0 
and 1 hours the reduction of resazurin to resorufin was the greatest, and hence over 
an assay period of 1 hour, resorufin concentration of IOllgmr1 was set to avoid 
significant dihydroresorufin production. 
Table 2.3 : Determination of the rate of production in J-HCET monolayers. 
Time Point (Hours) 
0-1 
1 - 2 
2-4 
4-8 
Rate of Resorufln 
Production (lJgmr1h-1) 
4 
2 
1 
0.37 
85 
Figure 2.1 : Resorufin production over 8 hours (mean±S.D, n=3). 
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Resazurin solution (section 2.1.6.4) was pre-warmed to 37°C. Medium was 
aspirated from the wells and 200111 resazurin solution applied. Plates were incubated 
at 37°C, 5% (v/v) C02 in air for 55 minutes. Plates were read at 60 minutes using the 
FLUORstar Galaxy with an excitation filter of 530±10nm and an emission filter of 
590±12.5nm. Resazurin solution was aspirated and medium pre-warmed to 37°C, 
added. Plates were returned to the incubator 37°C, 5% (v/v) CO2 in air for 24 hours. 
Standard curves were produced using samples of 0, 125, 250, 500, 1000, 2000, 4000, 
8000 and 16000ngmr1 resorufin in 5Jlgmr1 resazurin in HBSS (figure 2.2). The 
standarQ curve was used to determine the amount of resorufin in each sample from 
their respective absorbencies. 
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Figure 2.2 : Resazurin reduction assay standard curves (mean±S.D, n=3) . 
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For linear section; _ 96 well plate y =O.528x, _ 24 well plates (used with fluorescein 
leakage assay) y =O.168x where y is emission at 590±12.5nm and x is resorufin 
concentration (ngmr J). 
2.2.4.3 Combined fluorescein leakage- resazurin reduction assay 
At all times during the protocol the inserts were handled with sterile forceps . 
Medium was aspirated from the inserts which were subsequently transferred to a 
fresh 24 well plate, containing 400111 of resazurin solution per well (pre-warmed to 
370 C). Resazurinlsodium fluorescein (0.01 %) solution (2.l.6.1) (200111) was added 
to the insert, and the plate incubated for 90 minutes at 370 C and 5% CO2 (v/v) in air. 
After 85 minutes, the plate was removed from the incubator in preparation for the 
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removal of the RSIFL samples from each insert . The samples from the inserts were 
placed in a 96 well plate. The inserts were transferred to a fresh 24 well plate 
containing 500111 media (pre-warmed to 37°C) per well . Medium (500Ill) was added 
to the apical chamber and the plate returned to continue culture at 370 C and 5% CO2 
(v/v) in air. The 24 well plate containing the resazurin solution and leaked 
fluorescein was read in a FLUORstar Galaxy. Fluorescence was measured with an 
excitation filter of 485±lOnm, and an emission of 530± 12.5nm. The FL determined 
and the percentage of leakage across the J-HCET monolayer calculated (equation 
2.1). The samples from the inserts, on the 96 well plate were then transferred to the 
corresponding wells of the 24 well plate and the total resorufin levels measured with 
an excitation filter of530±lOnm and an emission filter of590±12.5nm. The resorufin 
standard curve (24 well plate; figure 2.2) was used to determine the conversion of 
resazurin to resorufin in each sample from their respective absorbencies. 
Equation 2.1 : Determining the degree ofleakage across the J-HCET monolayer 
Fluorescein that crossed the monolayer 
Fluorescein that crossed the no-cell insert 
2.2.4.4 Glutathione equivalents assay (GSHEQ) 
x 100 
The colorimetric GSH assay was used to determine the amount ofthiols within the J-
HCET monolayers. The method was adapted from Saville (1958) for use in 96 well 
plates. The assay worked on the assumption that the majority of thiols within the J-
HCET were those in the GSH molecules. Wells were aspirated and washed with 
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200,.tl HBSS. A 2 0 ~ M M glutathione standard ( 5 0 ~ l ) ) was run with each experiment to 
ensure consistency. Sulphosalicylic acid solution ( 5 0 ~ l ) ) was added to the wells and 
the plates agitated for 30 minutes on a rotatest plate shaker. Sodium nitrate (lmM, 
5 0 ~ l ) ) was added to each well and agitated on a rotatest plate shaker for 5 minutes. 
Aqueous ammonium sulphamate (20IlI, 0.5% w/v) was added to each well and the 
plate agitated for 15 minutes. Mercury (11) chloride (0.2% w/v) and sulphanilamide 
(0.68% w/v) solution, 6 5 ~ 1 1 was added to each well and immediately 5 0 ~ 1 , . .0.1 % 
(w/v) n-l-naphthylethylenediame dihydrochloride solution was added. The colour of 
the solution was allowed to develop for 5 minutes. Samples (200IlI) were transferred 
to the corresponding position in a 96 well plate and the absorbance measured using 
an ASYS HITECH Expert plate reader at 550±10nm. Glutathione (ImM) standard 
solution was used to create dilutions of 0, 1.56,3.13,6.25, 12.5,25,50 and 1 0 0 ~ M M
GSH in sulphosalicylic acid (5% v/v in dH20). Dilutions ( 5 0 ~ l ) ) were added to the 
wells of a 96 well plate and the glutathione equivalents (GSHEQ) assay performed. 
Samples (200IlI) were transferred to the corresponding position of a 96 well plate and 
the absorbance measured at 550±10nm. Absorbance readings were collated to 
produce a standard curve (figure 2.3). 
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Figure 2.3 : Glutathione equivalents assay standard curve (mean±S.D, n=9). 
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For linear section; y =O.0063x (where y is absorption at 550±12.5nm and x is 
glutathione content (pM). At glutathione concentrations above lOOpM the standard 
curves exhibits non-linear behaviour. 
2.2.4.5 Neutral red uptake (NRU) assay 
The neutral red uptake assay measures the uptake of the neutral red (vital dye) 
compound by cells and is a simple and effective measure of cell viability as used in 
the validated 3T3 phototoxicity study (Spielmann et ai. , 1998; Lovschall et ai. , 
2002). Media was aspirated from the wells and the mono layers washed twice with 
200J.11 HBSS (containing 1mM calcium). Medium containing neutral red dye 
(33J.1gmr1) was added (250J.11) and the plate incubated for 3 hours at 37oC, 5% C02 
(v/v) in air. The neutral red containing medium was aspirated and the cells washed 
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twice with HBSS to remove unbound dye. Neutral red desorb solution (the kenacid 
blue fixative solution; section 2.l.6.3a) was added (100JlI) to extract the dye in the 
cells vesicles and cytoplasm, and the plates shaken on a rotatest plate shaker for 40 
minutes. Plates were measured using an ASYS lflTECH Expert plate reader with an 
absorption filter of 550±1Onm. Medium only wells are used as controls to account 
for the direct adherence of dye to the proteins or lipid that could adhere from the 
medium to the tissue culture surfaces. These background values were subtracted 
before the graphs were produced. A standard curve was used to determine the uptake 
of neutral red in each sample from their absorbencies (figure 2.4). A standard curve 
was produced using samples of 0, 0.06, 0.12, 0.25,0.51, l.03, 2.06, 4.12, 8.25, 16.50 
and 33Jlgmr1 neutral red in desorb solution. NB neutral red can crystallise and this 
becomes obvious as it will significantly augment the OD readings. 
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Figure 2.4 : Neutral red assay standard curve (mean±S.D, n=4). 
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For linear section; y =O. 0398x (where y is absorption at 550±12.5nm and x is neutral 
red dye content (mgmr J). 
2.2.5 Imaging techniques 
2.2.5.1 Indirect immunohistochemistry 
Cultures were fixed in paraformaldehyde solution (1 % w/v in PBS) for 30 minutes 
and then 200111 Triton X-lOO (0.1 % v/v in PBS) for 5 minutes to permeabilize the 
cells. Normal goat serum (NGS) (5% v/v in PBS) was added for 30 minutes at room 
temperature to block non-specific binding of the secondary antibody. The primary 
antibody (table 2.0) was diluted in 0.1% BSA (w/v) in PBS and incubated at 4°C 
overnight. Monolayers were rinsed with BSA (0.1% w/v in PBS) solution and 
washed in fresh BSA solution. The secondary antibody (table 2.1) was diluted in 
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(0.1% BSA w/v in PBS), applied and incubated at room temperature for 1 hour in the 
dark. Slides were rinsed with BSA (0.1 % w/v in PBS) solution and washed in fresh 
BSA solution. Slides were washed in water and mounted using Vectashield™ 
containing propidium iodine (50Jlgmr1). The slides were viewed under a Leica 
Confocal Microscope. 
2.2.5.2 Transmission electron microscopy (TEM) 
All processing steps requiring the use of chemicals were carried out in a fume 
cupboard. J-HCET cells were fixed by immersion in 3% glutaraldehyde in O.IM 
phosphate buffer (pH 7.2) for 30 minutes at room temperature. Inserts were washed 
three times in O.lM phosphate buffer and stored in 6% sucrose in O.lM phosphate 
buffer at 4°C until required. This fixation does not add electron opacity to the J-
BCET, so staining and post fixation in osmium tetroxide (OS04), uranyl acetate and 
lead citrate for 30 minutes. This step is required when ultrathin sections are to be 
examined. The inserts were washed five times in distilled water before immersion in 
a 2% (w/v in distilled water) solution ofuranyl acetate for 30 minutes protected from 
light. The fixed cells were dehydrated through graded alcohols before infiltration 
with resin. During the dehydration steps the polycarbonate membrane was removed 
from the polystyrene casing of the culture insert and further processing carried out on 
the cells attached to the membrane alone. TransmitTM, a low viscosity low toxicity 
resin was used for these delicate samples. Once infiltrated with the 
resin/hardener/accelerator mixture, the blocks were moved to an oven and 
polymerised overnight at 70°C. Sections of 1 Jlm were taken to orientate the blocks 
for ultrathin sections of a suitable portion of the monolayer. Ultrathin sections (70-
93 
90nm) were cut on a Reichert Ultracut E microtome, placed on copper grids and 
contrasted with Reynolds lead citrate. Samples were then viewed in a Phillips 410 
Transmission Electron Microscope operated at 80KV. 
2.2.6 Analysis of data 
All experiments were performed at least in triplicate, with intra-experimental 
replicates performed for each experiment. The mean and standard deviations (S.D) 
were determined using raw data in Microsoft Excel XP. When repeat runs were 
available the repeat measure ANOV A (analysis of variance) test was employed with 
the post hoc Dunnett test to determine significant differences. Significance was set 
at p<O.05. For these statistical tests the n number used was the sample number, not 
the number of replicates. GraphPad Prism 4 software (GraphPad Software Inc, San 
Diego, USA) was used to perform the statistical analysis. 
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Chapter 3 
Development of culture response methods 
Development of culture response methods 
3.1 Determination of J·HCET cell line population doubling time 
3.1.1 Introduction 
Measurement of the population doubling time is used to quantify the response of the 
cells to different inhibitory or stimulatory factors, such as variations in nutrient 
concentration or hormonal effects in medium or toxic drug exposure (Freshney, 
1994). Studies were conducted to determine the effects that an animal product free 
human keratinocyte growth supplement (HKGS-V2), has upon the doubling time of 
the J-HCET corneal cell line. Unlike HKGS supplements which contain animal 
derived products, HKGS-V2 supplements require the use of a collagen matrix to aid 
initial cellular attachment upon seeding. Cascade Biologics Ltd produce an 
attachment matrix (type I collagen; TIC) specifically for use with the HKGS-V2 
supplements, however, the use of an alternative fibronectin-collagen (FNC) matrix 
produced by AthenaES was investigated as a potential substitute. The population 
doubling times were, therefore, determined for J-HCET cultured with HKGS and 
HKGS-V2 supplemented media on both coated and uncoated flasks. 
3.1.2 Materials and Methods 
Human corneal epithelial cells (J-HCET) cultured in either HKGS or HKGS-V2 
supplemented growth media (section 2.1.7.1) were seeded into 25cm2 flasks 
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(uncoated, TIC or FNC pre-coated as recommended by the manufacturer) at a density 
of 4xl04 cells per flask in Sml of medium. Triplicate flasks were established for 
each time point. Cultures were maintained at 370 C, 5% C02 (v/v) in air and refed 
with fresh medium every 48 hours. During the experiment J-HCET were harvested 
after 24 hours of growth and subsequently every 24 hours up to 120 hours. The total 
cell number was determined using a haemocytometer (section 2.2.3.2). The number 
of population doublings in 24 hours was calculated using the following equation. 
3.1.3 Results 
24 
Totlll cell number lit 96 hours) -1 
Total cell number ot 24 hours 
At 24 hours post seeding the cell number in the flasks had not significantly changed 
from the initial number seeded (figure 3.01), indicating a possible lack of attachment 
of J-HCET cells and/or a low initial rate of proliferation (i .e. an initial lag recovery 
phase post seeding) as a result of trypsinisation. In the subsequent 24 hours, (48 hrs 
post seeding) the cell number of both HKGS and HKGS-V2 cultures had 
significantly increased with a population doubling time of 22±0.03 and 21 ±0.S hours 
for HKGS or HKGS-V2 supplements respectively (figure 3.01). If the recommended 
TIC matrix was not applied to the culture flasks when, HKGS-V2 supplements were 
employed, the population doubling time was determined as 31±1.8 hours. The 
addition of a TIC matrix to flasks, when using the HKGS supplements, did not 
97 
significantly alter the population doubling time (figure 3.02) from that of the HKGS 
cultures grown on uncoated flasks. 
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Figure 3.01 : Growth curves of J-
HCET cultured in Epilife media 
containing either HKGS • or HKGS-V2 
supplements with • or without a 
collagen matrix over 120 hours. The 
J-HCET cell number increased 
significantly (* = P<0.05) with respect 
to 0 hour cultures when grown in either 
HKGS or HKGS-V2 supplemented 
media. There was no significant 
difference in cell number at each time 
point between the two supplements. 
From 72 to 120 hours the number of 
cells present in HKGS-V2 supplemented 
medium without a collagen coating was 
significantly (* P<0.05) lower 
compared to HKGS-V2 supplemented 
medium with a collagen coating 
(mean+SD, n=4). 
Figure 3.02 Growth curves of J-
HCET cultured in HKGS supplemented 
growth media in standard culture flasks 
• or with a collagen coating over 120 
hours. The J-HCET cell popUlation 
increased significantly (* = P<0.05) with 
respect to 0 hour cultures when cultured 
with or without matrix coating. There 
was no significant difference between 
the cell numbers at each time point 
between the two supplements . 
(mean+SD, n=4) . 
When an FNC matrix was employed the cell number had not significantly changed 
over the initial 24 hour period from the initial number seeded (figure 3.03 & 3.04), 
indicating a either low attachment or a low rate of proliferation, i.e. an initial lag 
recovery phase post seeding in this first 24 hours. The population doubling time for 
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J-HCET cultured in HKGS or HKGS-V2 supplemented media in FNC pre-coated 
flasks was determined as 18±0.8 and 43±1.3 hours respectively (figure 3.03 & 3.04), 
i.e. the FNC was not a substitute for the designated coating. 
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Figure 3.03 Growth curves of J-
HCET cultured in HKGS supplemented 
growth media in standard culture flasks 
_ or with a FNC coating _ over 120 
hours. The J-HCET cell popUlation 
increased significantly C* = P<O.05) with 
respect to 0 hour cultures when cultured 
with or without matrix coating. No 
significant difference is observed 
between cell number at any time point in 
either FNC or standard flasks. 
(mean+S.D, n=4). 
Figure 3.04 : Growth curves of J-
HCET cultured ID HKGS-V2 
supplemented growth media in standard 
culture flasks _ or with a FNC coating 
- over 120 hours . The J-HCET cell 
population increased significantly C* = 
P<O.05) with respect to 0 hour cultures 
when cultured with or without matrix 
coating. At 48 and subsequently up to 
96 hours the number of cells present 
when the matrix was employed was 
significantly C* P<O.05) lower 
compared to HKGS-V2 supplemented 
medium alone Cmean+SD, n=4). 
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3 .. 2 J-HCET seeding density required for monolayer formation 
3.2.1 Introduction 
Preliminary studies were carried out to determine a suitable seeding density whereby 
the J-HCET would become confluent 72 hours post seeding. This was performed so 
that the time taken to reach confluence could be predicted. In addition, the resazurin 
reduction-, neutral red uptake- and kenacid blue assays for cell activity, membrane 
integrity and total protein respectively, were optimised for use with the J-HCET cell 
line when utilizing 96 well plates. 
3.2.2 Materials and Methods 
J-HCET where seeded at lxl04, 5xl04, Ix10s, 2xlOs, 3xlOs, 4xlOs ,5xIOs, lxl06 and 
5xl06 cells mrl. One hundred microlitres of cell suspension were seeded per well 
into 96 well plates and incubated at 370 C, 5% CO2 (v/v) in air for 72 hours. The 
resazurin reduction- (section 2.2.4.2), neutral red uptake (section 2.2.4.5) and 
kenacid blue (section 2.2.4.1) assays were performed sequentially on the same 
cultures. 
3.2.3 Results 
In addition to protein measurements, microscopic observations revealed that a 
seeding density of 3xlOs cells mrl resulted in a confluent J-HCET monolayer 72 
hours post seeding and a protein content of 40llgmr1 (figure 3.05). At seeding 
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density above 3xl05 cells mrl (4x105, 5xlOs, lx106 and 5x106 cells mrl) a 
monolayer was also established 72 hours post seeding with protein measurements 
reaching a plateau of approximately 45llgmrl. This apparent inconsistency is 
associated with the increased cellular packing, within the J-HCET monolayer, that 
occurs at higher seeding densities. At seeding densities between lx104 and 5x104 
cells mrl resorufin production (resazurin reduction) increased proportionally with 
seeding density (figure 3.06). A plateau of resorufin production was achieved at 
seeding densities between 5x105 and 5xl06 cells mrl which was consistent with the 
total well protein content reaching a maximum at these higher seeding densities 
(figure 3.05). At seeding densities between lx104 and 4x104 cells mrl neutral red 
uptake increased proportionally with seeding density (figure 3.07). A plateau of 
neutral red uptake was achieved at seeding densities between 4x105 and 5x106 cells 
mrl which was consistent with protein content reaching a maximum. The profiles 
generated using the differing techniques are comparable. The levels of resorufin 
production, neutral red uptake and protein within the mono layers demonstrated no 
significant difference in J-HCET cultured in growth media supplemented with either 
HKGS or HKGS-V2. 
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Figure 3.05 : Effect of seeding 
density on protein content (Ilgmr') of J-
HCET cultures 72 hours post seeding 
grown in either HKGS • or HKGS-V2 • 
supplemented media. The protein 
content increased significantly (* = 
P<O.05) with respect to previous seeding 
densities when cultured using either 
supplement type up to and including 
4xJ05cells rnl-'. (mean+S.D, n=4). 
Figure 3.06 : Effect of seeding 
density on resorufm production (Ilgmr
'
) 
of J-HCET cultures 72 hours post 
seeding grown in either HKGS • or 
HKGS-V2 • supplemented media. The 
resorufm production increased 
significantly (* = P<O.05) with respect 
to previous seeding densities when 
cultured using either supplement type up 
to and including 4xJ05 cell mr. 
(mean+SD, n=4). 
Figure 3.07 : Effect of seeding 
density on neutral red uptake (Ilgml-') of 
J-HCET cultures 72 hours post seeding 
grown in either HKGS • or HKGS-V2 • 
supplemented media. Neutral Red 
uptake increased significantly (* = 
P<O.05) with respect to previous seeding 
densities when cultured using either 
supplement ~ e e up to and including 
4xJ05 cell rnl- . (mean+SD, n=3). 
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3.3 The effects of acute surfactant exposure on J-HCET monolayers 
3.3.1 Introduction 
Preliminary studies were carried out to determine the amount of damage caused by 
acute surfactant exposure to J-HCET monolayers, used to model the basal layer of 
the corneal epithelium. A range of surfactant (SDS, T20, CAPB, and BAK) 
concentrations were employed, to determine a toxicity profile. This was assessed 
using the resazurin reduction, neutral red uptake and kenacid blue assays. In 
addition the effects of Hanks balanced salt solution (HBSS) exposure was examined 
to ensure any observable effects where due to the surfactant concentrations and not 
the delivery vehicle. 
3.3.2 Materials and Methods 
Immediately pnor to use, test surfactants (SDS, T20, CAPB or BAK) were 
suspended in HBSS (containing ImM calcium chloride) to create concentrations as 
outlined in table 3.01. 
Table 3.01 : Surfactant toxicity profile concentration ranges. 
Surfactant Ionic Status Conc.ntration (mgmrt) in HISS 
Tween20 Non-ionic 500 450 400 350 300 250 200 
Sodium DodecyI Sulphate Anionic 1.60 0.80 0.40 010 0.10 0.05 0.025 
Cocamidopropylbentaine Amphoteric 0.50 0.45 0.40 0.35 0.30 0.25 0.2 
Benzalkonium Chloride Cationic 0.02 0.0175 0.015 0.0125 0.01 0.0075 0.005 
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J-HCET were seeded into the central 54 wells of five 96 well plates were seeded at 3 
x 105 cells mrl (lOOll1) for each surfactant. Phosphate buffered saline (100111) was 
applied to the outer 36 wells to prevent excessive evaporation of growth medium. 
Plates were incubated for 72 hours at 370 C and 5% CO2 (v/v) in air to allow the cells 
to attach and attain confluency. For each surfactant one plate was assayed following 
the 72 hour growth period, providing a pre-exposure control for that chemical. 
Medium was aspirated and the resazurin reduction (section 2.2.4.2), neutral red 
(section 2.2.4.5) and kenacid blue (section 2.2.4.1) assays performed. The medium 
was aspirated from the remaining plates and 200111 of each of the surfactant 
concentrations or HBSS (table 3.01) applied for 60 seconds. Wells were aspirated 
and the monolayers washed twice with 200111 ofHBSS (60 seconds) containing ImM 
calcium chloride. HBSS was aspirated and 200111 of cell culture media (pre-warmed 
to 370 C) applied. Plates were incubated at 370 C and 5% CO2 (v/v) in air. The 
resazurin reduction, neutral red uptake and kenacid blue assays were performed 
every 24 hours on different replicate plates up to 96 hours. 
3.3.3 Results 
3.3.3.1 Hanks balanced salt solution (HBSS) delivery vehicle 
HBSS (containing ImM calcium chloride) exposure was not associated with 
significant alterations in resorufin production, neutral red uptake or protein content 
of J-HCET mono layers cultured in media containing either HKGS or HKGS-V2 
supplements (table 3.02). 
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Table 3.02 : Effects of HBSS exposure on cell activity (Res), membrane integrity 
(NRU) and total protein content of J-HCET monolayers cultured in media containing 
either HKGS or HKGS-V2 supplements (mean±S.D., n=4). 
Supplement Exposur. Plnmet .. 
Time point post exPOIU,. 
Pre.xpolur. 2. Hours ..a Hours 72 Hours 96 Hours 
HKGS Medium Reson/in ( ~ g m r ' ) ) S:l:0.3 S:l:0.3 S:l:0.3 SiO.S S:l:0.3 
Ne1.tra1 Red (1I9IT1f') 21t1.S 22:1:1.0 22:1:0.8 23:1:0.3 23:1:0.S 
Protein ( ~ g m r ' ) ) 31i3.7 32:1:2 33:1:2.4 33:1:1.4 32:1:0.6 
HBSS Resorllin ( ~ g m r ' ) ) S:l:0.3 SiO.S S:l:0.2 S:l:0.3 S:l:0.3 
NNral Red ( ~ g m r ' ) ) 21i0.9 23:1:0.9 22:1:0.4 22:1:0.7 23:1:1.3 
Protein (1I9IT1f') 32:1:3.S 33:1:0.9 33:1:2.3 33:1:1.8 32:1:1.8 
HKGS-V2 Medium Resorllin ( ~ g m r ' ) ) S:l:0.2 SiO.6 S:l:0.6 S:l:0.2 S:l:0.1 
Neutral Red ( ~ g m r ' ) ) 21i1.9 21t2.6 20:1:2.3 22:1:1.1 21i0.S 
Protein ( ~ ' ) ) 33:1:4.1 34:1:3.4 32:1:2.9 33:1:2.S 31i2.6 
HBSS Resorllin ( ~ g m f ' ) ) S:l:0.4 Si 1.2 SiO.8 S:l:0.9 S:l:O.S 
Neutral Red ( ~ g m r ' ) ) 21t0.6 22:1:2.3 23:1:0.8 21:1:0.S 22:1:0.9 
Protein ( ~ g m r ' ) ) 33:1:1.2 32:1:3.6 34:1:2.S 33:1:1.2 3O:l:2.S 
3.3.3.2 Sodium dodecyl sulphate acute toxicity profile 
SDS at a concentration ofO.lmgmr1 caused the cell activity, membrane integrity and 
protein content of J-HCET mono layers to be significantly (P<0.05) reduced, 24 
hours post exposure, with subsequent recovery by 72 hours post exposure to levels 
comparable with control cultures (figure 3.08). At SDS concentrations of 0.2, 004, 
and 0.8mgmr1 resorufin production, neutral red uptake and protein content is 
significantly (p<0.05) reduced 24 hours post exposure and did not recover fully by 
96 hours (figures 3.08 to 3.10). At these concentrations recovery (in proportion to 
original exposure concentration) is observed but all measured parameters (resorufin, 
neutral red and protein) remain significantly (p<0.05) lower than controls. At a SDS 
concentration of 1.6mgmr1 all measured parameters were significantly reduced 
(P<0.05) 24 hours post exposure with no subsequent recovery over 96 hours. The 
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toxicity profiles for resorufin production, neutral red uptake and protein content were 
comparable for J-HCET cultured in growth medium containing either HKGS or 
HKGS-V2 supplements, (figures 3.08 to 3.10) only the HKGS being shown as for 
the seeding density study (figures 3.05 to 3.07). 
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Figure 3.08 : Production ofresorufm 
( ~ g m r l ) ) of J-HCET monolayers cultured 
in medium contammg HKGS 
supplements over 96 hours subsequent to 
acute (60 seconds) sodium dodecyl 
sulphate exposure _ Control, _ 
0.025mgmr
'
, 0.05mgmrl , O.lmgmr 
I , _ 0.2mgmr
'
, _ O.4mgmrl , _ 0.8mgmr 
I , and _ 1. 6mgmr 1 where • denotes a 
significant (P<0.05) decrease m 
resorufm production compared to 
control cultures (mean+SD., n=4). 
Figure 3.09 : Neutral red uptake 
( ~ g m m - l ) ) of J-HCET mono layers cultured 
in medium containing HKGS 
supplements over 96 hours subsequent to 
acute (60 seconds) sodium dodecyl 
sulphate exposure _ Control, _ 
0.025mgml-l, 0.05mgmrl, O.lmgmr 
I , _ O.2mgmr
'
, _ O.4mgmrl, _ 0.8mgmr 
I , and _ 1.6mgml-' where • denotes a 
significant (P<0.05) decrease in neutral 
red uptake compared to control cultures 
(mean+SD., n=3). 
Figure 3.10 : Protein content ( ~ g m m ­
I) of J-HCET monolayers cultured in 
medium containing HKGS supplements 
over 96 hours subsequent to acute (60 
seconds) sodium dodecyl sulphate 
exposure _ Control, _ O.025mgml-' , 
O.OSmgml-l , O.lmgml-r, _ O.2mgmr
'
, 
_ O.4mgmrl, _ 0.8mgmr
'
, and _ 
1.6mgml-' where • denotes a significant 
(P<O.OS) decrease in protein content 
compared to control cultures 
(mean+S.D., n=4). 
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3.3.3.3 Tween 20 acute toxicity profile 
At a T20 concentration of 350mgmr1 the cell activity, membrane integrity and 
protein content of J-HCET mono layers are significantly (P<0.05) reduced 24 hours 
post exposure. At this concentration limited recovery was observed in cell activity 
(resorufin production) over 96 hour culture period. Membrane integrity and protein 
content returned to levels comparable with control cultures by 96 hours. At T20 
concentrations of 400, 450 and 500mgmr1 all measured parameters (resorufin, 
neutral red and protein) were significantly reduced (P<0.05) 24 hours post exposure 
with no subsequent recovery by 96 hours (figures 3.11 to 3.13). The toxicity profiles 
for resorufin production, neutral red uptake and protein content were comparable for 
J-HCET cultured in growth media containing either HKGS or HKGS-V2 
supplements, only the HKGS results being shown. 
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Figure 3.11 : Production ofresorufin 
equivalents ( ~ g m m - I ) ) of J-HCET 
monolayers cultured in medium 
containing HKGS supplements over 96 
hours subsequent to acute (60 seconds) 
tween 20 exposure _ Control, _ 
200mgml-l, 250mgml-l, 300mgmrl, 
- 350mgmrl, . 400mgml·l, _ 450mgmr 
I, and _ 500mgmrl where • denotes a 
significant (P<0.05) decrease in 
resorufin production to control cultures 
(mean+S.D., n=4) . 
Figure 3.12 : Neutral red uptake 
( ~ g m l - I ) ) of J-HCET monolayers cultured 
in medium containing HKGS 
supplements over 96 hours subsequent to 
acute (60 seconds) tween 20 exposure _ 
Control, _ 200mgmrl, 250mgmrl, 
300mgml-l, _ 350mgmrl, _ 400mgml-l, 
- 450mgml-l, and _ 500mgml-1 where * 
denotes a significant (P<0.05) decrease 
in neutral red uptake compared to 
control cultures (mean+S.D., n=3) . 
Figure 3.13 : Protein content ( ~ g m r r
I) of J-HCET monolayers cultured in 
medium containing HKGS supplements 
over 96 hours subsequent to acute (60 
seconds) tween 20 ell."-posure _ Control, 
• 200mgmrl, 250mgmrl, 300mgml-
I, • 350mgml-l, 400mgml-I,_ 
450mgml-l, and _ 500mgmrl where • 
denotes a significant (p<0.05) decrease 
in protein content compared to control 
cultures (mean+S.D., n=4). 
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3.3.3.4 Cocamidopropylbetaine acute toxicity profile 
At CAPB concentrations of 0.3mgmr' and 0.35mgmr' the activity, membrane 
integrity and protein content of J-HCET monolayers was significantly (P<0.05) 
reduced 24 hours post exposure, with subsequent recovery in neutral red uptake and 
protein content by 96 hours to levels comparable with control cultures (figures 3.14 
to 3.16). At 0.35mgmr' the reduction of resorufin production did not recover by 
96hrs. At CAPB concentrations of 0.40, 0.45 and 0.50mgmr' resorufin production 
and neutral red uptake were significantly (P<0.05) reduced 24 hours post exposure, 
with limited recovery (in proportion to original exposure concentration) was 
observed over the subsequent times (figures 3. 14 to 3.16). Resorufin production and 
neutral red uptake remained significantly (P<0.05) lower than control cultures. The 
toxicity profiles for resorufin production, neutral red uptake and protein content were 
comparable for J-HCET cultured in growth media containing either HKGS or 
HKGS-V2 supplements, those in HKGS being shown. 
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Figure 3.14 : Production ofresorufin 
(J..lgmrl) of J-HCET monolayers cultured 
in medium contammg HKGS 
supplements over 96 hours subsequent to 
acute (60 seconds) 
cocamidopropylbetaine exposure • 
Control, • 0.20mgml'l , 0.25mgmrl , 
OJOmgmrl , _ 0.3Smgmr' , _ 0.40mgmr 
I , _ 0.45mgml", and _ O.SOmgmrl 
where • denotes a significant (P<0.05) 
decrease in resorufm production to 
control cultures (mean+SD., n=4). 
Figure 3.15 : Neutral red uptake 
(J..lgml'l) of J-HCET monolayers cultured 
in medium containing HKGS 
supplements over 96 hours subsequent to 
acute (60 seconds) 
cocarnidopropylbetaine exposure _ 
Control, _ 0.20mgml", 0.25mgrnr' , 
0.30mgml", _ 0.35mgml" , 0.40mgml' 
I , _ 0.45mgmrl , and _ 0.50mgrnr1 
where • denotes a significant (P<O.OS) 
decrease in neutral red uptake compared 
to control cultures (mean+SD., n=3). 
Figure 3.16 . Protein content 
(J..lgml' l) of J-HCET mono layers cultured 
in medium containing HKGS 
supplements over 96 hours subsequent to 
acute (60 seconds) 
cocarnidopropylbetaine exposure _ 
Control, _ 0.20mgmr1, 0.25mgrnrl , 
0.30mgml'l , • 0.35mgml'l, . 0.40mgrnr 
I , _ 0.45mgrnrl , and _ 0.50mgml' l 
where * denotes a significant (P<O.OS) 
decrease in protein content compared to 
control cultures (mean+SD., n=4). 
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3.3.3.5 Benzalkonium chloride acute toxicity profile 
At BAK concentrations of 100llgmr1 activity, of the J-HCET monolayers was 
significantly (P<0.05) reduced 24 hours post exposure (figure 3.17). At this 
concentration recovery was observed in resorufin production by 72 hours to levels 
comparable with control cultures. No significant alterations were observed in neutral 
red uptake or protein content at a BAK concentration of 100f,1gmr1. At BAK 
concentrations of 125, 150, 175, and 200f,1gmr1 resorufin production, neutral red 
uptake and protein content were significantly reduced (P<0.05) 24 hours post 
exposure with no subsequent recover by 96 hours (figure 3.17,3.18 and 3.19). The 
toxicity profiles for resorufin production, neutral red uptake and protein content were 
comparable for J-HCET cultured in growth media containing either HKGS or 
HKGS-V2 supplements, the HKGS medium results being shown. 
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Figure 3.17 : Production ofresorufin 
equivalents ()lgrnJ-1) of J-HCET 
monolayers cultured in medium 
containing HKGS supplements over 96 
hours subsequent to acute (60 seconds) 
benzalkonium chloride exposure • 
Control, • SO)lgml-l, 7S)lgrnl-l , 
100)lgrnl-l, • 12Sflgrnl-l , • lSOflgmrl, • 
l7Sflgmrl, and . 200flgmrl where * 
denotes a significant (P<O.OS) decrease 
in resorufm production compared to 
control cultures (mean+SD., n=4) . 
Figure 3.18 : Neutral red uptake 
()lgmrl) of J-HCET mono layers cultured 
in medium containing HKGS 
supplements over 96 hours subsequent to 
acute (60 seconds) benzalkonium 
chloride exposure • Control, • SOflgmr 
I, 7S)lgml-l, 100flgrnl-I , . l2Sflgmr 
I , • lSO)lgml-l, • 17S)lgml-l, and . 
200flgmrl where • denotes a significant 
(P<O.OS) decrease in neutral red uptake 
compared to control cultures 
(mean+SD., n=3). 
Figure 3.19 : Protein content ()lgml-
I) of J-HCET monolayers cultured in 
medium containing HKGS supplements 
over 96 hours subsequent to acute (60 
seconds) benzalkonium chloride 
exposure _ Control, _ SO)lgml-l, 
7S)lgrn1-I , lOOflgml-I , . 12S)lgmrl, • 
l S0)lgml-l , • 17S)lgrnJ-1, and . 
200)lgml-1 where • denotes a significant 
(P<O.OS) decrease in protein content 
compared to control cultures 
(mean+S.D., n=4). 
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3.4 Determination of maximal surfactant concentration in growth 
media for sustained J-HCET viability over 21 days. 
3.4.1 Introduction 
Preliminary studies were carried out to determine the maximal concentration of SDS, 
T20, CAPB and BAK, in growth medium, that would allow sustained J-HCET 
viability over a 21 day exposure period. A range of concentrations were employed, 
to determine a dose response of toxicity, assessed using neutral red uptake and 
kenacid blue assays. 
3.4.2 Materials and Methods 
Immediately pnor to use test surfactants (SDS, T20, CAPB or BAK), were 
suspended in growth medium (section 2.1.7.1) (containing ImM calcium chloride) to 
give the concentrations as outlined in table 3.03. Surfactant concentrations were 
made up in medium containing either HKGS or HKGS-V2 supplements. Chronic 
surfactant concentrations were stored at 40 C and used within 4 weeks of preparation. 
Table 3.03 : Concentration of surfactants used in the determination of subcytotoxic 
surfactant concentration. 
QJfada't 0I111111111Q15 inQwAhMlda"""", 
T . . . . . . , ~ ~ 5.:1) 7Jfl 11.57 17.00 25.00 36.75 54.02 79.41 116.73 
S o c k m ~ & l P * * 1.85 272 3.9:1 5.86 &62 1267 1a63 Z I . ~ ~ 4123 
~ ~ 0.64 Q.94 1 . ~ ~ 204 2!IiI 4.41 6.48 9.52 14.00 
Bel 1ZIIIait.m0blde 0.aJ25 0.0031 0.0046 0.cal5 0.CD44 0.(0)4 0 . 0 I ~ ~ o.a;n; o.cmt 
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J-HCET were seeded into the central 54 wells of eight 96 well plates at 3xl0s cells 
mrl (l00J.1l). Phosphate buffered saline (PBS) (l001l1) was applied to the outer 36 
wells to prevent excessive evaporation of growth media. Plates were incubated for 
72 hours at 37°C and 5% CO2 (v/v) to allow cells to attach and attain confluency. 
For each surfactant one plate was assayed, following the initial 72 hour growth to 
confluence period, providing a pre-exposure control for that chemical. Medium was 
aspirated and the neutral red (section 2.2.4.5) and kenacid blue (section 2.2.4.1) 
assays performed. The medium in the remaining plates was replaced with 200111 of 
medium containing surfactant concentrations as outlined in table 3.03. For each 
concentration 6 wells were employed. Plates were refed with fresh culture media. 
containing the appropriate surfactant, every 72 hours and incubated at 370 C and 5% 
C02 (v/v) in air. The neutral red uptake and kenacid blue assays were performed on 
one plate every 72 hours over 21 days (504 hours). 
3.4.3 Results 
SDS (figure 3.20alb) and T20 (figure 3.21a1b) concentrations employed above 
41lgmr1 and 251lgmrl respectively, resulted in significantly reduced neutral red 
uptake and protein content following 72 hours exposure, continuing up to 504 hours. 
Below these concentrations no significant effects on neutral red uptake or protein 
content were observed. CAPB (figure 3 .22a1b) concentrations employed above 
2.991lgmr1 resulted in a significant (p<O.05) reduction in neutral red uptake and 
protein content, compared to the control, after 288 hours up to 504 hours. 
Concentrations below 2.99J.1gmr1 had no significant effect on neutral red uptake or 
protein content. BAK (figure 3.23a1b) concentrations used above 0.0025J.1gmr1 
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significantly (p<0.05) reduced neutral red uptake and protein content after 144 hours 
up to 504 hours. Concentrations below 0.00251lgmrl had no significant effect on 
neutral red uptake or protein content. The toxicity profiles for neutral red uptake 
and protein content were comparable for J-HCET cultured in growth media 
containing either HKGS or HKGS-V2 supplements, the HKGS medium results being 
shown. 
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Figure 3.20a/b : Neutral red uptake (Jlgmr l ) (a) and protein content (Jlgmr l ) (b) of 
J-HCET mono layers cultured in HKGS supplemented media containing _ OJlgmr l 
(control) 2.72Jlgmr l 3.99Jlgmr l or - 5.86Jlgmr l sodium dodecyl sulphate over 
504 hours where * denotes a significant (P<0.05) decrease in neutral red uptake or 
protein content compared to control cultures (mean+S.D., n=3). 
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Figure 3.21a/b : Neutral red uptake (Jlgmr1) (a) and protein content (Jlgmr1) (b) of 
J-HCET monolayers cultured in HKGS supplemented media containing _ OJlgmr 1 
(control) 17Jlgmr l 25Jlgmr l or . 36.75Jlgmr l tween 20 over 504 hours where * 
denotes a significant (P<0.05) decrease in neutral red uptake or protein content 
compared to control cultures (mean+S.D., n=3). 
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Figure 3.22aJb : Neutral red uptake (llgmr1) (a) and protein content (Ilgmri) (b) of 
J-HCET mono layers cultured in HKGS supplemented media containing _ 0llgmr1 
(control) 2.041lgmr1 2.991lgmr1 or - 4.411lgmr1 cocamidopropylbetaine over 
504 hours where * denotes a significant (P<0.05) decrease in neutral red uptake or 
protein content compared to control cultures (mean+S.D., n=3). 
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Figure 3.23aJb : Neutral red uptake (llgmr1) (a) and protein content (llgmr1) (b) of 
J-HCET monolayers cultured in HKGS supplemented media containing _ 0llgmr1 
(control) 0.00251lgmrl 0.00311lgmrl or _ 0.00461lgmrl benzalkonium chloride 
over 504 hours where * denotes a significant (P<0.05) decrease in neutral red uptake 
or protein content compared to control cultures (mean+S.D. , n=3). 
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3.5 J-HCET doubling time when cultured in growth media containing 
subcytotoxic surfactant concentrations 
3.5.1 Introduction 
The previous studies determined subcytotoxic surfactant (SDS, T20, CAPB and 
BAK) concentrations do not reduce the viability of J-HCET mono layers as measured 
by the neutral red uptake and kenacid blue assays. It is essential to ensure that these 
surfactant concentrations do not alter the population doubling time. Subsequent 
variation in recovery profiles could then be considered to be due to a depression or 
acceleration of J-HCET metabolic activity. 
3.5.2 Materials and Methods 
Chronic exposure medium was prepared. Human corneal epithelial cells (J-HCET) 
were seeded into 25cm2 flasks (uncoated or TIC pre-coated) at a density of 4x104 
cells per flask in 5ml of medium. Triplicate flasks were established for each time 
point and surfactant type (SDS; 4llgmr1, T20; 25llgmrl, CAPB; 3llgmr1, BAK; 
0.0025Ilgmrl). Cultures were maintained at 370 C, 5% CO2 (v/v) in air and refed 
with fresh media every 48 hours. J-HCET were harvested (section 2.2.3.3) after 24 
hours from one flask, and subsequently from the other flasks at 24 hour intervals up 
to 120 hours and the cell number determined using a haemocytometer (section 
2.2.3.2). At 120 hours harvested cells were re-seeded into appropriately labelled 
25cm2 flasks and cultured for a further 120 hours. This was repeated and cell 
number determined every 24 hours to generate a growth curve over 21 days (504 
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hours). The population doubling time was calculated using the previous equation 
(section 3.1). 
3.5.3 Results 
J-HCET cells were exposed to subcytotoxic concentrations of SDS, T20, CAPB and 
BAK for a 21 day period. All surfactant exposed J-HCET population doubling times 
were compared to their corresponding control cultures. For cells grown in medium 
containing HKGS supplements, surfactant exposure did not alter the population 
doubling times (table 3.04). For cells cultured in medium containing HKGS-V2 
supplements on a TIC matrix coating, surfactant exposure significantly increased the 
population doubling times from that of the control (no exposure) cultures (table 
3.04). For cells cultured in medium containing HKGS-V2 supplements alone, 
surfactant exposure did not alter the population doubling times (table 3.04). This 
suggests that the sub cytotoxic surfactant concentrations have degraded the matrix 
pre-coated to the tissue culture plasticware hindering cellular adhesion. 
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Table 3.04 : Population doubling times of J-HCET cultured in subcytotoxic concentrations of surfactants over 21 days (mean±S.O, n=4). 
Supplement Surfactant Concentration (lJgmr1) Doubling Time (Hours) Between Days 0-5 5 -10 10 -15 15 - 21 
HKGS None (Control) N/A 22±1.3 21±0.5 21 ±0.1 21 ±0.1 
Sodium Dodecyl Sulphate 4.00 22±0.9 21±0.3 20±0.3 21 ±0.1 
Tween 20 25.00 22±1.3 21 ±0.1 21±0.3 21±0.3 
Cocam idopropylbetaine 3.00 21±0.6 21±0.6 20±0.4 21 ±0.5 
Benzalkonium Chloride 0.0025 21±1.4 20±0.2 21±0.1 21 ±0.3 
HKGS-V2Af None (Control) N/A 21±0.5 20±0.4 21±0.8 20±0.9 
Sodium Dodecyl Sulphate 4.00 26±0.2 25±0.4 24±0.5 25±0.2 
Tween 20 25.00 26±0.6 25±1.6 25±0.6 25±0.9 
Cocamidopropylbetaine 3.00 26±0.7 26±0.1 26±1.2 26±1.1 
Benzalkonium Chloride 0.0025 25±0.1 26±0.2 2S±0.7 26±1.3 
HKGS-V2 None (Control) N/A 30±S.6 30±0.S 28±0.1 29±0.3 
Sodium Dodecyl Sulphate 4.00 31±0.8 29±0.5 27±1.4 28±1.1 
Tween 20 25.00 31±0.3 29±0.3 29±0.S 30±0.8 
Cocam idopropylbetaine 3.00 30±0.1 29±0.1 28±1.9 30±0.7 
Benzalkonium Chloride 0.0025 29±0.3 28±0.3 27±0.8 29±0.S 
-N 
- M Culture flasks were pre-coated with the recommended type I collagen 
3.6 Evaluation of the effects of chronic subcytotoxic surfactant 
exposure to a human corneal cell line 
3.6.1 Introduction 
This study aims to investigate the chronic adverse effects of exogenous chemicals. 
Initially the viability of the J-HCET mono layers was monitored following chronic 
exposure to subcytotoxic concentrations of four representative surfactants; SDS, T20, 
CAPB and BAK. Interactions between surfactants were investigated to determine if 
chronic exposure to one surfactant, at subcytotoxic concentrations, rendered the J-
HCET monolayer more or less susceptible to a subsequent acute exposure to the 
same or different surfactant. Measurements of monolayer viability were made using 
the resazurin reduction, neutral red uptake and ken acid blue assays. 
3.6.2 Materials and Methods 
Culture flasks (80cm3) were seeded with 5xlOs of J-HCET cells in normal culture 
medium and incubated for 24 hours at 370 C, 5% (v/v) CO2 in air. Medium or 
medium containing subcytotoxic surfactant concentrations was added to each flask 
where appropriate. Cultures were maintained at 370 C, 5% (v/v) CO2 in air, re-fed 
with the appropriate medium every 72 hours over 432 hours (18 days) and 
subcultured once cells were 70-80% confluent. Cells were monitored on a daily 
basis at low magnification (xl0 objective) to ascertain the level of cell growth, cell 
morphology and to check for contamination. Following the 18 day exposure, J-
HCET cells were harvested from large culture flasks. The central 54 wells of five 96 
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well plates were seeded at 3xl05 cells mrl (lOOJ.1l) for each surfactant, as outlined in 
figure 3.24. Phosphate buffered saline (lOOJ-ll) was applied to the outer 36 wells to 
prevent excessive evaporation of growth medium. Plates were incubated for 72 
hours at 37°C and 5% C02 (v/v) in air to allow the cells to attach and attain 
confluency. At this point the cells have been cultured in subcytotoxic concentrations 
of the respective surfactant for 21 days. 
Figure 3.24: J-HCET seeding template to assess the effects of chronic 
subcytotoxic surfactant exposure. 
A 
B 
c Control J-HCET (unexposed) 
o 
E 
Control J-HCET (unexposed) 
F 
H 
Unexposed J-HCET 
Control J-HCET (SOS, T20, CAPB or 
BAI< pre-exposed) 
SOS, T20, CAPB or BAK pre-exposed 
J-HCET 
Surfactant pre-exposed J-HCET 
For each surfactant one plate underwent resazurin reduction assay then neutral red 
uptake and finally kenacid blue (total protein) assays. This provided a pre-exposure 
control for that chemical. In the remaining plates the medium was replaced in row C 
with either medium C2-6 or medium with chronic levels of the respective surfactant 
C7-11. Rows D to G (figure 3.24) were aspirated and 200J-lI of each surfactant, at a 
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predetermined concentration (section 3.3, SDS; 0.lmgmr1, T20; 325mgmr1, CAPB; 
0.3mgmr1 and BAK; 100Jlgmr1), was applied for 60 seconds. Cells were washed 
with 200JlI of PBS (2 x 60 seconds). Medium or medium containing subcytotoxic 
surfactant concentrations (200JlI) was applied. Plates were incubated at 37°C and 
5% C02 (v/v) in air. The resazurin reduction, neutral red uptake and kenacid blue 
assays were performed on replicate plates at 24 hour intervals, up to 96 hours. 
3.6.3 Results 
3.6.3.1 Effects of chronic subcytotoxic surfactant exposure on J-HCET 
resorufin production, neutral red uptake and protein content. 
Control un-exposed and pre-exposed cultures (figure 3.24, row C) showed the same 
levels ofresorufin production, neutral red uptake or protein content (table 3.05), over 
the course of the experiment. Resorufin, neutral red and protein levels were 
comparable in J-HCET cultured in growth media containing HKGS (table 3.05) or 
HKGS-V2 supplements (not shown). For the remaining experiments protein content 
data has not been shown. 
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Table 3.05 : Resorufin production, neutral red uptake and protein content of surfactant pre-exposed J-HCET monolayers cultured in medium 
containing HKGS supplements (mean±SD, n=3). 
Time Point 
Culture Conditions Parameter 
Pre-exposure 24 Hours 48 Hours 72 Hours 96 Hours 
Control (no exposure) Resorufin ( ~ g m r 1 ) ) 3.7±O.2 4.2±O.2 4.7±0.3 4.9±0.3 4.8±0.3 
Neutral Red ( ~ g m I - 1 ) ) 17±2.2 17±1.4 19±0.9 19±1.7 19±1.5 
Protein wgmr1) 51±6.1 50±3.8 58±2.4 58±4.9 59±4.3 
Sodium Dodecyl Sulphate ( 4 ~ g m r 1 ) ) Resorufin ( ~ g m r 1 ) ) 3.6±O.1 4.3±O.2 4.8±0.1 4.9±O.1 4.9±0.1 
Neutral Red ( ~ g m l - 1 ) ) 18±1.2 17±1.6 20±1.0 21±1.1 20±1.1 
Protein wgmr1) 53.6±3.4 51.6±4.6 58.3±3.9 59.5±3.1 58.0±3.0 
Tween 20 ( 2 5 ~ g m r 1 ) ) Resorufin ( ~ g m r 1 ) ) 3.1±O.2 4.2±O.2 4.8±O.2 5.1±O.5 4.9±O.2 
Neutral Red ( ~ g m I - 1 ) ) 17±1.0 17±O.3 20±1.1 21±1.9 22±1.5 
Protein wgmr1) 51±2.9 50±O.9 56±3.0 59±5.3 63±4.3 
Cocamidopropylbetaine (31JQmr1) Resorufin ( ~ g m r 1 ) ) 3.8±O.2 4.2±O.1 4.4±O.3 4.7±O.2 4.8±O.2 
Neutral Red ( ~ g m l - 1 ) ) 17±2.4 17±1.0 19±O.6 20±2.0 20±1.8 
Protein wgmr1) 52±6.8 50±3.0 56±1.6 59±5.6 59±5.1 
Benzalkonium Chloride ( O . 0 0 2 5 ~ g m r 1 : R e s o r u f i n n tgmr1) 3.7±O.2 4.2±O.4 4.9±O.2 4.9±0.2 4.8±O.4 
Neutral Red ( ~ g m I - 1 ) ) 17±1.5 17±1.6 19±O.9 21±1.4 20±1.8 
-
Protein wgmr1) 49±4.3 50±4.4 56±2.5 60±3.9 59±5.0 
N 
V\ 
3.6.3.2 Effects of SOS (0.4I.1gmr1) pre-exposure on surfactant toxicity profile 
Chronic subcytotoxic SDS exposure (figures 3.25 and 3.26) ( 4 ~ g m r l ) ) significantly 
(P<0.05) increased the toxicity of subsequent acute exposures of SDS (O.lmgmr\ 
CAPB (0.3mgmr1) and BAK ( l O O ~ g m r l ) ) demonstrated by reductions in the 
production of resorufin, neutral red uptake and protein content compared to control 
cultures. Resorufin, neutral red and protein levels were comparable in J-HCET 
cultured in growth media containing HKGS or HKGS-V2 supplements. 
3.6.3.3 Effects of T20 (25IJgmr1) pre-exposure on surfactant toxicity profile 
Tween 20 pre-exposure (figure 3.25 and 3.26) significantly (P<O.05) decreased the 
toxicity of subsequent acute exposures of SDS (0.lmgmr1), CAPB (0.3mgmrl) and 
BAK (lOOJ.Lgmr1). This was demonstrated by an increase in the production of 
resorufin, neutral red uptake and protein content at 24 and 48 hours post exposure for 
SDS and BAl<, and up to 72 hours for CAPB, compared to control cultures. At 96 
hours post exposure J-HCET monolayers exposed to acute T20 concentration 
demonstrate a significant (p<O.05) decrease in resorufin production, neutral red 
uptake and total protein content compared to control cultures. Resorufin, neutral red 
and protein levels were comparable in J-HCET cultured in growth media containing 
HKGS or HKGS-V2 supplements. 
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3.6.3.4 Effects of CAPB (3J,1gmr1) pre-exposure on surfactant toxicity profile 
Subcytotoxic CAPB exposure (figure 3.25 and 3.26) significantly (P<O.05) increased 
the toxicity of subsequent acute exposures of CAPB (0.3mgmr 1) and BAK 
(lO0J.1gmr1) demonstrated by reductions in the production of resorufin, neutral red 
uptake and protein content up to 96 hours compared to control cultures. Pre-
exposure to CAPB has no significant effects on resorufin production, neutral red 
uptake or protein content of J-HCET exposed to an acute concentrations or either 
SDS (O.lmgmr1) or T20 (325mgmr1). Resorufin, neutral red and protein levels were 
comparable in J-HCET cultured in growth media containing HKGS or HKGS-V2 
supplements. 
3.6.3.5 Effects of BAK (O.0025tJgmr1) pre-exposure on surfactant toxicity profile 
Chronic subcytotoxic BAK exposure (figure 3.25 and 3.26) significantly (P<0.05) 
increased the toxicity of subsequent acute exposures of SDS (0.1 mgmr\ CAPB 
(O.3mgmr1) and BAK (l00J.lgmr1) demonstrated by reductions in the production of 
resorufin, neutral red uptake and protein content up to 96 hours compared to control 
cultures. Pre-exposure to BAK has no significant effects on resorufin production, 
neutral red uptake or protein content of J-HCET exposed to an acute concentrations 
ofT20 (325mgmr1). Resorufin, neutral red and protein levels were comparable in J-
HCET cultured in growth media containing HKGS or HKGS-V2 supplements. 
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Figure 3.25 : Resorufin production (flgmrl) of J-HCET monolayers cultured in media containing HKGS supplements exposed to subcytotoxic concentrations of surfactants _ 
control culture, _ sodium dodecyl SUlphate, tween 20, cocamidopropylbetaine or , _ benzalkonium chloride for 21 days and subsequently exposed (60 seconds) to acute 
concentrations of a.) Sodium dodecyl sulphate (O.lmgmr'), b.) Tween 20 (325mgmr\ c.) Cocamidopropylbetaine (O.3mgmf') or d.) Benzalkonium chloride (lOOflgmrl) where * 
denotes a significant (P<0.05) decrease in resorufin and * a significant (P<0.05) increase in resorufin production compared to control cultures. (mean+S.D (n=4) 
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Figure 3.26 : Neutral red uptake (Ilgrnrl) of J-HCET monolayers cultured in media containing HKGS supplements exposed to subcytotoxic concentrations of surfactants -
control culture, _ sodium dodecyl sulphate, tween 20, cocamidopropylbetaine or , • benzalkonium chloride for 21 days and subsequently exposed (60 seconds) to acute 
concentrations of a.) Sodium dodecyl sulphate (O.lmgmrl), h.) Tween 20 (325mgml-I ) , c.) Cocamidopropylbetaine (O.3mgmrl) or d.) Benzalkonium chloride (lOOf./gml-l) where • 
denotes a significant (P<O.05) decrease in resorufin and • a significant (P<O.05) increase in resorufm production compared to control cultures. (mean+S.D (n=4) 
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This data has demonstrated that chronic sub cytotoxic surfactant exposure can 
modulate the response of J-HCET mono layers to subsequent acute exposures (table 
3.06) in both HKGS and HKGS-V2 supplemented growth medium. 
Table 3.06: Summary of the effects subcytotoxic surfactant exposure has on a 
subsequent acute exposure. 
Chronic Surfactant Ionic Status Parameter Significant (P<O.06) chang.ln toxicity of 
Exposure SDS (O.1mgmr1) T20 (32&mgmrl) CAPS (O.3mgmr1) SAK (100""mr1) 
Tween20 Non-ionic Resazurin R R R 
Neliral Red R R R 
Protein R R R 
Cocamidopropylbetaine Amphoteric Resazurin E E 
Neutral Red E E 
Protein E E 
Sodium dodecyl sulphate Anionic Resazurin E E E 
Neutral Red E E E 
Protein E E E 
Benzalkonium chloride Cationic Resazurin E E E 
Neutral Red E E E 
Protein E E E 
VVhere E denotes enhanced and R denotes reduced toxicity of the acute surfactant. 
Further analysis of the data obtained revealed that the ratio of resazurin production or 
neutral red uptake to total protein content per well remained constant (figure 3.07 
and 3.08) at approximately 0.08 and 0.35 respectively. This demonstrated that the 
culture viability remained constant. 
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Figure 3.27 : Ratio of resorufm production (fl gmr 1) per microgram protein of J-HCET monolayers cultured in media containing HKGS supplements exposed to subcytotoxic 
concentrations of surfactants _ control culture, _ sodium dodecyl sulphate, tween 20, cocamidopropylbetaine or , - benzalkonium chloride for 21 days and subsequently exposed 
(60 seconds) to acute concentrations of a.) Sodium dodecyl sulphate (O. lmgmrl ), h.) Tween 20 (32Smgmr1), c.) Cocamidopropylbetaine (O.3mgml·l) or d.) Benzalkonium chloride 
(100flgmr1) (mean+S.D., n=4). 
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Figure 3.28 : Ratio of neutral red uptake (flgml·l) per microgram protein of J-HCET monolayers cultured in media containing HKGS supplements exposed to subcytotoxic 
concentrations of surfactants _ control culture, _ sodium dodecyl sulphate, tween 20, cocamidopropylbetaine or , _ benzalkonium chloride for 21 days and subsequently exposed 
(60 seconds) to acute concentrations of a.) Sodium dodecyl sulphate (O.lmgmr\ h.) Tween 20 (325mgmr\ c. ) Cocamidopropylbetaine (0.3mgmr l) or d.) Benzalkonium chloride 
(lOOflgmrl ). (mean+S.D. , n=4). 
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"Cell viability and function" 
The following chapter is divided into three sections, containing experiments 
concerning J-HCET activity in relation to barrier function, those related to 
morphological changes as a consequence of medium composition, and experiments 
relating the barrier function to adhesion molecule expression and localisation. 
4.1 Optimal J-HCET seeding density for the formation of a competent 
barrier 
4.1.1 Introduction 
Multicellular organisms contain various compositionally distinct fluid compartments, 
which are bounded by epithelial and endothelial cell sheets (Tsukita and Furuse, 
1999). The corneal epithelium functions as a barrier that isolates the eye from the 
outside environment and pollutants in the tear film (Ban et al., 2003). For the 
epithelium to function as a barrier, maintaining the distinct internal environment of 
each compartment, the paracellular pathway between adjacent cells in the sheet must 
be sealed in a regulated way to prevent the diffusion of unwanted solutes and 
solvents. The apical and basolateral domains must be differentiated to allow 
selective active transport across the sheet (Tsukita and Furuse, 1999). Tight 
junctions (TJ's; Zona adherens) are directly involved in paracellular barrier function 
regulation. The TI's provide a continuous seal around the apical aspect of adjoining 
epithelial cells, thereby preventing the uninhibited passage of molecules between 
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adjacent epithelial cells via the paracellular pathway. When these junctions are 
compromised, as a result of chemical or physical injury, exogenously added sodium 
fluoresce in (MW 361) can penetrate between the cells and into the layers beneath the 
apical epithelium and reveal, using ultra violet light, the location of damage in the 
human eye (Cotton and Zanvit, 1997; Zanvit et aI., 1999). In order to act as a model 
of the corneal epithelium it is essential that the J-HCET cell line is able to form an 
effective barrier to the passage of exogenous chemicals. Previous studies with this 
cell line have shown that the combined fluorescein leakage and resazurin assays can 
be effectively employed (Combes et al., 1999; Moore et al., 2005). Preliminary 
studies were carried out to determine the optimal J-HCET seeding density to allow 
the formation of a barrier to the passage of sodium fluorescein within 3 days in vitro. 
Studies were conducted to confirm the optimal J-HCET seeding density onto 0.45Jl1l1 
polycarbonate inserts (Nuncleon) to allow the formation of a barrier to the passage of 
sodium fluorescein, as previously employed by Moore et al., (2005). 
4.1.2 Materials and Methods 
J-HCET (500J.1l) were seeded into Nunc Polycarbonate inserts at lxl04, 5xl04, 
lxlO.5, 5xl0.5, lxl06 and 5x106 cells mrl. Two inserts received 500J.11 of Epilife 
keratinocyte medium alone, i. e. were the no-cell insert controls. The eight inserts 
were placed into 24 well culture plates with 500J.11 of medium per well. Cultures 
were maintained at 37°C, 5% CO2 (v/v) in air. After 72 hours in culture the leakage 
of fluorescein across the monolayer was determined using the combined fluorescein 
leakage- resazurin reduction assay (section 2.2.4.3). The leakage data is expressed as 
a percentage of the leakage across the no-cell insert set at 100% whilst the resazurin 
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reduction as equivalents of resorufin (section 2.2.4.2). The total cell protein content 
on the inserts was established using the kenacid blue assay (section 2.2.4.1). 
4.1.3 Results 
Permeability to sodium fluorescein decreased proportionally with increasing seeding 
density (figure 4.01). A visual inspection of the inserts could not confirm the 
presence of a totally confluent l-HCET monolayer, due to the opacity of the 
polycarbonate membrane. Seeding at lx404 cells mrl did not significantly alter the 
flux of fluorescein into the basolateral chamber. At seeding densities of 5x404 to 
lx40s the leakage was significantly (P<O.05) reduced compared to the no cell control 
after 72 hours. The lowest flux occurred at 5x40s cells mrl when either HKGS or 
HKGS-V2 supplemented medium was employed, giving 5.2±O.53% and 4.2±O.11 % 
in HKGS and HKGS-V2 supplemented media respectively. This correlated with the 
resorufin production of approximately 4Jlgmrl and total protein content of 50Jlgmr1 
of the cultures, a plateau level that did not significantly increase with higher cell 
densities (figures 4.02 and 4.03). Seeding at a high density, whilst giving similar total 
cell protein and resazurin results, did adversely affect fluorescein leakage (figure 
4.01). 
4.1.4 Conclusions 
The formation of an effective barrier, in vitro depends upon formation of a confluent 
layer of cells. Studies with MDCK cells (Clothier and Samson 1996) have shown 
that if seeded at too high a density then adherence to parts of the culture surface was 
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compromised and that the small areas devoid of cells result in a high rate of 
fluorescein leakage. Therefore, the corneal cells act in the same way as previously 
observed with the MDCK cultures, namely that they need to "grow" to contluency to 
ensure a fully formed barrier in vitro. 
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Figure 4.01 : Effect of seeding 
density on fluorescein leakage across a 
J-HCET monolayer cultured in either 
HKGS • or HKGS-V2 . . Monolayers 
formed from seeding densities over 
lx104 cells mrl significantly decreased 
the leakage of fluorescein (* = P<O.05 
compared to no-cell insert). Seeding at 
5xlOs cells mrl gave the lowest flux of 
fluorescein. At higher seeding densities 
in HKGS media the leakage of 
fluorescein significantly increases 
proportionally (* = P<O.05) to density. 
In HKGS-V2 supplemented media a 
significant increase in leakage (* = 
P<O.05) is observed at a density of 5x406 
cells mrl . (mean±S.D, n=3). 
Figure 4.02 : Effect of seeding 
density on resorufin production in the J-
HCET monolayer cultured in either 
HKGS • or HKGS-V2 • . Monolayers 
formed from seeding densities over 
Ix104 cells ml- I demonstrate a 
significant (* = P<O.05) proportional 
increase in resorufin production up to a 
plateau level of 4.0flgml-l. (mean±S.D, 
n=3) . 
Figure 4.03 : Effect of seeding 
density on total protein concentration in 
the J-HCET monolayer cultured in either 
HKGS • or HKGS-V2 • supplemented 
media. Monolayers formed from 
seeding densities over Ix104 cells mrl 
demonstrate a significant (* = P<O.05) 
proportional increase in protein content 
up to a plateau level of 5x 105 cells mrl . 
(mean±S.D, n=3). 
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4.2 Modulation of barrier function by growth medium calcium 
concentration 
4.2.1 Introduction 
Tight junctions (TJ) are present around each human apical epithelial cell in vivo 
(Klyce and Beuerman, 1988; Smolin and Thoft, 1994). These prevent the movement 
of small molecules and ions between the tear film and the corneal stroma, which 
could otherwise result in corneal oedema and opacity, as the stroma fibres become 
separated (Saude, 1993). The expression and localization of the molecules that 
comprise the TJ complex are largely influenced by calcium dependent interactions 
with the cytoskeleton (Sugrue and Zieske, 1997). Preliminary studies were carried 
out to determine the optimal calcium concentration in the growth medium required to 
ensure the formation of a barrier to the passage of sodium fluorescein in vitro of 6% 
or less of the no-cell insert. 
4.2.2 Materials and Methods 
Cascade Biologics™ Epilife growth media was prepared as section 2.1.7.1 except 
calcium chloride was added to produce final concentrations of 0, 60, 80, 100, 500 
and 1000JlM. J-HeET were harvested (section 2.2.3.3) and 500JlI seeded into 
0.45Jlm Nunc polycarbonate inserts at 5x40s cells mrl suspended in growth media 
containing 0, 60, 80, 100, 500 or 1000JlM calcium. Two inserts received 500JlI of 
medium containing 60JlM calcium only and were referred to as the no-cell inserts. 
Inserts were placed into 24 well culture plates with 500JlI of medium in the wells 
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containing the same level of calcium as in the insert. Plates were maintained at 
37°C, 5% C02 (v/v) in air for 72 hours without a change in medium. The leakage of 
fluorescein across the monolayer was determined (section 2.2.4.3) as was the protein 
content (section 2.2.4.1). 
4.2.3 Results 
At calcium concentrations of 60llM to 100llM a significant reduction in fluorescein 
leakage was observed, compared to the no cell control (figure 4.04). The rates of 
resorufin production (figure 4.05) and total cell protein content (figure 4.06) were the 
same after 72 hours regardless of calcium concentration. To reduce the passage of 
fluorescein to approximately 6%, at 72 hours, a calcium concentration of 500J..lM or 
1 OOOIlM was required. 
4.2.4 Conclusions 
The degree of fluorescein leakage across J-HCET cells, cultured in medium with 
differing level of calcium, confirmed that the plant derived supplements do not 
significantly affect the capacity to form an effective barrier, i.e. the attainment of the 
leakage of 6% or (Clothier and Samson, 1996; Moore et aI., 2005). The production 
of resorufin, and total protein content of the J-HCET mono layers at all calcium 
concentrations remaining constant suggests that the alteration in fluoresce in flux 
across the J-HCET monolayer was due to modifications of the adhesion molecule 
location or production, influenced by calcium concentration. 
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Figure 4.04 : Affect of medium 
calcium concentration on sodium 
fluorescein leakage across a confluent 
layer of J-HCET cultured in either 
HKGS • or HKGS-V2 • supplemented 
media. Where * denotes a significant 
(P<0.05) reduction in fluorescein 
leakage compared to no cell insert and * 
denotes a significant reduction (P<0.05) 
in leakage compared to previous calcium 
concentration. No significant difference 
was observed in the leakage between 
different supplements at identical 
calcium concentrations. (mean±S.o, 
n=4) 
Figure 4.05 : Affect of medium 
calcium concentration on resorufm 
production (Ilgmrl) of confluent J-
HCET monolayers cultured in either 
HKGS • or HKGS-V2 • supplemented 
media containing 0, 60, 80, 100, 500 or 
1 0 0 0 ~ ~ calcium chloride. (mean±S.D, 
n=4) 
Figure 4.06 : Affect of medium 
calcium concentration on protein content 
of confluent J-HCET monolayers 
cultured in either HKGS • or HKGS-
V2 • supplemented media containing 0, 
60, 80, 100, 500 or IOOOIlM calcium 
chloride. (mean±S.o, n=4) 
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4.3 The effects of acute surfactant exposure on J-HCET barrier 
function 
4.3.1 Introduction 
Having established that with the appropriate calcium levels in the medium either of 
the two types of growth supplement can support effective barrier formation, studies 
were carried out to determine the amount of damage caused by acute surfactant 
exposure to J-HCET mono layers. Cultured in polycarbonate tissue culture inserts, a 
range of surfactant (SDS, T20, CAPB and BAK) concentrations were employed, to 
determine a toxicity profile. This was assessed using the combined fluorescein 
leakage- resazurin reduction followed by the kenacid blue total protein assays. In 
addition the effects of HBSS exposure was examined to ensure any observable 
changes where due to the surfactant exposure and not the delivery vehicle in which 
the surfactant was presented. 
4.3.2 Materials and Methods 
Immediately prior to use, test surfactants (SDS, T20, CAPB or BAK) were dissolved 
in calcium containing HBSS (1mM) to create concentrations as outlined in table 
4.01. 
142 
Table 4.01 : Surfactant toxicity profile concentration ranges. 
Surfactant Ionic Status Concentration(mgmr1) in HBSS 
Tween 20 Non-ionic 400 350 300 250 
Sodium Dodecyl Sulphate Anionic 0.80 0.40 0.20 0.10 
Cocamidopropylbentaine Amphoteric 0.50 0.40 0.30 0.20 
Benzalkonium Chloride Cationic 0.125 0.1 0.075 0.05 
J-HCET were seeded, (500,.d), into 2 Nunc Polycarbonate inserts at 5xlOs cells mrl 
suspended in Epilife™ growth medium containing subcytotoxic concentrations of 
SDS, T20, CAPB or BAK. Growth medium (SOOIJi) was added to the outer 16 wells 
to prevent excessive evaporation. Two inserts received 500IJI of medium alone and 
were referred to as the no-cell inserts. Inserts were placed into 24 well plates with an 
additional 500IJI of corresponding medium in the wells (figure 4.07). Plates were 
maintained at 37°C, 5% C02 (v/v) in air. For each surfactant 5 replicate plates were 
established. After 72 hours in culture the medium was aspirated from one plate and 
the combined fluoresce in leakage- resazurin reduction followed by the total protein 
kenacid blue assays performed as previously described (sections 2.2.4.4 and 2.2.4.1). 
From the remaining plates medium was aspirated from the inserts and 400IJI of one 
of each of the acute surfactant concentrations (table 4.01) applied for 60 seconds. 
The surfactant was removed and the monolayers washed with 200IJI ofHBSS (2 x 60 
seconds). HBSS was aspirated and 500IJI of cell culture medium (pre-warmed to 
37°C) applied. The combined fluorescein leakage- resazurin reduction and kenacid 
blue assays were performed on one plate per time point, every 24 hours over 96 
hours. 
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Figure 4.07 : Polycarbonate insert seeding template for acute surfactant exposure. 
No-cell HBSS Control 
c No-cell Control 
Surfactant 
Conc. 1 
Surfactant 
Conc.2 
Surfactant 
Conc. 3 
Surfactant 
Conc.4 
Where No-cell denotes 500pl media only, control represents J-HCET cultured in normal growth 
media and HBSS control denotes J-HCET exposed to HBSS only. 
4.3.3 Results 
4.3.3.1Sodium dodecyl sulphate acute toxicity profile 
Exposure to SDS at a concentration of 0.lmgmr1 caused the leakage of fluorescein 
across the J-HeET monolayer to be significantly (P<O.OS) increased at 24 hours post 
exposure, followed by subsequent full recovery of barrier function by 96 hours 
(figure 4.08). SDS concentrations of 0.2, 0.4 and 0.8mgmr1 caused a concentration 
dependent increase in leakage at 24 hours post exposure and subsequently partial but 
incomplete recovery by 96 hours (figure 4.08). The cell activity following exposure 
to 0.1, 0.2, 0.4 and 0.8mgmr1 SDS significantly decreased at 24 hours with 
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concentration dependent recovery by 72 hours (figure 4.09). The total cell number, 
i.e. the protein content, of the J-HCET monolayers exposed to 0.4 and 0.8mgmr i 
SDS was significantly decreased at 24 hours with subsequent complete recovery by 
48 hours (figure 4.10). 
4.3.3.1.1 Conclusion 
Whilst at 24 hours the leakage, cell activity and cell number show a concentration 
dependent reduction, at subsequent times the leakage was affected more than the cell 
activity whilst the cell number was unaffected. The toxicity profiles for fluorescein 
leakage, resorufin production and protein content were comparable for J-HCET 
cultured in growth media containing either HKGS (figure 4.08a) or HKGS-V2 
(figure 4.08b) supplements i.e. the different growth supplements do not affect 
recovery from injury. 
145 
Figure 4.08 ath : fluorescein leakage across J-HCET monolayers cultured in (a) HKGS or (b) HKGS-
V2 supplemented media over 96 hours subsequent to acute (60 seconds) sodium dodecyl sulphate exposure 
_ Control, _ O. lmgml-l, 0.2mgml-l, O.4mgml-l , and _ 0.8mgmr1 where· denotes a significant (P<0.05) 
decrease in resorufin production compared to control cultures (mean±S.D., n=3). 
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Figure 4.09 alb : Resorufm production ( ~ g m l - I ) ) of J-HCET monolayers cultured in (a) HKGS or (b) 
HKGS-V2 over 96 hours subsequent to acute (60 seconds) sodium dodecyl sulphate exposure _ Control , _ 
O. lmgml-I, 0.2mgrnl-l, O.4mgml-l , and - 0.8mgrnl-1 where • denotes a significant (P<0.05) increase in 
leakage compared to control cultures (mean±S.D., n=3). 
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Figure 4.10 alb : Protein content ( ~ g r n l - I ) ) of J-HCET monolayers cultured in (a) HKGS or (b) HKGS-
V2 over 96 hours subsequent to acute (60 seconds) sodium dodecyl sulphate exposure _ Control, _ 
O. lmgmrl, 0.2mgmrl , 0.4mgrnl-l, and _ 0.8mgml-l where * denotes a significant (P<0.05) increase in 
protein content compared to control cultures (mean±S.D., n=3) . 
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4.3.3.2 Tween 20 acute toxicity profile 
At a T20 concentration of 250mgmr1 the leakage of fluorescein across the J-HCET 
monolayer significantly (p<0.05) increased 24 hours post exposure with subsequent 
recovery of barrier function over 96 hours. At T20 concentrations of 300, 350 and 
400mgmr1 the level of fluorescein leakage to the basolateral chamber 24 hours post 
exposure and subsequently over 96 hours significantly (P<0.05) increased compared 
to the control cultures (figure 4.11). The production of resorufin by J-HCET 
monolayers exposed to 250, 300 and 350mgmr1 T20 significantly (P<0.05) 
decreased 24 hours post exposure with subsequent recovery by 72 hours (figure 
4.12). The protein content of J-HCET monolayers exposed to 350mgmr1 T20 
significantly (p<0.05) decreased 24 hours post exposure compared to control cultures 
with subsequent recovery by 48 hours (figure 4.13). Cultures exposed to 400mgmr 1 
T20 demonstrated significant (p<0.05) reductions in resorufin and protein production 
to almost undetectable levels whilst the level of fluorescein leakage to the basolateral 
chamber remained at approximately 80% over the entire 96 hour period. The 
toxicity profiles for fluorescein leakage, resorufin production and protein content 
were comparable for J-HCET cultured in growth media containing either HKGS or 
HKGS-V2 supplements, hence only those for HKGS were shown (figure 4.11 to 
4.13). 
4.3.3.2.1 Conclusions 
Whilst at 24 hours the fluorescein retention, cell activity and cell number show a 
concentration dependent decline, at subsequent times the reduced retention i. e. 
147 
increased leakage was affected more than the cell activity whilst the cell number was 
unaffected. The nature of the medium supplement did not affect the toxicity profiles, 
i.e. fluorescein leakage, resorufin production and protein content. The non-ionic 
surfactant did not interact with the cells differently as a result of choice of 
supplement. 
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Figure 4.11 : Leakage of fluorescein 
across J-HCET monolayers over 96 
hours subsequent to acute (60 seconds) 
tween 20 exposure _ Control, _ 
2S0mgml-l , 300mgrn\-I, 3S0mgrn\-I , 
and _ 400mgmr1 where • denotes a 
significant (P<O.OS) increase in 
fluorescein leakage compared to control 
cultures (mean±S.D., n=3) . 
Figure 4.12 : Production ofresorufm 
equivalents (Ilgmrl) of J-HCET 
monolayers over 96 hours subsequent to 
acute (60 seconds) tween 20 exposure _ 
Control, _ 2S0mgmrl, 300mgmrl, 
3S0mgmrl, and _ 400mgmr1 where * 
denotes a significant (P<O.OS) decrease 
in resorufm production compared to 
control cultures (mean±S.D., n=3) . 
Figure 4.13 : Protein content (Ilgrnl-
I) of J-HCET monolayers over 96 hours 
subsequent to acute (60 seconds) tween 
20 exposure _ Control, _ 2S0mgmr1, 
3 OOmgrnl-l , 3S0mgrnl-l, and _ 
400mgrn\-1 where * denotes a significant 
(P<0.05) decrease in protein content 
compared to control cultures 
(mean±S.D., n=3). 
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4.3.3.3 Cocamidopropylbetaine acute toxicity profile 
At a CAPB concentration of 0.2mgmr1 the leakage of fluorescein across the J-HCET 
monolayer significantly (p<0.05) increased 24 hours post exposure with subsequent 
recovery of barrier function over 96 hours. At CAPB concentrations of 0.3,0.4 and 
0.5mgmr1 the level of fluorescein leakage to the basolateral chamber 24 hours post 
exposure and subsequently over 96 hours significantly (P<0.05) increased compared 
to the control cultures (figure 4.14). The production of resorufin by J-HCET 
monolayers exposed to 0.2 and 0.3mgmr1 CAPB significantly (P<0.05) decreased 24 
hours post exposure compared to control cultures with subsequent recovery by 96 
hours. Cultures exposed to CAPB concentrations of 0.4 and 0.5mgmr1 demonstrated 
a significant (P<0.05) decrease in resorufin production with no subsequent recovery 
over 96 hours (figure 4.15). The protein content of J-HCET monolayers exposed to 
0.3, 0.4 and 0.5mgmr1 CAPB significantly (P<0.05) decreased 24 hours post 
exposure compared to control cultures with subsequent recovery by 96 hours (figure 
4.16). CAPB 0.2mgmr1 exposure did not significantly alter the protein content of J-
HCET mono layers. The toxicity profiles for fluorescein leakage, resorufin 
production and protein content were comparable for J-HCET cultured in growth 
medium containing either HKGS or HKGS-V2 supplements, hence only those for 
HKGS were shown. 
4.3.3.3.1 Conclusions 
At 24 hours the fluorescein retention, cell activity and cell number show a 
concentration dependent reduction, however, at subsequent times the leakage and 
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activity were affected more than protein content. The toxicity profiles for fluorescein 
leakage, resorufin production and protein content were comparable for J-HeET 
cultured in growth media containing either HKGS or HKGS-V2 supplements. 
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Figure 4.14 : Leakage of fluorescein 
across J-HCET monolayers over 96 
hours subsequent to acute (60 seconds) 
cocamidopropylbetaine exposure _ 
Control, _ 0.2mgml-' , 0.3mgmr' , 
O.4mgmr\ and _ 0.5mgmr' where * 
denotes a significant (P<0.05) increase 
in fluorescein leakage compared to 
control cultures (mean±S.D., n=3). 
Figure 4.15 : Production of resorufin 
equivalents (Ilgmr') of J-HCET 
mono layers over 96 hours subsequent to 
acute (60 seconds) 
cocamidopropylbetaine exposure _ 
Control, _ 0.2mgmr', 0.3mgmr', 
O.4mgml-', and _ 0.5mgmr' where * 
denotes a significant (P<0.05) decrease 
in resorufin production compared to 
control cultures (mean±SD., n=3). 
Figure 4.16 Protein content 
(Ilgml-') of J-HCET monolayers over 96 
hours subsequent to acute (60 seconds) 
cocamidopropylbetaine exposure _ 
Control, _ 0.2mgmr' , 0.3mgmr', 
0.4mgmr', and _ 0.5mgmr' where * 
denotes a significant (P<0.05) decrease 
in protein content compared to control 
cultures (mean±S.D., n=3). 
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4.3.3.4 Benzalkonium chloride acute toxicity profile 
At BAK concentrations of 50, 75 and 100J,lgmr1 no significant increase in 
fluorescein leakage is observed over 96 hours. A BAK concentration of 125J.lgmr1 
results in a significant (p<0.05) increase in fluorescein leakage to the basolateral 
chamber at 24 hours post exposure and subsequently over 96 hours (figure 4.17). 
Acute BAK concentrations of 50, 75, 100 and 125J,lgmr1 have no significant effects 
on either resorufin production or total protein content (figures 4.18 and 4.19) when J-
HCET were cultured in medium containing HKGS or HKGS-V2 supplements, hence 
only those for HKGS were shown. 
4.3.3.4.1 Conclusions 
A BAK concentration of 125J.lgmr1 was required to compromise the barrier function 
of J-HCET cells. Thus the other supplemented medium was tested for comparative 
effects. The toxicity profiles for fluorescein leakage, resorufin production and 
protein content were comparable for J-HCET cultured in growth media containing 
either HKGS or HKGS-V2 supplements. 
4.3.3.5 General conclusions 
There was a differential response profile to the different classes of surfactants, in the 
order T20, SDS, CAPB and BAK as most toxic. The cultures response was not 
affected either in respect of initial damage or duration or completeness of the 
recovery as a result of the growth supplement employed. 
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Figure 4.17 : Leakage of tluorescein 
across J-HCET monolayers over 96 
hours subsequent to acute (60 seconds) 
benzalkonium chloride _ Control, _ 
50flgmrl , 75flgrnl-l, lOOflgrnr l, and 
_ 125llgrnrl where * denotes a 
significant (P<0_05) increase in 
tluorescein leakage compared to control 
cultures (mean±SD_, n=3)_ 
Figure 4.18 : Production ofresorufin 
equivalents (Ilgml-I) of J-HCET 
mono layers over 96 hours subsequent to 
acute (60 seconds) benzalkonium 
chloride _ Control, _ 50flgrnl-l , 
7Sflgrnl-l , lOOflgrnl-l , and _ l2Sflgrnrl 
where * denotes a significant (P<O.OS) 
decrease in resorufin production 
compared to control cultures 
(mean±SD., n=3). 
Figure 4.19 : Protein content (flgmr 
I) of J-HCET monolayers over 96 hours 
subsequent to acute (60 seconds) 
benzalkonium chloride _ Control, _ 
SOflgrnl-\ 75flgrnrl , lOOflgrnr\ and 
- l2Sflgrnrl where * denotes a 
significant (P<0.05) decrease in protein 
content compared to control cultures 
(mean±SD., n=3) . 
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4.4 Effect of chronic surfactant exposure on J-HCET barrier function 
4.4.1 Introduction 
While acute exposure of 1 minute duration may not be affected by growth medium 
supplements, this does not mean that chronic exposure is also unaffected. Chronic 
sub cytotoxic surfactant exposure does not alter either the population doubling time 
(section 3.5) or the production of resorufin, neutral red uptake and protein content 
(section 3.6) of J-HCET. In addition to these parameters it was necessary to assess 
the effects chronic subcytotoxic surfactant exposure (SDS, T20, CAPB or BAK) 
have upon J-HCET barrier function when cultured in media containing either HKGS 
or HKGS-V2 supplements. 
4.4.2 Materials and Methods 
J-HCET were seeded, in 5 0 0 ~ 1 1 Epilife growth media, into polycarbonate inserts at 
5xl0.5 cells mrl containing subcytotoxic concentrations of SDS, T20, CAPB or BAI< 
(section 2.1.7.2). Two inserts were used per surfactant. Growth medium ( 5 0 0 ~ 1 ) ) was 
added to the outer 16 wells to prevent excessive evaporation. Two inserts received 
500Jll of medium alone, i.e. with no surfactant, and were referred to as the no-cell 
inserts. Inserts were placed into 24 well plates with an additional 500JlI of 
corresponding medium in the wells (figure 4.20). Plates were maintained at 370 C, 
5% C02 (v/v) in air for 72 hours. The fluorescein leakage (section 2.2.4.3) and 
kenacid blue (section 2.2.4.1) assays were performed every 72 hours upto 504 hours. 
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Figure 4.20: Polycarbonate insert seeding template for chronic surfactant exposure. 
No-cell Control Surfactant A 
No-cell Control Surfactant A 
Where No-cell denotes 500pl media only. control represents J-HCET cultured in normal growth 
media and Surfactant AlE denotes J-HCET cultured in media containing SDS. no. CAPE or BAK. 
4.4.3 Results 
No significant alterations in fluorescein leakage were observed compared to control 
cultures when J-HCET were cultured in growth media (with either HKGS (figure 
4.21) or HKGS-V2 (figure 4.24) supplements) containing SDS (4J,lgmr1), T20 
(25J,lgmr1), CAPB (3J,lgmr1) or BAK (O.0025J,lgmr l ). The degree of fluorescein 
leakage across the monolayer when cultured in medium containing subcytotoxic 
surfactant concentrations confirms that the surfactants do not significantly affect the 
capacity to produce an effective barrier (figures 4.21 and 4.24). In addition no 
significant alterations in either the production of resorufin (figures 4.22 and 4.25) or 
total protein content of the J-HCET mono layers was observed compared to the 
control cultures regardless of medium composition (figures 4.23 and 4.26). 
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4.4.4 Conclusions 
Subcytotoxic surfactant exposure of SDS; 4llgmrl, T20; 25llgmrl, CAPB 2.991lgmr 
1 or BAK; 0.0025Ilgmrl) have no significant effects on barrier function, total cell 
protein or activity over 21 days (504 hours), regardless of supplement (HKGS or 
HKGS-V2) employed. Even at 504 hours no indications of pending adverse reactions 
were noted. 
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Figure 4.21 : Barrier integrity of J-
HCET monolayers cultured in HKGS 
supplemented growth media _ containing 
- sodium dodecyl SUlphate ( 4 ~ g r n l - \ \
tween 20 (25flgrnl- ), 
cocamidopropylbetaine (3flgml-') or _ 
benzalkonium chloride (O.0025flgmrl) . 
(mean±S.D., n=3). 
Figure 4.22 : Resorufin production of 
J-HCET monolayers cultured in HKGS 
supplemented growth media _ containing 
- sodium dodecyl sulphate (4tgmrl), 
tween 20 (25flgrnl- ), 
cocamidopropylbetaine (3flgrnl-l) or -
benzalkonium chloride (0.0025flgmr'). 
(mean±S.D., n=3). 
Figure 4.23 : Protein content of J-
HCET monolayers cultured in HKGS 
supplemented growth media _ containing 
- sodium dodecyl sulphate (4tgrnl-\ 
tween 20 (25flgmr ), 
cocamidopropylbetaine (3 flgmr l) or _ 
benzalkonium chloride (0.0025flgrnl-I). 
(mean±S.D., n=3) . 
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Figure 4.24 : Barrier integrity of J-
HCET monolayers cultured in HKGS -V2 
supplemented growth media _ containing 
- sodium dodecyl sulphate (4egmr \ 
tween 20 (25flgmr ), 
cocamidopropylbetaine (3 flgml-1) or _ 
benzalkonium chloride (0.0025flgml·\ 
(mean±S.o. , n=3). 
Figure 4.25 : Resorufm production of 
J-HCET monolayers cultured in HKGS-V2 
supplemented growth media _ containing 
_ sodium dodecyl sulphate ( 4 ~ g m l · \ \
tween 20 (25flgml· ), 
cocamidopropylbetaine (3 Jlgml.l) or _ 
benzalkonium chloride (0.0025Jlgmr1). 
(mean±S.D., n=3) . 
Figure 4.26 : Protein content of J-
HCET monolayers cultured in HKGS-V2 
supplemented growth media _ containing 
- sodium dodecyl sulphate ( 4 ~ g m l - \ \
tween 20 (25Jlgml· ), 
cocarnidopropylbetaine (3Jlgml·l) or _ 
benzalkonium chloride (0.0025Jlgmr\ 
(mean±S.D., n=3) . 
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4.5 Evaluation of the effects acute surfactant exposure has on barrier 
function following chronic subcytotoxic exposure 
4.5.1 Introduction 
Having defined the acute toxic and chronic non-toxic concentrations of the 
representative surfactants in the two media, the effects of chronic exposure on acute 
response can be investigated. Initially the viability of the J-HCET mono layers was 
monitored following chronic exposure to subcytotoxic concentrations of the four 
representative surfactants; SDS, T20, CAPB and BAK. Interactions between 
surfactants were investigated to determine if chronic exposure to one surfactant, at 
the subcytotoxic concentrations, rendered the J-HCET monolayer more or less 
susceptible to a subsequent acute exposure with the same or surfactant of different 
ionicity. Measurements of monolayer activity and integrity were made using the 
combined fluorescein leakage-resazurin reduction and kenacid blue assays. 
4.5.2 Materials and Methods 
Culture flasks (80cm3) were seeded with 5xl05 of J-HCET cells and incubated for 24 
hours at 37°C, 5% (v/v) C02 in air. Medium or medium containing subcytotoxic 
surfactant concentrations was added to each flask where appropriate. Cultures were 
maintained at 370 C, 5% (v/v) C02 in air, re-fed with the appropriate medium every 
72 hours over 18 days (432 hours) and subcultured once cells were 70-80% 
confluent. Cells were monitored on a daily basis at low magnification (xl0 
objective) to ascertain the level of cell growth, cell morphology and to check for 
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contamination. Following the 18 day exposure, J-HCET cells were harvested from 
large culture flasks (section 2.2.3.3) and 500J,l1 seeded into Polycarbonate inserts at 
5xlOs cells mrl suspended in the respective growth medium containing sub cytotoxic 
concentrations of SOS, T20, CAPB or BAK (section 2.1.7.2) four replicates inserts 
per surfactant. Growth media (500J,li) was added to the outer 16 wells to prevent 
excessive evaporation. Two inserts received 500J,l1 of medium alone and were 
referred to as the no-cell inserts. Inserts were placed into 24 well plates with an 
additional 500J,l1 of corresponding medium in the wells and incubated at 37°C, 5% 
C02 (v/v) in air for 72 hours. For each surfactant 5 replicate plates were established. 
Medium was aspirated from one plate and the combined fluoresce in leakage-
resazurin reduction (section 2.2.4.3) and total protein kenacid blue (section 2.2.4.1) 
assays performed. From the remaining plates medium was aspirated and 400J,l1 of 
each of the acute surfactant concentrations (table 4.01) applied for 60 seconds. This 
was then removed from the inserts via aspiration, and the mono layers washed with 
200J,l1 of HBSS (2 x 60 seconds). HBSS was aspirated and 500J,l1 of cell culture 
media (pre-warmed to 37°C) applied. The combined fluorescein leakage-resazurin 
reduction and kenacid blue assays were performed every 24 hours over 96 hours. 
4.5.3 Results 
4.5.3.1 Effects of surfactant pre-exposure on acute SOS (800J,lgmr1) toxicity 
Chronic subcytotoxic SOS (4J,lgmrl) and BAK (0.0025Ilgmrl) exposure 
significantly (p<0.05) increased the toxicity of a subsequent acute SOS (800llgmr1) 
exposure, demonstrated by an increase in fluorescein leakage (figure 4.27) and 
reductions in the production of resorufin (figure 4.28) and protein content (figure 
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4.29) compared to control cultures over 96 hours. T20 (25I.1gmr1) pre-exposure 
significantly (P<0.05) decreased the toxicity of subsequent acute exposures of SDS 
(800llgmr1) whilst CAPB (3Ilgmr1) pre-exposure did not significantly modulate the 
toxicity of subsequent acute SDS exposures. 
4.5.3.2 Effects of surfactant pre-exposure on acute T20 (300mgmr1) toxicity 
SDS (4Ilgmr1), T20 (25Ilgmrl), CAPB (3Ilgmrl) or BAK (0.0025Ilgmrl) pre-
exposure did not significantly modulate the toxicity of subsequent acute T20 
(300mgmr1) exposures. Demonstrated by fluorescein leakage (figure 4.30), resorufin 
production (figure 4.31) and protein content (figure 4.32) levels equivalent to the 
control over 96 hours. 
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Figure 4.27: Leakage of 
fluorescein across J-HCET 
mono layers cultured in media 
containing HKGS supplements 
exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocarnidopropylbetaine or 
, _ benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
sodium dodecyl sulphate (0.8mgmr l ), 
where * denotes a significant (P<0.05) 
mcrease and * a decrease m 
fluorescein leakage compared to 
control at the same time point. 
(mean±S.D. , n=3) . 
Figure 4.28: Resorufm production 
(llgml' l) of J-HCET monolayers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocarnidopropylbetaine or 
, _ benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
sodium dodecyl sulphate (0.8mgmr\ 
where * denotes a significant (P<0.05) 
increase and * a decrease in resorufm 
production compared to control at the 
same time point. (mean±S.D. n=3) . 
Figure 4.29: Protein content 
(Ilgmr l ) of J-HCET monolayers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, _ benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
sodium dodecyl sulphate (0.8mgml,I), 
where * denotes a significant (P<0.05) 
increase and * a decrease in protein 
content compared to control at the 
same time point. (mean±S.D., n=3). 
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Figure 4.30: Leakage of 
fluorescein across J-HCET 
monolayers cultured in media 
containing HKGS supplements 
exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, - benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
tween 20 (300mgmr '). (mean±SD., 
n=3). 
Figure 4.31: Resorufm production 
(flgmr
'
) of J-HCET monolayers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, - benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
tween 20 (300mgmr\ (mean±S.D., 
n=3). 
Figure 4.32: Protein content 
(Ilgml-l) of J-HCET monolayers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, - benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
tween 20 (300mgml-\ (mean±SD., 
n=3). 
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4.5.3.3 Effects of surfactant pre-exposure on acute CAPB (O.5mgmr1) toxicity 
Chronic subcytotoxic SDS (4Jlgmr1), CAPB (3Jlgml-l) and BAK (O.0025Jlgmr1) 
exposure significantly (p<O.05) increased the toxicity of subsequent acute CAPB 
(500J.1gmr1) exposure demonstrated by an increase in fluorescein leakage (figure 
4.33) and reductions in the production of resorufin (figure 4.34) and protein content 
(figure 4.35) as a consequence of cell death compared to control cultures over 96 
hours. T20 (25Jlgmr1) pre-exposure significantly (p<O.05) reduced the toxicity of 
subsequent acute CAPB (500J.1gmrl) exposure. 
4.5.3.4 Effects of surfactant pre-exposure on acute BAK (125IJgmr1) toxicity 
Chronic subcytotoxic SDS (4J.1gmr1), CAPB (3J.1gml-l) and BAK (O.0025Jlgmr1) 
exposure significantly (p<O.05) increased the toxicity of subsequent acute BAK 
(125Jlgmr1) exposure demonstrated by an increase in fluorescein leakage (figure 
4.36) and reductions in the production of resorufin (figure 4.37) and protein content 
(figure 4.38) compared to control cultures over 96 hours. T20 (25 J.1smr 1 pre-
exposure did not significantly modulate the toxicity of subsequent acute BAK 
(125Jlgmr1) exposure. 
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Figure 4.33: Leakage of 
fluorescein across J-HCET 
mono layers cultured in media 
containing HKGS supplements 
exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, _ benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
cocarnidopropylbetaine (0.5mgmr l ) , 
where • denotes a significant (P<0.05) 
mcrease and • a decrease m 
fluorescein leakage compared to 
control at the same time point. 
(mean±S.D., n=3). 
Figure 4.34: Resorufin production 
(llgml'l) of J-HCET monolayers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocarnidopropylbetaine or 
, - benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
cocarnidopropylbetaine (0.5mgmr l ) , 
where • denotes a significant (P<0.05) 
increase and • a decrease in resorufm 
production compared to control at the 
same time point. (mean±S.D., n=3). 
Figure 4.35: Protein content 
(Ilgmr l ) of J-HCET monolayers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, - sodium dodecyl sulphate, 
tween 20, cocarnidopropylbetaine or 
, • benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
cocarnidopropylbetaine (0. 5mgmr\ 
where • denotes a significant (P<0.05) 
increase and • a decrease in protein 
content compared to control at the 
same time point. (mean±SD., n=3) . 
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Figure 4.36: Leakage of 
fluorescein across J-HCET 
mono layers cultured in media 
containing HKGS supplements 
exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, - benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
benzalkonium chloride (125/lgmr\ 
where - denotes a significant (P<0.05) 
increase in fluorescein leakage 
compared to control at the same time 
point. (mean±S.D. , n=3). 
Figure 4.37: Resorufin production 
(/lgmr l ) of J-HCET monolayers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, - benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
benzalkonium chloride (125/lgmr\ 
where - denotes a significant (P<0.05) 
decrease in resorufin production 
compared to control at the same time 
point. (mean±S.D., n=3) . 
Figure 4.38: Protein content 
(/lgml-I) of J-HCET mono layers 
cultured in media containing HKGS 
supplements exposed to subcytotoxic 
concentrations of surfactants _ control 
culture, _ sodium dodecyl sulphate, 
tween 20, cocamidopropylbetaine or 
, - benzalkonium chloride for 21 days 
and subsequently exposed (60 
seconds) to an acute concentration of 
benzalkonium chloride (125/lgmr l ), 
where - denotes a significant (P<0.05) 
decrease in protein content compared 
to control at the same time point. 
(mean±S.D., n=3) . 
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4.5.4 Conclusion 
This data, in conjunction with the data obtained in chapter 3 demonstrates that 
chronic subcytotoxic surfactant exposure can modulate the response of J-HCET 
monolayers to subsequent acute exposures (table 4.02). 
Table 4.02: Summary of the effects subcytotoxic surfactant exposure has on a 
subsequent acute exposure. 
ChroniC Surfactant 
Exposure 
Ionic Status Parameter Significant (P<O.06) change In toxicity of 
SOS (O.8mgmr1) T20 (300mgmrl) CAPB (O.6mgmr1) BAK (126IJC1mrl) 
Tween20 Non-ionic Leakage 
Resazurin 
Protein 
eocamidopropylbetaine Amphoteric Leakage 
Resazurin 
Protein 
Sodium dodecyl sulphate Anionic Leakage 
Benzalkonium chloride 
Resazurin 
Protein 
Cationic Leakage 
Resazurin 
Protein 
R 
R 
R 
E 
E 
E 
E 
E 
E 
R 
R 
R 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
E 
Where E denotes enhanced and R denotes reduced toxicity of the acute surfactant. 
Further analysis of the data obtained revealed that the ratio of resazurin production to 
total protein content per well remained constant at approximately 0.08Jlgmr1 
resorufin per Jlgmr1 protein. This demonstrated that the culture activity remained 
constant and alterations in resorufin production or fluorescein leakage were due to 
cell loss, and thus reduced barrier integrity. This loss was also likely to be due to cell 
detachment due to affects on cell adhesion molecules rather than necrosis, since 
resazurin per protein was unaffected. Hence a more detailed investigation of the 
adhesion molecule expression and location was undertaken. 
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Chapter4b 
Effects of medium composition on barrier function 
"Morphology and adhesion molecule expression" 
Effects of medium composition on barrier function 
"Morphology and adhesion molecule expression" 
4.6 Modulation of J-HCET monolayer morphology by growth media 
calcium concentration 
4.6.1 Introduction 
The corneal epithelium functions as a barrier that isolates the eye from the outside 
environment (Ban et al., 2003). For in vitro models to mimic this function a 
confluent sheet of cells maintaining the distinct insert internal environment from the 
extra insert well compartment the paracellular pathway between adjacent cells in the 
sheet must be tightly sealed to prevent the diffusion of solutes, whilst the apical and 
basolateral domains must be differentiated to allow active transport across the sheet 
(Tsukita and FUTUse, 1999). Tight junctions (TJ) are directly involved in paracellular 
sealing (barrier function) and in vivo provide a continuous seal around the apical 
aspect of adjoining epithelial cells, thereby, preventing the free passage of molecules 
between adjacent epithelial cells (paracellular pathway). Thus for the in vitro model 
to be representative the cells should not only express the appropriate adhesion 
molecules but do so in the relevant locations. TJ complex includes two integral 
transmembrane proteins: c1audin; occludin and membrane associated proteins such as 
zonula occludins-l (ZO-I), ZO-2 and ZO-3 (Tsukita et ai, 2001). ZO-1 has a 
molecular mass of220kD (Stevenson et aI., 1986; Lapierre 2000) was one of the first 
proteins identified and localized to the TJ where in conjunction with ZO-2, and ZO-3 
(Lapierre 2000) acts as a scaffolding or plaque protein responsible for connecting the 
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proteins occludin and the claudins to the f-actin cytoskeleton (Citi, 1993; Anderson, 
2001; Poritz et aI., 2004). There are antibodies available to these adhesion moeclues 
so that their location in vitro and in vivo can be determined. Sugrue and Zieske 
(1997) showed that the expression and localization to the interior surface of the 
plasma membrane of ZO-I. It now appears that ZO-1 is a ubiquitous component of 
the tight junction in all epithelia and endothelia (Sugrue and Zieske, 1996) 
interacting with occludin (Stevenson et aI., 1986; Citi, 1993; Tsukita and Furuse, 
1999) an integral membrane protein involved in the permeability barrier function of 
the tight junction. However, it has been shown that ZO-l may be found at non-tight 
junctional locations (Schnabel et al., 1990; Howarth et al., 1992; Miragall et al., 
1994) leading to the unfortunate misinterpretation that the presence of ZO-1 
immunoreactivity equates to the presence of tight junctions (Sugrue and Zieske, 
1996). Occludin is a 60 - 65kDa protein with four tansmembrane domains (Furuse 
et aI., 1993; Balda and Matter 2000; Ban et al., 2003) with both N- and C- termini 
oriented into the cytoplasm (Balda and Matter 2000). Occludin appears to be the 
most important and relatively well characterized transmembrane protein of the tight 
junction (Kale et ai, 2003) with the C-terminal interacting in vitro with several 
intracellular scaffolding proteins including ZO-I, ZO-2, ZO-3 (Furuse et aI, 1993; 
Balda and Matter 2000; Ban et ai, 2003) and f-actin (Goodenough, 1999;Wittchen et 
ai, 1999). To date there have been no reports of occludin isoforms - that is, 
different occludin-related genes - although two forms of occludin are generated by 
alternate splicing (Morita et al., 1999; Tsukita and Furuse, 1999). The level of 
occludin expression in various cell types correlates well with the number of tight 
junction strands (Saitou et al., 1997; Tsukita and Furuse, 1999). Claudins, 23kDa 
integral membrane proteins bearing four transmembrane domains, have been 
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identified as components of TJ strands (Furuse et al., 1998; Tsukita and Furuse 
2002), and to be directly involved in intercellular sealing in simple epithelia 
(Anderson 2001; Tsukita et al., 2001; Balda and Matter, 2000; Furuse et aI., 2002; 
Ban et al., 2003). Claudin-l and -2 were originally identified because they 
cofractionated with occludin from sonicated fractions (Furuse et al., 1998). There is 
no evidence for a distinct interaction between occludin and claudin (Balda and 
Matter 2000), and claudins do not copurify with occludin from detergent solubilised 
membranes (Balda and Matter 2000). At least 24 members of the claudin family 
have been identified (Furuse et al., 1998; Gow et al., 1999; Tsukita and Furuse, 
2002). In contrast to occludin, individual claudins are generally expressed in only a 
restricted number of specific cell types, suggesting that they are associated with 
tissue-specific functions of tight junctions (Balda and Matter 2000) but the level of 
claudin expression does not correlate with the number of tight junction strands 
(Saitou et al., 1997; Tsukita and Furuse, 1999). Besides their membrane topology, 
different claudin members share other structural features, suggested by the 
observation that eight different claudins can bind to the three submembrane proteins 
ZO-I, ZO-2 and ZO-3 by interaction involving the claudins C-terminal cytosolic 
domain and the PDZ domain of the submembrane plaque proteins (Simon, 1999). 
Whilst the cells do not appear to have their activity and cell number modulated by 
transfer into variable calcium concentrations over 72 hours, it is important to confirm 
that subtle or significant changes were not occurring morphologically or in the nature 
of key adhesion molecules, responsible for barrier integrity. Initially the effects of 
calcium concentrations were examined. 
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4.6.2 Materials and Methods 
J-HCET were resuspended in growth media containing 0, 60, 80, 100, 500 or 
1000flM calcium chloride and seeded at 3xl0s cells mrl (200111) into 8 well chamber 
slides. Cells were incubated at 37oC, 5% C02 (v/v) in air for 72 hours. Slides were 
examined using a Nikon phase contrast/fluorescence microscope. 
4.6.3 Results 
Despite the omission of calcium from the growth media, J-HCET retained the ability 
to proliferate but the monolayers revealed individual J-HCET clearly distinguishable 
from neighbouring cells (figure 4.39a and 4.40a). At calcium concentration of 60flM 
and above, J-HCET monolayers cultured in either HKGS (figure 4.39b/c/d/elf) or 
HKGS-V2 (figure 4.40b/c/d/e/f) supplemented media adopt the typical "cobblestone 
like" appearance commonly described in studies (Furuse et al., 1993; Balda and 
Matter 2000; Ban et al., 2003) utilising corneal cell lines, with no visible gaps 
between the cells. 
4.6.4 Conclusions 
The corneal cells can grow for up to 72 hours in the absence of exogenous medium 
calcium but reveal compromised morphology and cell-cell contact. The differing 
growth supplements do not appear to affect these responses. Thus the endogenous 
calcium reserves, from growth routinely in 60llM calcium containing Epilife™ 
medium, allow the c.ells to grow in the normal fashion, but appears to affect cell 
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adhesion. This affect on adhesion could either be due to reduced adhesion 
molecule/s levels or mislocation. 
Figure 4.39a/b/c/d/e/f: Greyscale phase contrast micrographs of J-HCET 
monolayers cultured in HKGS supplemented Epilife media containing a) 0 b) 60 c) 
80 d) 100 e) 500 and f) 1 0 0 0 ~ M M calcium. (x400 magnification). 
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Figure 4.40a/b/c/d/e/f: Greyscale phase contrast micrographs of J-HCET 
mono layers cultured in HKGS-V2 supplemented Epilife media containing a) 0 b) 6 
c) 80 d) 100 e) 500 and f) 1000llM calcium. (x400 magnification). 
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4.7 Modulation of f-actin by growth media calcium concentration 
4.7.1 Introduction 
Since the transfer to 0J.1M calcium medium results in a modified morphological 
appearance and since 60J.1M and 8 0 ~ ~ affect adversely the barrier function, as 
measured by sodium fluorescein leakage (reported in chapter 4a), but morphology 
was normal, the cytoskeleton was investigated. Fibrous actin (f-actin) plays an 
important role in anchorage of key adhesion molecules. 
4.7.2 Materials and Methods 
J-HCET were seeded at the same density and calcium concentrations as for section 
4.2 into 8 well chamber slides. Cells were incubated at 37°C, 5% CO2 (v/v) in air 
for 72 hours. The cultures were fixed in paraformaldehyde solution (1% w/v in PBS) 
for 30 minutes. Triton X-lOO (200JlI; 0.1 % v/v in PBS) was added for 5 minutes to 
permeabilize the cells. Monolayers were rinsed with BSA solution (0.1 % w/v in 
PBS) and washed in fresh BSA solution. Fluorescein isothiocyanate (FITC) 
conjugated phalloidin (Imgmrl) was suspended in I.5ml PBS and 200JlI applied to 
the chambers. Slides were incubated at 37°C, 5% C02 (v/v) in air for 1 hour in the 
dark. Slides were rinsed with BSA solution and washed in fresh BSA solution. 
Slides were washed in water and mounted using Vectashield™ containing propidium 
iodine (50Jlgml"1). Immunostaining of J-HCET mono layers cultured in the 
keratinocyte media (KGM) supplemented with animal derived products and calcium 
(lOOJlM) routinely used in the ICCV AMlECV AM validation trial (Strickland et al., 
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2003) was employed as a control (figure 4.41). Slides were viewed under a Leica 
Confocal Microscope. 
4.7.3 Results 
In control J-HCET monolayers the absence of phalloidin staining (figure 4.41 a) 
demonstrates no auto-fluorescence at the wavelengths used to visualise the phalloidin 
binding. 
Figure 4.41a/b/c/d: (a) KGM cultured J-HCET monolayer PBS alone (b) the same J-
HCET monolayer stained with propidium iodide nuclear staining. (c) KGM cultured 
J-HCET monolayer with FITC conjugated phalloidin (d) the same J-HCET 
monolayer with propidium iodide staining of the nuclei. (x400 magnification) 
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The staining with propidium iodide confirmed the presence of a complete monolayer 
which had been active prior to fixation since distinct nucleoli can be observed (figure 
4.41b and 4.41d). The combined staining confirmed no cross fluorescence signal 
between phalloidin and propidium iodide (figure 4.41c/d). When J-HCET were 
culture in medium containing HKGS supplements to obtain complete localisation of 
the phalloidin binding to the periphery of the cells at least SOO",M calcium in the 
medium was required (figure 4.42e1f). Marked membrane association was also 
observed at IOO",M calcium (figure 4.42d). HKGS-V2 supplements produced a 
similar pattern except that the IOOIlM calcium did not induce the same degree of 
membrane localisation (figure 4.43d and figure 4.42d). 
4.7.4 Conclusions 
A calcium concentration of at least SOOIlM is required for the expression and correct 
intracellular localisation of f-actin in J-HCET cells cultured in either HKGS or 
HKGS-V2 supplemented Epilife™ medium. 
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Figure 4.42a/b/c/d/e/f: Fluorescence micrograph of J-HCET cell FITC-phalloidin 
stained for f-actin . HKGS supplemented Epilife media containing a) 0 b) 60 c) 80 d) 
100 e) 500 and f) 1000JlM calcium. (x400 magnification). 
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Figure 4.43a/b/c/d/e/f: Fluorescence micrograph of J-HCET cell FITC-phalloidin 
stained for f-actin . HKGS-V2 supplemented Epilife media containing a) 0 b) 60 c) 
80 d) 100 e) 500 and f) 1000llM calcium. (x400 magnification) . 
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4.8 Modulation of ZO-1 by growth media calcium concentration 
4.8.1 Introduction 
Having established that calcium concentrations affect f-actin distribution the effects 
on adhesion molecules in the two media was evaluated. Studies were conducted to 
determine the effects of growth medium calcium concentration have upon the 
expression and localisation ofZO-l in J-HCET monolayers, since ZO-1 is located in 
TJ and other adhesion junctions. 
4.8.2 Materials and Methods 
J-HCET seeded at the same density and calcium concentrations as for section 4.2 
into 8 well chamber slides. Cells were incubated at 37°C, 5% C02 (v/v) in air for 72 
hours. Indirect immunohistochemistry was performed as outlined in section 2.2.5.1 
using a mouse anti-ZO-l primary antibody (table 2.0). Immunostaining of J-HCET 
monolayers cultured in the keratinocyte medium (KGM) supplemented with animal 
derived products and calcium to give a final concentration of 100J.lM routinely used 
in the ICCV AMlECV AM validation trial (Strickland et al., 2003) was employed as a 
control (figure 4.44). Slides were viewed under a Leica Confocal Microscope. 
4.8.3 Results 
In control J-HCET monolayers the absence of ZO-1 immunostaining (figure 4.44a) 
demonstrates no auto-fluorescence at the wavelengths used to visualise the FITC 
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labelled anti-lO-l binding. The staining with propidium iodide confirmed the 
presence of a complete active monolayer (figure 4.44b). The combined staining 
confirmed no cross fluorescence signal between lO-l and propidium iodide (figure 
4.44c/d) . 
Figure 4.44a/b/c/d: (a) KGM cultured J-HCET monolayer in PBS no pnmary 
antibody but exposed to secondary antibody. (b) The same J-HCET monolayer 
propidium iodide staining. (c) KGM cultured J-HCET monolayer binding of mouse 
anti-lO-l. (d) The same J-HCET monolayer propidium iodide staining. (x400 
magnification) . 
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When J-HCET were culture in medium containing HKGS supplements, at low 
calcium concentrations (OJ.lM to 80J.lM) ZO-1 expression was not membrane 
localised but diffuse within the cytoplasm (figure 4.45a1b/c). When J-HCET were 
cultured in media containing 100J.lM calcium, there was limited localization to the 
plasma membrane but most immunostaining remains diffuse within the cytoplasm 
(figure 4.45d). At medium concentrations of calcium at 500J.lM and 1000J.lM, ZO-1 
immunostaining completely encircles the squamous epithelial cells (figure 4.4Se/f). 
ZO-1 staining appears as clusters of immunoreactivity especially at contact points 
between three or more cells; this may reflect overlapping of membrane contacts. 
When J-HCET were cultured in medium containing HKGS-V2 supplements, at low 
calcium concentrations (OJ.lM to 100J.lM) ZO-1 was present but diffuse within the 
cytoplasm and not located to the plasma membrane (figure 4.46a1b/c/d). At calcium 
concentrations of 500J.lM and 1000J.lM in complete media ZO-1 immunostaining 
completely encircles the large squamous epithelial cells (figure 4.46e/f). It was also 
evident that ZO-1 staining appears in the same pattern as observed in the Epilife™ 
supplemented with the HKGS supplements. 
4.8.4 Conclusions 
A calcium concentration of at least 500J.lM was required for the expression and 
correct intracellular localisation of ZO-1 to the cell membrane in J-HCET cells 
cultured in either HKGS or HKGS-V2 supplemented Epilife™ medium. The pattern 
of ZO-1 expression was suggestive of being compatible with a competent seal 
between adjacent abutting cells, indicative of the presence of a functional barrier to 
paracellular flow, regardless of the medium growth factor supplementation. Thus 
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from the FL data it would appear that ZO-1 is associated with the TJ's, and that 
HKGS-V2 does not inhibit TJ formation. 
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Figure 4.45alb/c/d/e/f: Immunofluorescent staining of ZO-1 in J-HCET monolayer 
cultured in HKGS supplemented Epilife media containing a) 0 b) 60 c) 80 d) 100 e) 
500 and f) 1 O O O ~ M M calcium. (x400 magnification) . 
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Figure 4.46a!b/c/d/e/f: Immunofluorescent staining of ZO-1 in J-HCET monolayer 
cultured in HKGS-V2 supplemented Epilife media containing a) 0 b) 60 c) 80 d) 100 
e) 500 and f) 1000llM calcium. (x400 magnification) . 
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4.9 Modulation of occludin by growth media calcium concentration 
4.9.1 Introduction 
Since ZO-1 is ubiquitous (Schnabel et al., 1990; Howarth et al., 1992; Miragall et 
al., 1994) to establish the morphological correlation between barrier function and 
tight junctions another adhesion molecule was examined. Despite the ZO-1 being 
localised, it is an internal membrane marker, not a transmembrane component of the 
tight junction. Occ1udin was the first transmembrane protein of tight junctions that 
was identified (Furuse et al., 1993; Balda and Matter 2000). Studies were conducted 
to determine the effects of growth medium calcium concentration has upon the 
expression and localisation of occludin in J-HCET mono layers, to confirm effects 
upon tight junctions. 
4.9.2 Materials and Methods 
The same approach was taken as in section 4.8.2 except; the primary antibody being 
rabbit anti-occludin (table 2.0) was diluted in 0.1 % BSA (w/v) in PBS and incubated 
with the cells at 4°C overnight. Immunostaining of J-HCET mono layers cultured in 
the keratinocyte media (KGM) supplemented with animal derived products and 
calcium (100J.1M) routinely used in the ICCV AMlECV AM validation trial 
(Strickland et al., 2003) was employed as a control (figure 4.47). Slides were viewed 
under a Leica Confocal Microscope. 
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4.9.3 Results 
In control J-HCET monolayers the absence of occludin immunostaining (figure 
4.47a) demonstrates no auto-fluorescence at the wavelengths used to visualise the 
FITC labelled anti-occludin binding. The staining with propidium iodide confirmed 
the presence of a complete active monolayer (figure 4.47b). The combined staining 
confirmed no cross fluorescence signal between occludin and propidium iodide 
(figure 4.47c1d). Staining of the KGM cultured controls also confirms a scattered 
pattern of occludin distribution at the margins of the cells that form the monolayers. 
With this more diffuse pattern of staining, it was more difficult to observe variations 
in the distribution of the staining pattern. It does appear that at lOOJ.lM and above 
(figure 4.48d/e/f) the, distribution and concentration hot spots were very similar to 
control staining. At 80J.lM there appears to be fainter staining, but still located to the 
margins of the cells (figure 4.48c). There was a marked contrast with the HKGS-V2 
supplements, with more concentrated localisation to the membranes but only at 
500llM calcium and above (figure 4.49a/b/cld versus elf). As a result of the more 
diffuse staining pattern it was difficult to determine if the level of staining was 
altered or just its localisation. 
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Figure 4.47a/b/c/d: (a) KGM cultured J-HCET monolayer exposed to PBS. (b) J-
HCET monolayer stained with propidium iodide. (c) KGM cultured J-HCET 
monolayer exposed to primary mouse anti-occludin then secondary FITC antibody. 
(d) Same J-HCET monolayer propidium iodide staining. (x400 magnification) . 
4.9.4 Conclusions 
A calcium concentration of at least 500llM was required for the expression and 
correct intracellular localisation of occludin in J-HCET cells cultured in either HKGS 
or HKGS-V2 supplemented Epilife™ medium. Occludin expression and localisation 
appears to be similar to the control cultures at much lower calcium concentrations in 
Epilife™ medium supplemented with HKGS supplements. However, the possibility 
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remains that calcium concentration could affect expression levels of this molecule. 
The focal pattern imposed upon the more diffuse membrane localisation at the higher 
calcium concentration would be consistent with occludin associated with the TJ via 
ZO-l internally, but may be in excess of that which can be associated. 
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Figure 4.48alb/c/d/e/f: Immunofluorescent staining of occludin in J-HCET 
monolayer cultured in HKGS supplemented Epilife media containing a) 0 b) 60 c) 80 
d) 100 e) 500 and f) 1 OOOIlM calcium. (x400 magnification). 
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Figure 4.49a!b/c/d/e/f: Immunofluorescent staining of occludin in J-HCET 
monolayer cultured in HKGS-V2 supplemented Epilife media containing a) 0 b) 60 
c) 80 d) 100 e) 500 and t) 1000llM calcium. (x400 magnification) . 
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4.10 Modulation of Claudin-1 by growth media calcium concentration 
4.10.1 Introduction 
The barrier function is not only regulated by the membrane based molecules, but also 
those that have a paracellular cleft domain e.g. occludin and claudin. Claudin-l and -
2 were originally identified because they cofractionated with occludin from sonicated 
fractions (Furuse et al., 1998). There is no evidence for a distinct interaction 
between occ1udin and c1audin (Balda and Matter, 2000), and claudins do not copurify 
with occ1udin from detergent solubilised membranes (Balda and Matter, 2000). In 
contrast to occludin, individual claudins are generally expressed in only a restricted 
number of specific cell types, suggesting that they are associated with tissue-specific 
functions of tight junctions (Balda and Matter, 2000) but the level of claudin 
expression does not correlate with the number of tight junction strands (Saitou et al., 
1997; Tsukita and Furuse, 1999). Studies were conducted to determine the effects of 
growth medium calcium concentration has upon the expression and localisation of 
Claudin-1 a transmembrane molecule associated with ZO-1 in J-HCET monolayers. 
4.10.2 Materials and Methods 
The same approach was taken as in section 4.8.2 except; the primary antibody was 
rabbit anti-claudin-1 (table 2.0) was diluted in 0.1 % BSA (w/v) in PBS and incubated 
with the cells at 40 C overnight. Immunostaining of J-HCET mono layers cultured in 
the keratinocyte media (KGM) supplemented with animal derived products and 
calcium to give a final concentration of 100llM routinely used in the 
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ICCV AMlECV AM validation trial (Strickland et al., 2003) was employed as a 
control (figure 4.50). Slides were viewed under a Leica Confocal Microscope. 
4.10.3 Results 
In control J-HCET monolayers the absence of Claudin-l immunostaining (figure 
4.50a) demonstrates no auto-fluorescence at the wavelengths used to visualise the 
FITC labelled anti-c1audin-l binding. The staining with propidium iodide confirmed 
the presence of a complete monolayer (figure 4.50b). The combined staining 
confirmed no cross fluorescence signal between cIaudin-l and propidium iodide 
(figure 4.50cld). Interaction with the control corneal cells in KGM with 100llM 
calcium revealed a beaded appearance along the cell/cell membrane contacts, but 
absent where one cell did not abut another (figure 4.50c). 
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Figure 4.S0a/b/c/d: (a) KGM cultured J-HCET monolayer exposed to PBS instead 
of primary antibody. (b) The same J-HCET monolayer with propidium iodide 
staining. (c) KGM cultured J-HCET monolayer received rabbit anti-Claudin-l and 
secondary antibody. (d) The same J-HCET monolayer with propidium iodide 
staining. (x400 magnification) 
When the HKGS supplements were used, a calcium concentration of 500llM was 
required (figure 4.51 e) to generate a comparable distribution as observed for the 
KGM medium. Interestingly there also appears to be nuclear or cytoplasmic binding 
of thi s antibody at calcium concentrations of 1 OOIlM and lower (figure 4 .51 aIb/c/d) . 
A marked difference was observed with the corneal cell grown in HKGS-V2 
supplemented medium . At calcium concentrations of 1 OOIlM and below only nuclear 
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staining was observed (figure 4.S2a/b/c/d). A calcium concentration of SOOj.1M 
(figure 4.S2e) was required to generate a similar distribution as observed for the 
KGM medium. In those cells expressing membrane staining, nuclear staining was 
absent, and vice versa. In contrast to both ZO-1 and occludin, claudin-l was only 
correctly localised in areas where J-HeET monolayer had begun to multilayer. 
4.10.4 Conclusions 
A calcium concentration of at least 500llM is required for the expression and correct 
localisation of claudin-l in J-HeET cells cultured in either HKGS or HKGS-V2 
supplemented Epilife™ medium. In addition, claudin-l immunostaining in "hot 
spots" occurs only where J-HeET have begun to multilayer. 
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Figure 4.S1alb/c/d/e/f: Immunofluorescent staining of Claudin-l in J-HCET 
monolayer cultured in HKGS supplemented Epilife™ media containing a) 0 b) 60 c) 
80 d) 100 e) 500 and f) lOOOIlM calcium. (x400 magnification) . 
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Figure 4.S2aJb/c/d/e/f: Immunofluorescent staining of Claudin-l in J-HCET 
monolayer cultured in HKGS supplemented Epilife™ media containing a) 0 b) 60 c) 
80 d) 100 e) 500 and f) 1000JlM calcium. (x400 magnification) . 
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Effects of medium composition on barrier function 
"Relating adhesion molecule expression and localisation to barrier function" 
4.11 Effect of subcytotoxic surfactant exposure on f-actin, ZO-1, 
occludin and Claudin-1 in J-HCET cultured in HKGS 
supplemented media 
4.11.1 Introduction 
Although it has been demonstrated (section 4.4) that subcytotoxic surfactant 
exposure does not disrupt J-HCET barrier function or viability, the combined 
fluorescein leakage- resazurin reduction assay does not provide information as to the 
expression and localisation of the molecular components of the tight junction. In 
order to establish that chronic surfactant exposure does not alter the J-HCET tight 
junctions, the expression and localisation of f-actin, ZO-I, occludin and Claudin-l 
were examined in monolayers cultured in medium containing subcytotoxic surfactant 
concentrations. 
4.11.2 Materials and Methods 
polycarbonate inserts were prepared as section 4.4 except the kenacid blue assay was 
not performed on all replicates. J-HCET cultures used for the initial total protein 
assay were aspirated and immunolabelled for f-actin, ZO-1 and Claudin-l employing 
the same protocols as in sections 4.7, 4.8 and 4.10 respectively. For occludin 
immunostaining a similar approach was taken as in section 4.9 except that the 
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primary antibody was mouse anti-occludin (table 2.0). Immunostaining of J-HCET 
mono layers cultured in the keratinocyte medium (KGM) supplemented with animal 
derived products and calcium (1 OOJlM) routinely used in the ICCV AMlECV AM 
validation trial (Strickland et al., 2003) were employed as a control. Slides were 
viewed under a Leica Confocal Microscope. To visualise the cell-cell and cell matrix 
junctions, control J-HCET cultures were prepared for Transmission electron 
microscopy (TEM) (section 2.2.5.2). Samples were then viewed in a Phillips 410 
Transmission Electron Microscope operated at 80KV. 
4.11.3 Results 
4.11.3.1 J-HCET viability and function 
Subcytotoxic surfactant exposure of SDS; 4Jlgmr1, T20; 25 Jlgmr1, CAPB 2.99Jlgmr 
1 or BAK; 0.0025Jlgml-1) have no significant effect on barrier function (figure 4.21), 
activity (figure 4.22) or total cell protein (figure 4.23) or over 21 days (504 hours). 
At 504 hours no indications of pending adverse reactions were noted. The combined 
fluorescein leakage- resazurin reduction and kenacid blue assay are unable to 
demonstrate the expression and localisation of f-actin, ZO-l and occludin. 
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4.11.3.2 Expression and localisation of f-actin, ZO-1 and occludin 
Immunohistochemistry controls were prepared as outlined in sections 4.7 through 4.9 
for f-actin, ZO-1 , and occludin and examined microscopically confirming the 
efficacy of the staining protocols. Cultures were examined prior to surfactant 
exposure to ensure the correct expression and localisation of f-actin, ZO-1 , occ1udin 
and Claudin-l (figure 4.56). 
Figure 4.56 : Images representative of (a) occ1udin, (c) ZO-l , (c) f-actin and (d) 
Claudin-l expression in J-HCET monolayers cultured in HKGS supplemented 
medium prior to sub cytotoxic surfactant exposure. (magnification x400) . 
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No observable alteration in the expression and localisation of f-actin (figure 4.57), 
ZO-l (figure 4.58) or occludin (figure 4.59) occurred compared to control cultures 
after 432 hours of continuous exposure to sub cytotoxic SDS, T20, CAPB or BAK 
concentrations. However, at 504 hours of continuous exposure to BAK 
(0.0025J.1gmr1) the expression pattern of ZO-l compared to control cultures was 
significantly altered. The distinctive "chicken wire" pattern begins to degrade with a 
significant loss of fluorescence at abutting J-HCET membranes (figure 4.58). This 
cannot be attributed to cell loss as the total cell protein and viability of the cultures 
remain unaltered (figures 4.54 and 4.55). This alteration in ZO-l expression and 
localisation is not associated with a significant increase in fluorescein leakage (figure 
4.53). No significant alterations in the expression and localisation of f-actin or 
occludin are observed at similar time points (figures 4.57 and 4.59) 
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4.11.3.3 Expression and localisation of Claudin-1 
Although it was demonstrated that Claudin-l expression and localisation is 
dependent upon a medium calcium concentration of ImM (section 4.10) it was also 
observed that immunostaining only occurs in "hot spots" where J-HCET have begun 
to multilayer. This is in contrast to other components of the tight junction f-actin, 
ZO-l and occludin which are expressed and correctly localised in mono layers. 
Claudin-l immunostaining of the control J-HCET cultures reveal a generalised 
pattern of nuclear staining (figure 4.60) i.e. as seen in figure 4.51d. Although 
claudin-l has been reported to be important in the barrier function of the human 
cornea (Ban et al., 2003) the leakage offluorescein (figure 4.53) across the J-HCET 
cultures is within the defined limits (Clothier and Samson, 1996) indicative of an 
intact barrier. Of the total area available for cellular attachment on the polycarbonate 
insert, less than 5% demonstrate J-HCET multilayering and so therefore the role 
claudin-l plays in barrier function of this human cornea equivalent in vitro is 
unclear. 
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Figure 4.60 : Claudin-l expression in 
J-HCET monolayers cultured in 
HKGS supplemented medium (a) 72 
hours (b) 144 Hours (c) 196 hours (d) 
216 hours (e) 288 hours (t) 360 hours 
(t) 432 hours and (g) 504 hours of 
continuous culture (magnification 
x400) . 
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4.11.3.4 Transmission electron microscopy of J-HCET junctions 
To gain insight into the ultrastructure of the tight junctions, in addition to 
immunostaining, J-HCET cultures were evaluated by TEM. Ultrastructure features 
common to the human corneal epithelium are observed in the J-HCET model. These 
include surface cell microvilli, nuclear membranes, mitochondria, Golgi bodies, 
endoplasmic reticulum, tight junctions and numerous intracellular digitations and 
desmosomes. Tight junctions are clearly visible at the apical domain of abutting J-
HCET in both multilayer (figure 4.61) and monolayer (figure 4.62) regions 
respectively. The close interaction of the abutting J-HCET membranes in the tight 
junctions were confirmed by tilting the TEM grid obtaining images at ± 150 (figure 
4.63). Numerous desmosome junctions were observed with pinocytotic vessels 
(figure 4.62) clearly visible. 
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Figure 4.61 : Multilayer region of the J-HCET cells showing projections into the 
polycarbonate insert pores (P), and tight junctions at the apex (TJ). 
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Figure 4.62 : Monolayer region of the J-HCET cells showing TJ's, desmosomal 
junctions and pinocytotic vesicles at both apical and basal regions . 
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Figure 4.63 : To confirm the presence of the tight junctions the image was tilted plus 
or minus 15 degrees. The close approximation of the junction was still observed . 
Note the pinocytotic vesicle (P) adjacent to the tight junction (TJ) and desmosomal 
junction (D). 
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4.11.4 Conclusions 
Subcytotoxic benzalkonium chloride exposure appears to disrupt ZO-l expression 
and localisation after 432 hours of continuous exposure. No alterations are observed 
in the expression and localisation of f-actin or occludin. Although it has been 
reported (Ban et al., 2003) that claudins are involved tight junction formation it 
appears that although expressed, claudin-l has a limited apparent role in the tight 
junctional prevention of sodium fluorescein leakage in the predominantly monolayer 
model employed in this study. Ultrastructure features common to the human corneal 
epithelium are observed in the J-HCET model. 
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Effects of chronic Timolol maleate exposure 
5.1 Maximal concentration of buthionine sulphoxamine required to 
reduce glutathione levels with no alteration of J-HCET viability 
5.1.1 Introduction 
Since Timolol maleate is detoxified in vivo via conjugation with glutathione (GSH) 
(Megaw, 1984; Riley, 1990) is important to establish that a similar mechanism 
occurs in vitro. Buthionine sulphoxamine (BSO) is known to reduce GSH (Mulder 
and Ouwerkerek-Mahadevan, 1997; Pastore et al., 2003). Since timolol maleate 
containing eye drops can be preserved with benzalkonium chloride and used 
repeatedly for glaucoma, it is possible that its use could affect the corneal epithelial 
levels of GSH. BSO was used to confirm if timolol maleate toxicity could be 
affected in vitro in human corneal cells following reduction in available GSH. 
5.1.2 Materials and Methods 
Immediately prior to use, buthionine sulphoxamine was completely dissolved in 
growth media (section 2.1.7.1) to create concentrations of 0.5, 1,5, 10,50, 100, and 
5 0 0 ~ M . . J-HCET seeded into the central 54 wells of two 96 well plates, 1 0 0 ~ 1 1 of 
3xl0s cells ml-1. Phosphate buffered saline ( 1 0 0 ~ l ) ) was added to the outer 36 wells 
to prevent excessive evaporation of growth medium. Plates were incubated for 72 
hours at 37°C and 5% C02 (v/v) in air to allow the cells to attach and attain 
confluence. One plate was then assayed to provide a measure of the pre-exposure 
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control levels. Medium was aspirated and the NRU (section 2.2.4.2), glutathione 
equivalents (section 2.2.4.3) and KB (section 2.2.4.1) assays performed. The 
medium was aspirated from the remaining plate and 200111 of one of each of the BSO 
concentrations applied as appropriate. Plates were incubated at 370 C and 5% CO2 
(v/v) in air for 48 hours. The neutral red uptake assay and the glutathione 
equivalentslkenacid blue assays were performed on the same cultures. 
5.1.3 Results 
Over a 48 hour period the presence of at least 50llM BSO was required to reduce 
glutathione by 50% (figure 5.01) whilst not affecting cell viability (figure 5.02) or 
total cell number (figure 5.03). Between 50 and 500llM the level of reduction in 
GSH is not enhanced. 
5.1.4 Conclusion 
BSO can be used to reduce the GSH levels by 50% at a non-cytotoxic concentration. 
This was a desired reduction since it allows for the measuring of further reduction 
upon timolol maleate exposure, and/or timing of recovery to normal level with the 
BSO removal. 
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Figure 5.01 : Glutathione content 
(flM) of J-HCET monolayers cultured in 
- HKGS or _ HKGS-V2 supplemented 
medium contammg buthionine 
sulphoxamine for 48 hours. Where * 
denotes a significant (P<O.05) decrease 
in glutathione content. (mean+S.D. , 
n=3). 
Figure 5.02 : Neutral red uptake 
(flgml-l) of J-HCET monolayers cultured 
m _ HKGS or _ HKGS-V2 
supplemented medium contamlng 
buthionine sulphoxamine for 48 hours . 
(mean+S.D. , n=3). 
Figure 5.03 : Protein content (flgIUr 
I) of J-HCET monolayers cultured in _ 
HKGS or 
-
HKGS-V2 supplemented 
medium containing buthionine 
sulphoxamine for 48 hours . 
(mean+SD., n=3). 
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5.2 The effects of acute Timolol Maleate exposure on J·HCET 
monolayers 
5.2.1 Introduction 
Glaucoma is characterised by an abnormally high intraocular pressure due to a 
buildup in the aqueous humour, inside the anterior chamber of the eye. The fluid 
compresses the lens into the vitreous body and puts pressure on the neurons of the 
retinal ganglion (Woods et al., 2002). If the pressure continues to rise, there is a 
progression from mild visual impairment to irreversible destruction of the neurons of 
the retina, degeneration of the optic disk and blindness. Glaucoma is painless, the 
other eye compensates, and a person may experience considerable retinal damage 
and visual loss before the condition is diagnosed. It is estimated that worldwide, 
approximately 66.8 million people are affected by primary glaucoma, a direct 
disturbance of the aqueous outflow (Barlett and Jaanus, 2001). Although our current 
understanding of the pathogenesis of glaucomatous optic neuropathy is poor it has 
been consistently suggested that ischemia plays a role in the aetiology, of at least 
some forms, of glaucoma (Flammer, 1994; Hayreh et al., 1999; Osborne et al., 2004) 
The dying of ganglion cells can be mitigated by intraocular injection of glutamate 
receptor antagonists (Lagreze et al., 1998). Yet despite treatment with lOP lowering 
agents, retinal ganglion cell death continues in many patients (Wood et al., 2002). 
The prescription of topical anti-glaucomic preparations is standard for newly 
diagnosed patients (Barlett and J aanus, 2001). The ~ - a d r e n o c e p t o r r antagonists, 
which comprise selective ~ l l (e.g. betaxol) and non-selective ~ d d ~ 2 2 (e.g. timolol) 
adrenoceptor antagonists, are one of the most important classes of pharmaceuticals 
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used to clinically lower elevated intraocular pressure (lOP) in glaucoma patients 
(Brooks and Gillies, 1992; Zimmerman, 1993; Wood et al., 2002). ~ ~ adrenoceptors 
are widely distributed throughout the body and are subdivided into ~ , , and ~ 2 2
receptors according to their location and functions. ~ 1 1 receptors are predominant in 
the heart and those found in the eye control the formation of aqueous humour ~ 2 2
receptors predominate in other organs such as the lung, peripheral blood vessels and 
skeletal muscle. This is a clinically useful subclassification but is not absolute: for 
example there are ~ 2 2 receptors in the heart and ~ , , receptors in the kidney 
(Zimmerman, 1993). Timolol maleate (TM) is one of the drugs of choice for 
treatment of glaucoma (Uusitalo et al., 1998; Aggarwal and Kaur, 2005). Since 
excessive loss of timolol maleate through nasolacrimal drainage can cause 
respiratory and cardiovascular side effects (Everitt and Avorn, 1990). Timolol 
maleate has the potential to have adverse side effects on the corneal epithelium. 
Whilst standard surfactants are good indicators of the effects following chronic 
exposure, there are pharmaceuticals designed for chronic/repeat use in the eye. 
Preliminary studies were carried out to determine the amount of damage caused by 
acute timolol maleate exposure to J-HCET monolayers. This was assessed using the 
resazurin reduction, glutathione equivalents and kenacid blue assays. The normal 
eye drop solutions preserved with BAK contains timolol maleate at a concentration 
of2.5mgmr'. 
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5.1.2 Materials and Methods 
Immediately prior to use, timolol maleate was completely dissolved in HBSS 
(containing lmM calcium chloride) to create concentrations of 0.5, 0.74, 1.09, 1.6, 
2.36, 3.47, 5.1 and 7.5mgmr l . J-HCET were seeded at 3 x lOs cells mrl (lOOIll) per 
54 central wells. Phosphate buffered saline (100111) was applied to the outer 36 wells 
to prevent excessive evaporation of growth medium. Plates were incubated for 72 
hours at 37°C and 5% C02 (v/v) in air to allow the cells to attach and attain 
confluence. One plate was assayed following the 72 hour growth period, providing a 
pre-exposure control. Medium was aspirated and the resazurin reduction (section 
2.2.4.2), glutathione equivalents (section 2.2.4.3) and kenacid blue (section 2.2.4.1) 
assays performed. The medium was aspirated from the remaining plates and 200lli 
of each of the timol01 maleate concentrations in HBSS or HBSS alone applied for 60 
seconds. Wells were aspirated and the monolayers washed twice with 200lll of 
HBSS (60 seconds) containing lmM calcium chloride. HBSS was aspirated and 
200111 of cell culture medium (pre-warmed to 37°C) applied. Plates were incubated 
at 37°C and 5% C02 (v/v) in air for 48 hours. The resazurin reduction, glutathione 
equivalents and kenacid blue assays were performed on the remaining plate. The 
experiment was repeated with J-HCET co-exposed to 50llM BSO. 
5.1.3 Results 
Low concentrations of timolol maleate (0.5mgmr l to 1.6mgmrl ) significantly 
(p<0.05) increased the levels of intracellular GSH (figure 5.05), with no significant 
alterations in either resorufin production (figure 5.04) or total cell protein (figure 
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5.06). Timolol maleate, at a concentration of3.47mgmrl, significantly reduced cell 
activity (figure 5.04) and GSH concentration (figure 5.05) with no alteration in total 
culture protein (figure 5.06). At a concentration of 7.5mgmr1, cell activity, GSH 
concentration and total cell protein were significantly reduced (figure 5.04, 5.05 and 
5.06). When J-HCET monolayers were co-exposed to 50llM BSO, the stimulatory 
effects on intracellular GSH, of the timolol maleate concentration was negated. Cell 
activity (figure 5.07) was significantly reduced at concentrations between 1.09mgml" 
1 and 7.5mgmr1 with corresponding significant decreases in GSH (figure 5.08) 
compared to control cultures. At timolol concentrations of 5.1 and 7.5mgmr1 the 
total cell protein was significantly reduced (figure 5.09). 
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Figure 5.04 : Resorufin production 
(Jlgrnl-I) of J-HCET monolayers cultured 
in medium containing either _ HKGS or 
- HKGS-V2 supplements exposed to 
Timolol Maleate concentrations for 48 
hours. Where * denotes a significant 
(P<O.05) decrease in resorufin compared 
to control (Omgmrl) cultures . 
(mean+SD., n=3). 
Figure 5.05 : Glutathione content 
(JlM) of J-HCET monolayers cultured in 
medium containing either _ HKGS or _ 
HKGS-V2 supplements exposed to 
Timolol Maleate concentrations for 48 
hours. Where * denotes a significant 
(P<O.05) decrease and * a significant 
increase in glutathione content compared 
to control (Omgmrl) cultures. 
(mean+SD., n=3). 
Figure 5.06 : Protein content (Jlgmr 
I) of J-HCET monolayers cultured in 
medium containing either _ HKGS or _ 
HKGS-V2 supplements exposed to 
Timolol Maleate concentrations for 48 
hours . Where * denotes a significant 
(P<O.05) decrease in protein content 
compared to control (Omgmrl) cultures. 
(mean+S.D. , n=3) . 
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Figure 5.07 : Resorufin production 
(flgml·l) of J-HCET monolayers cultured 
in medium containing _ HKGS or _ 
HKGS and BSO (JOOflM) exposed to 
Timolol Maleate concentrations for 48 
hours. Where * denotes a significant 
(P<O.05) decrease in resorufin compared 
to control (Omgmrl) cultures. 
(mean+S.D. , n=3). 
Figure 5.08 : Glutathione content 
(flM) of J-HCET monolayers cultured in 
medium containing _ HKGS or _ 
HKGS and BSO (JOOflM) exposed to 
Timolol Maleate concentrations for 48 
hours. Where * denotes a significant 
(P<O.05) decrease and * a significant 
increase in glutathione content compared 
to control (Omgmfl) cultures. 
(mean+S.D., n=3) . 
Figure 5.09 : Protein content (flgmr 
I) of J-HCET monolayers cultured in 
medium containing _ HKGS or _ 
HKGS and BSO (JOOflM) exposed to 
Timolol Maleate concentrations for 48 
hours . Where * denotes a significant 
(P<O.05) decrease in protein content 
compared to control (Omgmrl) cultures. 
(mean+S.D., n=3). 
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5.3 Determination of maximal timolol maleate concentration in 
growth media that allow sustained J-HCET viability over 21 days 
(504 hours). 
5.3.1 Introduction 
Preliminary studies were carried out to determine the maximal concentration of 
timolol maleate, in growth medium, that would not alter the J-HCET viability over a 
21 day (504 hour) exposure. A range of concentrations were employed, to determine 
a toxicity dose response, assessed using resazurin reduction- glutathione equivalents 
and kenacid blue assays. 
5.3.2 Materials and Methods 
Immediately prior to use timolol maleate was completely dissolved in growth 
medium (section 2.1.7.1) (containing ImM calcium chloride) to give concentrations 
of 0.17, 0.25, 0.36, 0.54, 0.79, 1.16 and 1.70mgmrl. Concentrations were made up 
in medium containing either the HKGS or HKGS-V2 supplements. J-HCET were 
seeded into the central 54 wells of eight 96 well plates at 3xl05 cells mrl (l00f..Ll). 
Phosphate buffered saline (PBS) (lOOJll) was applied to the outer 36 wells to prevent 
excessive evaporation of growth media. Plates were incubated for 72 hours at 37°C 
and 5% (v/v) C02 in air to allow cells to attach and attain confluence. One plate was 
assayed following the 72 hour growth period, providing a pre-exposure control. 
Medium was aspirated and the resazurin reduction (section 2.2.4.2), glutathione 
equivalents (section 2.2.4.4) and kenacid blue (section 2.2.4.1) assays performed. 
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The medium in the remaining plates was replaced with 200111 of medium containing 
the timolol maleate concentrations. For each concentration 6 replicate wells were 
employed. Plates were refed with fresh culture medium containing the appropriate 
timolol maleate concentration every 72 hours and incubated at 370 C and 5% CO2 
(v/v) in air. The resazurin reduction, glutathione equivalents and kenacid blue assays 
were performed every 72 hours over 504 hours. 
5.3.3 Results 
Only at 0.25mgmr1 timolol and below was the culture activity (figures 5.10 and 
5.13), GSH (figures 5.11 and 5.l4) and total protein content (figures 5.12 and 5.15) 
unaffected, compared with untreated controls. Most concentrations caused a 
significant reduction in culture activity and GSH concentration at 144 hours post 
exposure whilst a concentration of 1. 7mgmr1 causes a significant GSH reduction at 
72 hours. A similar pattern is observed regardless of supplement type employed i.e. 
HKGS or HKGS-V2 
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Figure 5.10 : Production ofresorufin 
equivalents ( ~ g m l l l ) ) of J-HCET 
mono layers cultured in HKGS 
supplemented media containing _ 0 
mgml·1 _ 0.17 mgmrl 0.25mgmr', 
0.36mgmr\ _ 0.54mgmr
'
, 0.79mgmr 
I , _ 1.16mgml·l , and _ 1.70mgmr l 
Timolol Maleate over 505 hours where * 
denotes a significant (P<0.05) decrease 
in resorufm production compared to 
control cultures (mean+S.D. , n=3). 
Figure 5.11 : Glutathione content 
( ~ M ) ) of J-HCET monolayers cultured 
in HKGS supplemented media 
containing _ 0 mgmrl _ 0.17 mgmrl 
0.25mgml·' , 0.36mgmr', _ 0.54mgmr 
I , _ 0.79mgml·l , _ 1.16mgmrl, and _ 
1.70mgmrl Timolol Maleate over 505 
hours where * denotes a significant 
(P<0.05) decrease in glutathione content 
compared to control cultures 
(mean+S.D., n=3). 
Figure 5.12 : Protein content ( ~ g m r r
I) of J-HCET monolayers cultured in 
HKGS supplemented media c o n t a i n i n ~ ~
_ 0 mgmr _ 0.17 mgmrl 0 . 2 5 m ~ m m , ,
0 . 3 6 m m · I , , _ O.54mgmr , 
0.79mgmr , _ 1.l6mgmrl, and _ 
1.70mgmrl Timolol Maleate over 505 
hours where * denotes a significant 
(P<0.05) decrease in protein content 
compared to control cultures 
(mean+SD., n=2). 
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Figure 5.13 : Production of resorufin 
equivalents (Ilgmrl) of J-HCET 
monolayers cultured in HKGS- V2 
supplemented media containing a 0 
mgmrl _ 0.1 7 mgmrl 0.2Smgmrl, 
0.36mgml·I, _ 0.S4mgmrl, _ 0.79mgmr 
I, _ 1.16mgmrl, and a 1.70mgmrl 
Timolol Maleate over SOS hours where • 
denotes a significant (P<O.OS) decrease 
in resorufm production compared to 
control cultures (mean+S.D., n=3). 
Figure 5.14 : Glutathione content 
(1lM) of J-HCET monolayers cultured 
in HKGS-V2 supplemented media 
containing _ 0 mgmrl _ 0.17 mgmrl 
0.2Smgml·l, 0.36mgmrl, _ 0.S4mgmr 
I, _ 0.79mgml,l , _ 1.16mgmrl , and _ 
1.70mgmrl Timolol Maleate over 50S 
hours where • denotes a significant 
(P<O.OS) decrease in glutathione content 
compared to control cultures 
(mean+S.D., n=3) . 
Figure 5.15 : Protein content (f.lgmr 
I) of J-HCET monolayers cultured in 
HKGS-V2 supplemented media 
containing _ 0 mgmrl _ 0. 17 mgmrl 
0.2Smgmrl , O,36mgmrl, _ 0.S4mgmr 
I, _ 0.79mgml·I, _ 1.J6mgmrl, and _ 
1.70mgml,I Timolol Maleate over 505 
hours where • denotes a significant 
(P<0.05) decrease in protein content 
compared to control cultures 
(mean+S.D" n=2). 
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5.3.4 Conclusion 
A timolol concentration of O.25mgmr1 is considered the highest concentration of 
timolol in growth medium that does not modulate the cell activity, GSH level or total 
protein (section 5.1.4) over a 21 day continuous exposure. 
5.4 J-HCET doubling time when cultured in growth media containing a 
subcytotoxic Timolol Maleate concentration 
5.4.1 Introduction 
The previous studies determined a sub cytotoxic timolol maleate concentration that 
does not reduce the viability of J-HCET monolayers as measured by the resazurin 
reduction, glutathione equivalents and kenacid blue assays. It is essential to ensure 
that this ~ ~ blocker at this concentration did not alter the population doubling time. 
Subsequent variation in recovery profiles could then be considered to be due to a 
depression or acceleration of J-HCET mitotic activity. 
5.4.2 Materials and Methods 
Medium was prepared containing timolol maleate at a final concentration of 
O.25mgmr1. Human corneal epithelial cells (J-HCET) were seeded into 25cm2 flasks 
(uncoated or TIC pre-coated) at a density of 4xl04 cells per flask in 5ml of medium. 
Triplicate flasks were established for each time point. Cultures were maintained at 
370C, 5% C02 (v/v) in air and refed with fresh medium every 48 hours. J-HCET 
228 
were harvested (section 2.2.3.3) after 24 hours, and subsequently every 24 hours up 
to 120 hours and the cell number determined using a haemocytometer (section 
2.2.3.2). After 120 hours of exposure the cells were re-seeded into appropriately 
labelled 2Scm2 flasks and cultured for a further 120 hours, with the cell number 
determined every 24 hours to generate a growth curve. This process was repeated 
over S04 hours. The population doubling time was calculated using the previous 
equation (section 3.1). 
5.4.3 Results 
Timolol maleate (0.24mgmr1) exposure does not significantly alter the growth rate 
of J-HCET cultured over S04 hours utilising either HKGS or HKGS-V2 supplements 
(table S.OI). In addition, the recommended coating matrix for use with the HKGS-
V2 supplements was not removed by the subcytotoxic concentrations as occurred 
with subcytotoxic surfactant concentrations (section 3.1). 
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Table 5.01 : Population doubling times of J-HeET cultured in HKGS or HKGS-V2 
supplemented medium containing sub cytotoxic timolol maleate concentrations 
(mean±S.D, n=3). 
Supplement Exposure 
Doubling Time (Hours) Between Days 
0-5 5 -10 10 ·15 15·21 
HKGS None (Control) 22±1.3 21±O.S 21±O.1 21±O.1 
Timolol Maleate 22±O.9 21±O.3 20±O.3 21±O.1 
HKGS-V2'" None (Control) 21±O.S 20±O.4 21±O.8 20±O.9 
Timolol Maleate 21±O.2 20±O.4 21±O.S 21±O.2 
HKGS-V2 None (Control) 30±S.6 30±O.S 28±O.1 29±O.3 
Timolol Maleate 31±O.8 29±O.S 27±1.4 28±1.1 
5.5 Evaluation of the effects of chronic subcytotoxic timolol maleate 
exposure to a human corneal cell line 
5.5.1 Introduction 
This study aims to investigate the chronic adverse effects of exogenous chemicals, 
using a J-HeET monolayer model. Timolol maleate has the potential to have 
adverse side effects on the corneal epithelium. Studies were conducted to determine 
the effects chronic timolol exposure had on the subsequent activity and glutathione 
content following an acute (60 second) Timolol exposure. 
230 
5.5.2 Materials and Methods 
Culture flasks (80cm3) were seeded with 5 x l O ~ ~ of J-HCET cells and incubated for 24 
hours at 37°C, 5% (v/v) C02 in air. Medium or medium containing timolol maleate 
(0.24mgmr1) was added to each flask where appropriate. Cultures were maintained 
at 37°C, 5% (v/v) C02 in air, re-fed with the appropriate medium every 72 hours 
over 432 hours (18 days) and sub cultured once cells were 70-80% confluent. Cells 
were monitored on a daily basis at low magnification (x40) to ascertain the level of 
cell growth, cell morphology and to check for contamination. Following the 18 day 
exposure, J-HCET cells were seeded into the central 54 wells of two 96 well plates at 
3 x 105 cells mrl (1001l1). Phosphate buffered saline (100",1) was applied to the outer 
36 wells to prevent excessive evaporation of growth medium. Plates were incubated 
for 72 hours at 37°C and 5% C02 (v/v) in air to allow the cells to attach and attain 
confluence. One plate was assayed following the 72 hour growth period, providing a 
pre-exposure control. Medium was aspirated and the resazurin reduction (section 
2.2.4.2), glutathione equivalents (section 2.2.4.3) and kenacid blue (section 2.2.4.1) 
assays performed. Immediately prior to use, timolol maleate was completely 
dissolved in HBSS (containing ImM calcium chloride) to create concentrations of 
0.5, 0.74, 1.09, 1.6, 2.36, 3.47, 5.1 and 7.5mgmr1. The medium was aspirated from 
the remaining plates and 200",1 of each of the timolol maleate concentrations or 
HBSS alone for 60 seconds. Wells were aspirated and the mono layers washed twice 
with 200J.11 of HBSS (60 seconds) containing ImM calcium chloride. HBSS was 
aspirated and 200J.11 of cell culture medium (pre-warmed to 370 C) applied. Plates 
were incubated at 37°C and 5% C02 (v/v) in air for 48 hours. The resazurin 
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reduction, glutathione equivalents and kenacid blue assays were performed on the 
remaining plate. 
5.5.3 Results 
In J-HCET cultured in medium containing HKGS supplements pre-exposure to 
O.24mgmr1 timolol increased the toxic response of subsequent acute concentrations 
between 0.74 and 5.1mgmr1 as indicated by a significant (P>0.05) decrease in the 
production ofresorufin compared to control cultures (figure 5.16). Additionally, the 
stimulation of GSH levels at timolol concentrations of between 0.5 and 1.6mgmr1 
was annulled (figure 5.l7) with a dose dependent decline in GSH levels across the 
range of concentrations employed. Measurements of total culture protein 
demonstrate a significant reduction compared to control cultures at concentrations of 
5.1 and 7.5mgmr1 (figure 5.18). A comparable pattern of increased toxicity was 
observed in J-HECT cultured in HKGS-V2 supplemented medium as revealed by 
resorufin production (figure 5.19), glutathione levels (figure 5.20) and total protein 
content (figure 5.21). 
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Figure 5.16 : Resorufin production 
(flgmr l) of J-HCET monolayers cultured 
in HKGS supplemented medium _ no 
pre-exposure or _ Timolol (O.24mgmrl) 
504 hour pre-exposure subsequently 
exposed to Timolol Maleate 
concentrations for 48 hours. Where· 
denotes a significant (P<0.05) decrease 
in resorufm compared to control (no pre-
exposure) cultures at the same time 
point. (mean+S.D., n=3). 
Figure 5.17 : Glutathione content 
(flM) of J-HCET monolayers cultured in 
HKGS supplemented medium _ no pre-
exposure or _ Timolol (0 .24mgmr l ) 504 
hour pre-exposure subsequently exposed 
to Timolol Maleate concentrations for 48 
hours. Where· denotes a significant 
(P<0.05) decrease in glutathione 
compared to control (no pre-exposure) 
cultures at the same time point. 
(mean+S.D., n=3). 
Figure 5.18 : Protein content (flgmr 
I) of J-HCET monolayers cultured in 
HKGS supplemented medium _ no pre-
exposure or _ Timolol (0.24mgmrl) 504 
hour pre-exposure subsequently exposed 
to Timolol Maleate concentrations for 48 
hours. Where· denotes a significant 
(P<0.05) decrease in protein compared 
to control (no pre-exposure) cultures at 
the same time point. (mean+S.D., n=3). 
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Figure 5.19 : Resorufin production 
(flgmrl) of J-HCET monolayers cultured 
in HKGS-V2 supplemented medium • 
no pre-exposure or _ Timolol 
(0.24mgmrl) 504 hour pre-exposure 
subsequently exposed to Timolol 
Maleate concentrations for 48 hours . 
Where • denotes a significant (P<0.05) 
decrease in resorufin compared to 
control (no pre-exposure) cultures at the 
same time point. (mean+SD., n=3). 
Figure 5.20 : Glutathione content 
(flM) of J-HCET monolayers cultured in 
HKGS-V2 supplemented medium _ no 
pre-exposure or • Timolol (O.24mgmr l ) 
504 hour pre-exposure subsequently 
exposed to Timolol Maleate 
concentrations for 48 hours. Where * 
denotes a significant (P<0.05) decrease 
in glutathione compared to control (no 
pre-exposure) cultures at the same time 
point. (mean+S.D., n=3). 
Figure 5.21 : Protein content (flgmr 
I) of J-HCET monolayers cultured in 
HKGS-V2 supplemented medium • no 
pre-exposure or _ Timolol (O.24mgmr') 
504 hour pre-exposure subsequently 
exposed to Timolol Maleate 
concentrations for 48 hours . Where * 
denotes a significant (p<0.05) decrease 
in protein compared to control (no pre-
exposure) cultures at the same time 
point. (mean+S.D., n=3) . 
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5.5.4 Conclusion 
Timolol maleate pre-exposure over 21 days (504 hours) significantly increased the 
toxicity of subsequent acute timolol exposure in J-HCET cultured in media 
containing either HKGS or HKGS-V2 supplements. 
5.6 The effect timolol maleate (O.24mgmr1) pre-exposure has upon 
barrier integrity when J-HCET monolayers are exposed to a 
clinically relevant concentration (2.5mgmr1) of timolol maleate 
5.6.1 Introduction 
Ophthalmic liquid formulations contain in addition to drug and water, adjuvants: e.g. 
surfactants (acting as drug solubilizers, and/or spreading agents); preservatives 
(preventing microbial contamination) and viscosity increasing agents (prolonging the 
time of residence in the periocular area) (Chetoni et al., 2003). Since ocular 
penetration enhancers act by inducing ultrastructural changes in the corneal 
epithelium, their use has be cause for recent concern (Chetoni et al., 2003). While 
reversible, transient alterations of corneal tissues might be acceptable, ocular damage 
produced by surfactants, particularly on long term administration as in the treatment 
of glaucoma, are raising concern. It has been established (section 4.1 and 4.2) that 
the formation of an intact barrier in the J-HCET cell line is dependent upon both a 
confluent monolayer being achieved and the correct level of extracellular calcium 
chloride (1 mM). Timolol maleate is known to have some calcium/sodium channel 
blocking activities (Osborne et al., 2004) blunting the influx of calcium into stressed 
235 
cells (Melena et al., 1999; Chidlow et al., 2000). Therefore, studies were conducted 
to determine if chronic subcytotoxic timolol exposure affects the recovery of J-
HCET barrier function subsequent to a clinically relevant acute timolol exposure. 
5.6.2 Materials and Methods 
Culture flasks (80cm3) were seeded with 5xl0s of J-HCET cells and incubated for 24 
hours at 37°C, 5% (v/v) C02 in air. Medium or medium containing timolol maleate 
(0.24mgmrl) was added to each flask where appropriate. Cultures were maintained 
at 37°C, 5% (v/v) C02 in air, re-fed with the appropriate medium every 72 hours 
over 432 hours (18 days) and subcultured once cells were 70-80% confluent. Cells 
were monitored on a daily basis at low magnification (xl0 objective) to ascertain the 
level of cell growth, cell morphology and to check for contamination. Following the 
18 day exposure, J-HCET cells were harvested from the large culture flasks (section 
2.2.3.3) and medium culture flasks (80cm3) were seeded with 5xlOs of J-HCET cells 
and incubated for 24 hours at 37°C, 5% (v/v) C02 in air. Medium or medium 
containing timolol maleate (0.24mgmrl) was added to each flask where appropriate. 
Cultures were maintained at 37°C, 5% (v/v) CO2 in air, re-fed with the appropriate 
medium every 72 hours over 432 hours (18 days) and subcultured once cells were 
70-80% confluent. Cells were monitored on a daily basis at low magnification (x 1 0 
objective) to ascertain the level of cell growth, cell morphology and to check for 
contamination. Following the 18 day exposure, J-HCET cells were harvested from 
the culture flasks (section 2.2.3.3) and 5001-11 seeded into polycarbonate inserts at 
5xl0s cells mr) suspended in the respective growth medium. Growth media (5001-11) 
was added to the outer 16 wells to prevent excessive evaporation. Two inserts 
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received 500111 of medium alone and were referred to as the no-cell inserts. Inserts 
were placed into 24 well plates with an additional 500111 of corresponding medium in 
the wells and incubated at 37°C, 5% C02 (v/v) in air for 72 hours. Medium was 
aspirated from one plate and the combined fluorescein leakage/resazurin reduction 
(section 2.2.4.3) and total protein kenacid blue (section 2.2.4.1) assays performed. 
From the remaining plates medium was aspirated and 200111 of a 2.5mgmr1 timolol 
maleate solution (in HBSS) applied for 60 seconds. Inserts were aspirated and the 
monolayers washed with 200111 ofHBSS (2 x 60 seconds). HBSS was aspirated and 
500111 of cell culture media (pre-warmed to 37°C) applied. The combined 
fluorescein leakagelresazurin reduction and kenacid blue assays were performed 
every 5 minutes over 35 minutes. One insert from each time point was set aside prior 
to kenacid blue exposure for immunohistochemical studies (section 5.7). 
5.6.3 Results 
Acute (60 second) exposure to a timolol concentration of 2.5mgmr1 significantly 
(p<O.05) increased the level of fluorescein leakage across J-HCET mono layers 5 
minutes post exposure compared to control cultures, with subsequent recovery at 35 
minutes (figure 5.22). A similar effect was observed in J-HCET pre-exposed to 
timolol, with incomplete recovery observed at 35 minutes post exposure (figure 
5.22). An acute (60 second) exposure to timolol (2.5mgmr1) did not significantly 
alter either the production of resorufin or total protein content of J-HCET 
monolayers cultured in media containing HKGS supplements either with or without 
prior subcytotoxic exposure (figures 5.23 and 5.34) over 35 minutes. 
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Figure 5.22 : Fluorescein leakage 
across J-HCET monolayers cultured in _ 
HKGS supplemented media (control), _ 
exposed to 2.5mgmrl timolol maleate 
(60 seconds) or cultured in media 
containing timolol maleate (0.24mgmrl) 
for 504 hours and subsequently exposed 
to a timolol concentration of 2.5mgmr l 
for 60 seconds. Where * denotes a 
significant increase compared to control 
cultures and * denotes a significant 
increase in leakage compared to non-
pre-exposed cultures at a similar time 
point. (mean+S.D., n=3) 
Figure 5.23 : Resorufin production 
(flgmr l ) in J-HCET monolayers cultured 
In _ HKGS supplemented media 
(control), _ exposed to 2.5mgmr l 
timolol maleate (60 seconds) or 
cultured in media containing timolol 
maleate (0.24mgmrl) for 504 hours and 
subsequently exposed to a timolol 
concentration of 2.5mgmr l for 60 
seconds. (mean+S.D., n=3) 
Figure 5.24 : Protein content (flgmr 
I) of J-HCET monolayers cultured in _ 
HKGS supplemented media (control), _ 
exposed to 2.5mgmrl timolol maleate 
(60 seconds) or cultured in media 
containing timolol maleate (0.24mgmrl) 
for 504 hours and subsequently exposed 
to a timolol concentration of 2.5mgmr l 
for 60 seconds. (mean+S.D., n=3) 
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5.6.4 Conclusion 
Acute timolol maleate exposure disrupts the barrier function, with subsequent 
recovery over 35 minutes whilst having no effect on cell activity. In cultures pre-
exposed to subcytotoxic timolol concentrations a similar pattern of barrier disruption 
was observed with only partial recovery by 35 minutes post exposure. 
5.7 Effects on adhesion molecule expression of an acute (60 second) 
timolol maleate (2.5mgmr1) exposure in J-HCET monolayers and 
monolayers pre-exposed to 0.24mgmr1 timolol maleate for 504 
hours 
5.7.1 Introduction 
The expression and localisation of the key adhesion molecules f-actin, ZO-l, and 
occludin were examined in J-HCET mono layers treated with timolol maleate, with 
samples set aside from section 5.6. 
5.7.2 Material and Methods 
J-HCET cultures used in fluorescein leakage studies (section 5.6) were retrieved and 
labelled for f-actin, and ZO-l employing the same protocols as in sections 4.7 and 
4.8 respectively. For occludin immunostaining a similar approach was taken as in 
section 4.9 except that the primary antibody was mouse anti-occludin (table 2.0). 
Immunostaining of J-HCET mono layers cultured in the keratinocyte medium (KGM) 
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supplemented with animal derived products and calcium ( 1 0 0 ~ M ) ) routinely used in 
the ICCV AM/ECV AM validation trial (Strickland et al., 2003) were employed as a 
control (figure 5.25). Slides were viewed under a Leica Confocal Microscope. 
5.7.3 Results 
Immunohistochemistry controls were prepared as outlined in sections 4.7 through 4.9 
to for f-actin, ZO-l, and occludin and examined microscopically confirming the 
efficacy of the staining protocol. The adhesion molecules f-actin, ZO-l and occludin 
in J-HCET monolayers stained prior to acute timolol (2.5mgmr1) exposure 
demonstrate correct intracellular localisation (figure 5.25). 
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Figure 5.25 : Images representative of (a) occ\udin, (c) ZO-l and f-actin (d) 
expression in J-HCET monolayers cultured in HKGS supplemented medium (in the 
presence or absence of 0.24mgmr1 timolol maleate) immediately prior to acute 
(2.5mgmr1) timolol maleate exposure. (magnification x400) . 
When the images of the adhesion molecules occ\udin, ZO-l and f-actin (figure 5.25) 
prior to acute timolol exposure were interpreted in conjunction with the fluorescein 
leakage data (figure 5.22) the barrier function of the J-HCET monolayer was intact. 
Alterations in adhesion molecule expression (f-actin, ZO-l , and occludin) may not be 
attributed to the loss of cell confluency due to cell death as total culture protein 
measurements made at 5 minute intervals over the 35 minute period reveal no 
significant decrease compared to control cultures. This was further confirmed by 
propidium iodide staining of the J-HCET nuclei demonstrating the presence of an 
intact monolayer at all time points. 
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5.7.3.1 Effect of acute timolol exposure on f-actin, ZO-1 and occludin in 
non-pre-exposed J-HCET cultures 
The pre-exposure status (figure 5.25) and subsequently up to 10 minutes post timolol 
(2.5mgml-I) exposure f-actin expression was found at the periphery of the cell 
adopting the classical "chicken wire" appearance. At 15 minutes post exposure, f-
actin expression begins to appear more concentrated in certain cells groups with 
bright fluorescence. This tends to mask the majority of the cells that are thus seen in 
paler "chicken wire" pattern. In certain cells there appears to be intense cytoplasmic 
labelling as if the timolol maleate exposure has stimulated f-actin production in 
certain cells (figure 5.26). Thus the peripheral location of the f-actin labelling is not 
lost during the 35 minutes post exposure. Immediately following acute timolol 
exposure and subsequently up to 10 minutes post exposure, ZO-I immunostaining 
was completely lost from the cell-cell contact location. There is a focal point of 
labelling in the cell cytoplasm that could indicate that the ZO-I is not lost but 
condensed into a vesicle within the cells. ZO-I staining begins to appear at the 
periphery of abutting J-HCET 15 minutes post exposure with a few focal points still 
visible even at 35mins. Complete recover by 35 minutes post exposure in ZO-l 
expression and localization (figure 5.26) is almost achieved but there is still some 
indications of beading of the expression along abutting cell membranes. Five 
minutes post acute timolol exposure and subsequently up to 15 minutes post 
exposure, occ1udin expression at the periphery of abutting J-HCET was completely 
disrupted. Occ1udin staining appears at the periphery of abutting J-HCET at 20 
minutes post exposure with indications of recovery by 35 minutes post exposure in 
occludin expression and localisation (figure 5.26). However, this was not complete 
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and cytoplasmic staining was retained even at 35 minutes which render the 
appearance different from that of the control (c.f figure 5.25b and figure 5.26 at 35 
mins). Thus apart from the Occludin, where the level of labelling does appear to 
decline at 5 and 10 minutes the effect of timolol maleate at 2.5mgmr1 results in 
relocation of the adhesion molecules rather than loss, which would facilitate rapid 
restitution of the barrier functioning. 
5.7.3.2 Effect of acute timolol exposure on f-actin, ZO-1 and occludin 
timolol pre-exposed J-HCET cultures 
At pre-exposure and subsequently up to 10 minutes post timolol (2.Smgml-l) 
exposure f-actin expression was found at the periphery of the cell adopting the 
classical appearance of "chicken wire". At 15 minutes post exposure, f-actin 
expression began to appear more cytoplasmic with the "chicken wire" pattern 
becoming indistinct with continued diffuse staining up to 35 minutes post exposure 
(figure 5.27). Immediately following acute timolol exposure and subsequently up to 
10 minutes post exposure, ZO-l immunostaining was completely disrupted with 
focal localisation in vesicles. ZO-l staining appears at the periphery of abutting J-
HCET 15 minutes post exposure which appears more rapid relocation than with the 
non-chronically exposed cells (figure 5.26 l5mins verses 5.27 15 mins). 
Subsequently up to 35 minutes post exposure recovery in the ZO-l expression and 
localization was the same as for the non-chronically exposed cells (c.f figure 5.26 
with figure 5.27). Five minutes post acute timolol exposure and subsequently up to 
10 minutes post exposure, occludin expression at the periphery of abutting J-HeET 
was completely disrupted. Occludin staining appeared at the periphery of some of 
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the abutting J-HCET at 15 minutes post exposure with more complete recovery by 35 
minutes post exposure in both expression and localisation (figure 5.27). This was 
again earlier than found in the non-chronically exposed timolol maleate cells (c.f 
figure 5.26 with 5.27). 
5.7.4 Conclusion 
Acute timolol maleate exposure results in a relocation of the adhesion molecules ZO-
1 and occludin from the cell-cell contact points within 5 minutes of application. This 
correlated with the reduction in the barrier function of J-HCET mono layers with 
respect of fluorescein leakage. Disrupting the location and/or expression of the 
adhesion molecules ZO-l and occludin, essential for the formation of tight junctions, 
the barrier function is compromised. Over a period of 35 minutes, ZO-l and 
occludin expression and localization had recovered sufficiently to restore the barrier 
function. When J-HCET were pre-exposed to a sub cytotoxic timolol concentration 
similar effects were observed except ZO-1 and occludin were seen at the cells 
junctions after only 15 minutes and occludin expression was only partial restored by 
35 minutes. This does indicate that the localisation of Occuldin may be the more 
significant factor since there was a significant increase in fluorescein leakage at 35 
minutes compared to the J-HCET exposed which had not been pre-exposed (figure 
5.22). 
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Figure 5.26 : Expression and localisation of f-actin, ZO-l , and occludin over 35 minutes in J-HCET monolayers cultured in HKGS 
supplemented media exposed to Timolol maleate (2.5mgmr1) for 60 seconds. 
<r) 
~ ~
N 
.5 
.... 
C.I 
~ ~
~ ~
~ ~
I 
o 
N 
.5 
"0 
= ~ ~
(j 
o 
5 minutes 10 minutes 15 minutes 20 minutes 25 minutes 30 minutes 35 minutes 
Figure 5.27 : Expression and localisation of f-actin, ZO-1 , and occ1udin over 35 minutes in J-HCET monolayers cultured in HKGS 
supplemented media containing O.24mgmr1 timolol maleate subsequently exposed to 2 .5mgmr1 timolol for 60 seconds. 
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General discussion 
6.1 Introduction 
The study aimed to develop a simple human corneal epithelial cell (J-HCET) based 
model, based on the differential effects of chronic and acute exogenous chemical 
exposure, to predict potential in vivo eye irritation effects. In this model assess the 
change in cell activity and monolayer barrier integrity, was employed as a measure 
of acute to mild damage, after chronic/repeat exposure. 
It has been established that the fluorescein leakage assay with MOCK cells (Tchao, 
1988; Shaw et al., 1990) can predict the irritant effects of chemicals (Brantom et al., 
1997) or cosmetic formulations (Cottin and Zanvit., 1997) that cause mild effects to 
corneal epithelium. In combination with the resazurin reduction assay (Clothier and 
Samson, 1996) an enhance prediction of chronic or repeat exposure effects has been 
produced for skin irritation (Clothier et al., 1999). This was then transferred to 
human corneal epithelium in vitro (Clothier et al., 2000). 
Whilst measures of barrier function are important, observations concerning the 
expression and localisation of f-actin and its association with the key adhesion 
molecules, ZO-I, occludin and claudin-l was also required since changes in these 
may not be detected as a change in cell activity but should be as leakage. The J-
HCET monolayers (Araki-Sasaki et al., 1995) were employed since the ability of 
cells to modulate toxic insults can differ even when they express similar adhesion 
molecules. Differential toxic responses were noted in the phototoxicity study 
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(Spielmann et al., 1998; Clothier et al., 1999) between the human corneal cells and 
human keratinocytes (Combes et al., 1999). 
Chronic exposure to subcytotoxic concentrations of four representative surfactants; 
BAK (cationic), SDS (anionic), CAPB (amphoteric) and T20 (non-ionic) and one 
clinically relevant pharmaceutical, timolol maleate, indicated that low concentration 
over a 21 day period do not affect the cell number, activity or barrier function, but 
may alter, marginally, the expression of the key adhesion molecules. Interactions 
between surfactants following chronic exposure to one surfactant, at subcytotoxic 
concentrations, modulated the subsequent J-HCET response to a subsequent acute 
exposure with the same or different surfactants. This revealed cross reactivity 
between the effects of different surfactants as described by Herlofson (1996) in the 
buccal cavity treated with CAPB or SDS. The aim of ascertaining if chronic 
exposure modulates the response to the same type of surfactant or to surfactants in 
general was achieved. Whilst standard surfactants were good indicators of the 
effects following chronic exposure, there were pharmaceuticals designed for repeat 
use in the eye e.g. timolol maleate in the treatment of glaucoma. Since timolol 
maleate was detoxified in vivo via conjugation with glutathione (GSH) (Megaw, 
1984; Riley, 1990) the effects on glutathione levels could have consequences 
resulting following chronic exposure, allowing for the examination of a distinct 
intracellular detoxicification pathway role in compromising the barrier function. 
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6.2 Development of the chronic exposure model 
6.2.1 Evaluation of the J-HCET cell line 
A number of validation studies; ECIHO (Balls et al., 1995), CTF A (Gettings et al., 
1996), COLIPA (Brantom et al., 1997), !RAG (Bradlaw et al., 1997) and 
MHW/JCIA (Ohno et al., 1999) have employed cell monolayers expressing adhesion 
junction in vitro, e.g. SIRC, HeLa, MDCK and CHL. Few of these studies have 
taken into account the specialised nature of the human corneal epithelium when 
considering toxicity endpoints or the associated adhesion molecules and 
detoxification pathways. According to the European Centre for the Validation of 
Alternative Methods (ECV AM) review of in vitro methods (Worth and Balls, 
2002b), models need to match human in vivo expression of differentiated function 
with the relevant cell phenotypes. Two cell lines derived from human corneocytes 
have been used to model the corneal epithelium in vitro, the J-HCET (Araki-Sasaki 
et ai, 1995) and Gillette HCE-T (Kahn et al., 1993; Ward et al., 1997b) cell lines. 
Kahn et al, (1993) infected primary human corneal explants with an Adeno 12-SV40 
(AdI2-SV40) hybrid virus, resulting in a number human corneal epithelial cloned 
cell line with an extended life span. Although exhibiting an extended in vitro life 
span, the cell line employed was not continuous, and can only be utilised upto 20 
generations (Kruszewski et al., 1997), thereby limiting its availability and ultimate 
usefulness. Growth of this cell line upon a collagen membranes, at an air-liquid 
interface, promoted multilayering, more closely approximating corneal morphology 
observed in situ (Kahn et al., 1993) retaining a variety of phenotypic characteristics 
(Ward et al., 1997b). In contrast, Araki-Sasaki (et ai, 1995) isolated human corneal 
250 
epithelial cells which were subsequently transfected, with the SV 40 virus to obtain a 
continuous growing cell line (J-HCET). This cell line was reported to grow for more 
than 400 generations exhibiting a cobblestone-like appearance similar to normal 
corneal epithelia in culture (Araki-Sasaki et ai, 1995; Moore et al., 2005). The 
ability to progress past 20 generations was confirmed in this study, even in the 
presence of different media. When cultured at the air-liquid interface the 
transformed corneal cells differentiated in a multilayer fashion (Araki-Sasaki et ai, 
1995) similar to that reported for the HCE-T cell line (Ward et al., 1996). Although 
both the J-HCET and HCE-T cell lines meet the criteria set down in the ECV AM 
review of in vitro methods (Worth and Balls, 2002b) an important criterion for the 
selection of a cell line for use in a validated in vitro model was the availability and 
stability over time. The limited volume of material and the variability between cell 
cultures from different donor eyes makes it difficult to perform routine biochemical 
and physiological investigations on primary isolated human corneal epithelial cells 
(Bednarz et ai, 2000). In terms of longevity, the J-HCET cell line is superior to the 
HCE-T line (Khan et al., 1993), due to its ability to undergo more than 400 
generations before senescence. 
An important consideration in the development of an in vitro model of chronic ocular 
toxicity was the selection of an appropriate growth medium. The growth of many 
cell types in culture requires serum in the medium (Castro-Munozledo and 
Hemandez-Quintero, 1997) as a source of hormones, cytokines, vitamins, 
attachment, spreading and growth factors (Tezel and Del Priore, 1998). The absence 
of these can have profound effects upon in vitro cultures (Tezel and Del Priore, 
1998). With the identification, cloning and recombinant production of essential 
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growth factors several chemically defined, serum free media are now available 
commercially. The development of serum free cell culture medium has been 
stimulated (Taub, 1990; Bjare, 1992; Ranaldi et ai, 2003; Fitzsimmons et al., 2004; 
Van der Valk et al., 2004) and increasing numbers of formulations for the culture of 
primary isolates and continuous cell lines are available (Taub, 1990; Bjare, 1992; 
Fitzsimmons et al., 2004) although serum free media are generally more cell type 
specific (Tezel and Del Priore, 1998). The collection of foetal bovine serum (FBS) is 
a controversial issue due to the possible distress suffered by the foetus prior to- and 
during harvesting (Van der Valk et al .. 2003). With the upcoming implementation of 
the REACH program it has been estimated that the total worldwide consumption of 
FBS will significantly increase due to the expansion of in vitro toxicity testing (Van 
der Valk et al., 2003). In keeping with the principles of the Three R's ofRussell and 
Burch, (1959) a chemically defined culture medium and supplement package (HKGS 
and HKGS-V2) manufactured by Cascade Biologics was selected. Most research 
into in vitro alternatives to the Draize eye test has been directed towards modelling 
acute toxicity. Consequently there was limited published data regarding the 
behaviour of the J-HCET cell line over exposure periods greater than 96 hours. In 
order to assess the potential use of the J-HCET (Araki-Sasaki et ai, 1995) it was 
necessary to determine the phenotypic stability during prolonged culture on a 
synthetic membrane as the characteristic morphology of cell lines can be lost during 
prolonged culture (Engelmann and Bohnke, 1990; Albert et ai, 1972; Turksen et ai, 
1989). The expression of functional and correctly expressed and located adhesion 
molecules including tight junctions, as well as the growth rate when cultured in the 
medium where the chosen endpoints. 
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6.2.2 Population doubling time of the J-HCET cell line 
Many of the properties which can be used to differentiate a transfected cell from a 
non-transfected control were also observed when tumour cells were compared with 
their normal in vivo counterparts. Although the J-HCET cell line created by Araki-
Sasaki et al., (1995) has been employed in this study, due to its transformation, both 
the phenotypic stability and replicative capacity of the cell line may degenerate 
during prolonged in vitro culture (Freshney 1994). The degeneration of a cell line in 
vitro may be monitored by simply monitoring changes in the population doubling 
time. Population doubling time may be affected by senescence, and medium 
composition of different inhibitory or stimulatory factors, such as variations in 
nutrient concentration or hormonal effects in medium or toxic drugs (Freshney, 
1994). The problem of primary and transfected cell lines retaining their in vivo 
characteristics when employed in in vitro toxicity studies has recently been addressed 
by Strickland et al., (2003). They concluded that monitoring the population doubling 
time was essential to ensure that toxicity profiles were not modulated as a 
consequence of the long term usage of a specific batch of cells that were changing 
over time. In addition, when conducting chronic toxicity studies, alterations in the 
population doubling time may reveal subtle alterations in cell biochemistry not 
necessarily identified using the more common biological endpoints (e.g. resazurin 
reduction and neutral red uptake). From the data presented in a recent study by 
Araki-Sasaki et al., (2000) the population doubling time of the J-HCET cell line, 
cultured in RPMI-1640 (Gibco BRL Inc., Grand Island, NY) supplemented with 10% 
FCS can be approximated to 48 hours. By investigating the population doubling 
time of the J-HCET cell line with the basic Epilife medium, but with two different 
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growth supplements, HKGS [bovine pituitary extract (0.2% v/v), bovine insulin 
(5J.1gmr1), hydrocortisone (0.I8J.1gmr1), bovine transferring (5J.1gmr1), human 
epidermal growth factor (0.2ngmr1)] or HKGS-V2 [human recombinant insulin-like 
growth factor type-I, prostaglandin E-2, human recombinant epidermal growth 
factor, hydrocortisone and a proprietary plant extract at undisclosed concentrations] 
the effects of the change in medium was ascertained. The doubling time was 
extended by 50% as a result of HKGS-V2 supplement addition in the absence of the 
coating matrix. The increased doubling time observed with the HKGS-V2 
supplement was in agreement with observations made by Cook et al., (2003) 
concerning the population doubling time of primary keratinocytes, utilising the same 
combination of medium and supplements. Cook et al., (2003) showed that the 
variation in doubling time between the HKGS and HKGS-V2 supplements was 
negated by pre-coating the tissue culture plasticware with a Type I Collagen 
attachment matrix. This was also true for the corneal cells. Interestingly, in the 
cornea, Type I Collagen forms the major component of the corneal stroma on which 
the epithelium sit (Suzuki et al., 2003). Hence, the problem was not directly due to 
the effects of the plant growth supplements, rather than human/animal derived, on 
growth, but on the attachment of the cells when seeded in the respective media. 
Hence, when the recommended attachment factor was employed the popUlation 
doubling time of J-HCET cultured in HKGS-V2 supplemented medium was the same 
as for the HKGS supplemented medium at around 24 hours. The attachment matrix 
had no effect on the doubling time of J-HCET cultured in HKGS supplemented 
medium. Interestingly, the population doubling time of the J-HCET cell line in 
medium containing either supplement was significantly shorter than that obtained by 
Araki-Sasaki et al., (2000) when RPMI medium containing 10% FCS was employed. 
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These results suggest that the HKGS-V2 supplements manufactured by Cascade 
Biologics were limited in their ability to support cellular attachment to tissue culture 
plasticware without the use of an addition attachment matrix (Type I Collagen), or 
that the HKGS variant does contain some collagen. In vivo, corneal epithelial cells 
rest on a thin layer of extracellular matrix, called the basement membrane (BM), 
which plays an essential role in epithelial adhesion to the underlying Bowman's layer 
(Attachment of corneal epithelial cells to their underlying substratum is the process 
that forms the basis for establishment of cell migration, the assembly of complex 
adhesive structures, cell polarity and morphology (Steele et al., 1997». In vitro, the 
proliferation of anchorage dependent cells may only occur after adhesion to the 
culture surface. Cells adhere to a culture surface through a multi-step process. 
Initially the absorption of the attachment factors e.g. cold insoluble globulin (CIG) 
often secreted as fibronectin onto the culture surface, enable a) contact between the 
cell and the surface, b) attachment to the coated surface through interactions between 
multivalent heparin sulphate synthesized by the cell and CIG adsorbed onto the 
culture surface and c) finally spreading of the attached cells (Steele et al., 1997). 
These processes were supported by the unevenly distributed negative surface charge 
of mammalian cells, and it was the density of the charges on the surfaces in contact, 
and not the polarity, that was the governing factor for adhesion. The variation in 
population doubling time between J-HCET cultured in HKGS or HKGS-V2 medium 
may be due to alterations of charge density on the cells or the absence of essential 
medium components as a result of the use of plant extracts. 
It has been demonstrated that the initial attachment of cultured corneal epithelial 
cells to oxygen-containing synthetic polymers i.e. tissue culture polystyrene (TCPS) 
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was dependent upon the presence of exogenous vitronectin (Vn) found in the culture 
medium (Steele et al., 1997). Vitronectin, also known as S-protein, serum spreading 
factor and epibolin, is a mixture of two monomeric glycoproteins (65 and 75kDa) 
present in blood and the extracellular matrix of many tissues. Vitronectin and 
fibronectin are the two major adhesive proteins in plasma and serum. Like many 
other adhesion molecules, vitronectin binds to cells through interaction of the Arg-
Gly-Asp sequence in its cell binding domain with vitronectin-specific cell surface 
receptors (Steele et al., 1997). When used as a thin coating on tissue culture 
surfaces, vitronectin is useful to promote cell attachment, spreading, proliferation, 
and differentiation. The largest proportion of vitronectin in cell culture medium 
comes from foetal calf serum (FCS). The defined medium and supplement package 
employed did not contain the exogenous animal serum. As an alternative, bovine 
pituitary extract (BPE) forms a vital component of the HKGS supplements. Asami et 
al., (1984), Mattinger et al., (2002), Cook et al., (2003), have demonstrated that 
bovine pituitary extract may act as an alternative to serum for the in vitro culture of 
epithelial cells and may provide a source of the required attachment proteins. The 
use of Type I Collagen attachment factor returns the popUlation doubling time of J-
HeET to "normal" but still raises the question as to the way this could have affected 
responses to subsequent cytotoxic/irritant insults. 
6.2.3 Acquisition of the polarised cell phenotype 
The European cosmetics industry has had a long term interest in the development, 
validation and use of non-animal alternatives to assess the safety of cosmetic 
ingredients and formulations and to set "safe" human exposure levels, either as stand 
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alone methods or part of a tiered testing strategy (Brantom et al., 1997). The 
fluorescein leakage assay for integrity of the epithelial barrier function was evaluated 
in the COLIP AlEU study of coded cosmetic ingredients and formulations (Brantom 
et al., 1997). This study was undertaken following the EC/OH study (Balls et al., 
1995). The ECIHO study was designed to identify those in vitro assays that were 
capable of predicting eye irritation, correlated to the Draize scores for chemicals with 
"good" in vivo data taken from the ECETOC list (ECETOC Technical Report 48 (1) 
1992). Brantom et al., (1997) demonstrated that there was a good correlation 
between in vivo irritancy classifications, of the restricted cosmetic ingredients list of 
test agents, and those determined using the fluorescein leakage assay. However, for 
an alternative method to be considered reliable, it must demonstrate both 
interlaboratory and intralaboratory reproducibility (Curren et al., 1995; Balls and 
Karcher, 1995). Brantom et al., (1999) evaluated the performance of the fluorescein 
leakage assay and concluded that although the fluorescein leakage assay 
demonstrated good interlaboratory reproducibility between the two investigating 
laboratories and a reasonable statistical fit within its prediction model, there was 
insufficient data to assess its reliability. In addition, the fluorescein leakage test was 
incapable of discriminating between MMAS scores of between 30 and 110 (Brantom 
et al.,. 1997) and was, therefore, more suitable for distinguishing between non-
irritants or moderate irritants, i.e. between R34 and non classified (Balls and 
Clothier., 1992). With the fixed dose approach distinction of R36 from R41 
classified chemicals has been possible (Clothier et al., 1994). 
Monolayers of epithelial cell lines e.g. MOCK, J-HCET and HCE-T maintain low 
permeability through expression of tight junctions between the cells, and this 
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function was very important to avoid cellular damage after the ocular introduction of 
a xenobiotic (Zanvit et al., 1999). Such tight junctions are expressed when the 
epithelial monolayers were grown on permeable supports (Cottin and Zanvit, 1997; 
Ward et al., 1997b; Moore et al., 2005) and were thus impermeable to most 
chemicals, including the non-toxic dye sodium fluorescein. Unlike many alternatives 
to the Draize test for predicting eye irritation from acute xenobiotic exposure, the 
fluorescein leakage assay specifically includes damage to the epithelial barrier 
function, an important first stage in the generation of ocular irritancy (Cottin and 
Zanvit, 1997). The formation of an effective barrier, in vitro depends upon 
formation of a confluent layer of cells. Previous studies with MDCK cells (Clothier 
and Samson 1996) have demonstrated that if the original cell seeding density was too 
high, then adherence to parts of the culture surface was compromised and that the 
small areas devoid of cells result in a high rate of fluorescein leakage. Barrier 
function studies conducted using the J-HCET cell line confirmed this observation, 
namely that J-HCET need to "grow" to confluency to ensure a fully formed barrier in 
vitro regardless of the growth supplements employed (e.g. HKGS or HKGS-V2). 
The establishment of a confluent monolayer was not sufficient for the formation of a 
barrier. The expression and correct localisation of the components of the tight 
junction, i.e. f-actin, ZO-1 and occludin were dependent on the medium calcium 
concentrations (Kruszewski et al., 1997; Ward et al., 1997b; Moore et al., 2005). 
The use of defined media and supplement packages in this study permits exacting 
control over the calcium concentration in the cell culture medium. The degree of 
fluorescein leakage across J-HCET monolayer demonstrated that a calcium 
concentration of between O.SmM and ImM is required to form an effective barrier to 
the passage of fluorescein, similar to the 1 mM specified with the Gillette human 
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corneal cells culture method (Khan et al., 1993; Kruszewski et al., 1997; Ward et al., 
1997b). In the absence of calcium, the J-HCET continue to grow but lack the typical 
"cobblestone" appearance described by Araki-Sasaki et al., (1995) with space 
between neighbouring cells. Total cell protein measurements conducted in this study 
confirm that the alteration in fluorescein flux across the J-HCET monolayer was due 
to modifications of the adhesion molecules influenced by calcium concentration 
(Moore et al., 2005), rather than areas of the culture surface being devoid of cells. In 
addition the plant derived supplements do not significantly alter the calcium 
concentration required to form an effective barrier. The attainment of the leakage of 
6% or less, the level routinely accepted as indicative of the fully functional barrier 
with MDCK cells (Clothier and Samson, 1996) also applied to predict confluence 
with the J-HCET cells (Moore et al., 2005), was confirmed, and was half that 
attainable with the RPM! medium with 10% FCS (Clothier, personal 
communication). TEM images clearly demonstrated the presence of pinocytotic 
vesicles at all faces of the corneal cells in monolayer. These may be responsible for 
the transport of material from the apical to the basolateral domain through the cell, 
thereby bypassing the tight junctions, and accounting for the barrier function in vitro 
retaining some leakage, even if well below 6%. 
In addition to the cell seeding density, medium supplements and the calcium 
concentration, the choice of culture insert (providing a two chamber system) can 
affect responses (Ward et al., 1997a). Tissue culture inserts are commercially 
available, with membrane growth surfaces manufactured from a variety of materials, 
with different pore sizes and pore densities. Experiments with MOCK cells revealed 
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that the composition of the insert could affect the apparent leakage characteristics 
(Ward et al., 1997a). This led to research evaluating the predictivity and sensitivity 
of the fluorescein leakage assay using different insert types with their human corneal 
epithelial cell line (Wilkinson et al., 2005). Chemical incompatibilities vary with 
different membrane material types (Ward et al., 1997a; Cottin and Zanvit, 1997). 
For example, it has been demonstrated that acetic acid, the positive control within the 
standard fluorescein leakage protocol (Shaw et al., 1990) utilising Anopore 
membranes, is incompatible with the Millicell-HA membrane (Cottin and Zanvit, 
1997) where exposure to acetic acid led to the destruction of the insert material. 
Manufactures of inserts, utilised in the fluorescein leakage assay, have issued 
warnings of membrane incompatibilities, since these membrane are mainly intended 
for filtration purposes. Membrane destruction as a consequence of chemical 
incompatibility was not the only problem. Membrane adsorption or chemical 
binding effects were not always known or reported. Since the majority of published 
fluorescein leakage assay protocols (Tchao, 1988; Shaw et al., 1990; Clothier and 
Samson, 1996; Moore et al., 2005) entail an acute (minutes) exposure to high 
concentrations (mgmr1) of test material, differential binding could alter chemical 
exposure time to the cultures significantly (Ward et al., 1997a). Ward et al., (l997a) 
reported that cationic surfactants appeared to preferentially adsorb to particular types 
of membrane material and cause sodium fluorescein to bind to the membrane, giving 
false negatives, where the degree of leakage no longer correlates with the degree of 
damage to the monolayer. Chemical binding may occur when using the Draize test, 
binding to the corneal epithelium or tear film, so the differential binding to various 
membrane materials could be significant when in vitro/in vivo comparisons were 
made (Ward et al., 1997a). In addition, the selection of a growth support has been 
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demonstrated to influence the growth and differentiation of morphological and 
biochemical characteristics of the MDCK cell line commonly employed in 
permeability studies (Cook et al .. 1989; Butor and Davoust, 1992). 
Although the growth supplement employed (HKGS or HKGS-V2) can alter the J-
HCET population doubling time, the development of an intact barrier was 
unaffected, even when the collagen 1 coating was omitted. In order to optimise the 
fluorescein leakage assay for use with the J-HCET cell line and medium package. the 
use of an attachment factor was omitted when inserts were used due to potential 
problems associated with attachment matrix degradation, binding to and penetration 
of fluorescein through the underlying matrix. Interestingly and in contrast to the 
cells grown directly on the culture plates, the development of an intact barrier was 
identical for both HKGS and HKHS-V2 supplemented medium. To understand how 
J-HCET cultured in HKGS-V2 supplemented medium were able to attach to the 
polycarbonate membrane without the use of the recommended attachment matrix 
transmission electron microscopy of cells on the insert was employed. The J-HCET 
cells proj ect processes into the pores of the insert material, thereby anchoring the 
monolayer to the polycarbonate membrane, as seen with MOCK cells (Cottin and 
Zanvit, 1997). The in vitro use of the combined fluorescein leakage-resazurin 
reduction assay was considered a relevant mechanistic endpoint for the irritancy 
potential of cosmetic ingredients and formulations (Clothier et al., 1995). An 
advantage of using the fluorescein leakage assay over transepithelial resistance 
(TER), to examine barrier function of epithelial sheets, was that it was dependent on 
the correct expression of the adhesion components of the tight junction in situ, and 
not the additional transportation of ions through the cells. 
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6.2.4 Morphological analysis of components of the tight junction 
Among the various intercellular junctions the tight junctions (T J' s), origin all y 
defined and identified as zonulae occludens (lO) of simple epithelial and endothelial 
(Langbein et al., 2002) are commonly regarded as well understood in terms of 
structure and function. They are characteristically recognised in electron microscopy 
as small subapical regions of direct contact between the plasma membranes of 
abutting cells, with very limited intermembraneous material or extracellular gaps and 
are often referred to as "sites of fusion" or "kissing points" (Langbein et al., 2002). 
Recent studies reveal that the TJ complex includes both transmembrane proteins e.g. 
claudin or occludin and membrane associated proteins e.g. zonula occludins-l (ZO-
1), lO-2 and lO-3 (Balda and Matter, 2000; Tsukita et al., 2001; Langbein et al., 
2002; Ban et al., 2003). Occludin was the first transmembrane protein, of tight 
junctions, to be identified (Furuse et al., 1993; Balda and Matter 2000). Occludin is 
a 60 - 65kDa protein with four transmembrane domains (Furuse et al., 1993; Balda 
and Matter 2000; Ban et al., 2003) with both N- and C- termini oriented into the 
cytoplasm (Balda and Matter 2000). Occludin appears to be the most important and 
relatively well characterized transmembrane protein of the tight junction (Kale et al., 
2003) with the C-terminal interacting in vitro with several intracellular scaffolding 
proteins including ZO-I, ZO-2, ZO-3 (Furuse et al., 1993; Balda and Matter 2000; 
Ban et al., 2003). Claudins were more recently discovered and are a family of tight 
junction proteins of 22-24kDa (Table 6.01). Claudin-l and -2 were originally 
identified because they cofractionated with occludin from sonicated junctional 
fractions (Balda and Matter, 2003). However, there was no evidence for a direct 
interaction between occludin and claudin, and claudins do not copurify with occludin 
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from detergent-solubilised membranes. In contrast to occludin, individual claudins 
are generally expressed in only a restricted number of specific cell types - suggesting 
that they are associated with tissue specific functions. Thus in normal TJ's either 
occludin or claudin occurs. 
Table 6.0x : Characteristic features of different claudins. 
Claudin Distinctive Characteristics 
1 Presert in high-resistance epithelial (e.g. cornea) and absent in leaky epithelia (e.g. proximal tubule) 
2 Presert in leaky epithelia (e.g. proximal tubule) and absent in tight eplhelia (e.g. cornea) 
3 Present in the tigl1er segments of the nephron 
4 Its expression decreases paracellular conductance through a selective decrease ins odium permiability 
5 Constlutes T J strands in endothelial cells 
6 Preseri in embryonic epithelia, overexpression generates defective epidermal permiability barrier 
7 DoYII regWited in head and neck squamous cell carcinomas 
8 Presert in the tighter segments ofthe nephron 
The effects of variable calcium concentration on the adhesion molecules of the J-
HCET monolayer tight junctions were clearly revealed in the immunohistochemistry 
of the adhesion molecules confirming what was shown by Moore et al., (2005) with 
a different keratinocyte medium. During morphogenesis, mechanical forces 
generated by the dynamic rearrangements of cell-cell contacts and the cytoskeleton 
modulate changes in cell shape, motility and function (Jamora and Fuch, 2002). For 
the establishment of an intact barrier, abutting J-HCET must be intimately associated 
through both adherens and tight junctions. These junctions are ultimately anchored 
via scaffolding proteins interacting with the f-actin cytoskeleton whose expression 
and correct localisation is known to be calcium dependent (Jamora and Fuch, 2002). 
The location of f-actin to the periphery of the J-HCET was confirmed to be calcium 
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concentration dependent, for at low calcium concentrations ( ~ 6 0 J . 1 M ) ) the f-actin was 
diffuse. As the calcium concentration is increased to ImM the f-actin relocalises to 
the periphery. Once f-actin had formed the internal cytoskeletal network, other 
components of the tight junction i.e. ZO-I, occludin and claudin-I were correctly 
localised and interacted. The location of the ZO-1 and occludin to the cell membrane 
was confirmed to be equally calcium ion concentration dependent, in both the media, 
and the comparable effects of calcium when the cells were grown on the 
polycarbonate inserts and the fluorescein leakage measured also confirmed the 
calcium dependence of the formation of the adhesion molecules (Cereijido et al., 
1980; Meldolesi et al., 2004). The expression of claudin-I was found to be equally 
calcium ion concentration dependent. However, unlike f-actin, ZO-1 and occludin, 
the expression of c1audin-l to the periphery of abutting J-HCET was dependent upon 
multilayering. Yi et al., (2000) demonstrated c1audin-l specific immunostaining in 
the wing and basal layers of rat corneal epithelium i.e. claudin-l was only located in 
areas of stratification. Using RT-PCR, Yi et al., (2000) also demonstrated the 
presence ofclaudin-l, -2, -3, -9, -14, and -15 transcripts suggesting the expression of 
these in the J-HCET cell line. However, no data was obtained in the study of Yi et 
al., (2000) regarding the intracellular localisation of these claudin members in vi Iro. 
It is clear from the TEM photomicrographs that the areas of stratification upon the 
polycarbonate insert were limited and so the role that c1audin-1 plays in this 
monolayer model, with regard to barrier function was equivocal. The physical 
barriers that epithelial sheets establish to the passage of molecules are highly 
selective, and that this selectivity is dependent upon their physiological location. 
The corneal epithelium for example was known to express c1audin-1 (Furuse et al., 
1998; Yi et al., 2000) and extremely tight junctions in vivo. However, in vitro, in the 
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monolayer model developed during this study, claudin-l expression and localisation 
was limited. This leads to the hypothesis that occludin was able to form the 
backbone of a tight junction complex but for added functionality the expression of 
specific claudins were required in other areas of the epithelium. A calcium 
concentration of between 500flM and 1 mM was required for the formation of an 
intact barrier to the passage of sodium fluorescein; this was in contrast to the level 
routinely employed by Clothier and Samson (1996) of 100flM with the MOCK cell 
line was employed, but the MOCK culture medium contained bovine serum that 
contained calcium ions, so the exact calcium concentration was unknown. Similar 
effects on adhesion molecules were observed regardless of supplement type 
employed. Hence the f-actin interactions with other components of the tight junction 
(Anderson et al., 1993; Portiz et al., 2004) occurred in both media even though the f-
actin cytoskeleton was highly dynamic (Hall, 1994). 
6.3 Application of the J-HCET culture model to the test compounds 
6.3.1 Chronic and acute toxicity of surfactants 
Surfactants are organic compounds which are broadly classified into four categories; 
anionic, cationic, amphoteric and non-ionic, each exhibiting unique properties and 
applications. Surfactants are ubiquitous within our daily environment, being 
significant active components in both household products, personal care products, 
cosmetics, pharmaceuticals and endogenously in the human liver. Over a lifetime 
our eyes will be regularly exposed inadvertently, through personal care products, or 
deliberately, through the use of ophthalmic pharmaceuticals to surfactants. Being 
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an important category of ingredient in cosmetics (Vives et al., 1997), their potential 
capacity to cause ocular irritation and at what concentration is required information 
in accordance with duty of care legislation. Surfactants are indispensable as 
solubilising agents in the isolation, purification, and reconstitution or crystallisation 
of membrane proteins (Kragh-Hansen et al., 1998). Furthermore, at lower non-
solubilising concentrations (i.e. below the Critical Micelle Concentration; CMC), 
these compounds are known to permeabilise and perturb membrane structure and 
function (Kragh-Hansen et al., 1998). The toxic effects of surfactants are thought to 
be related to the ionic nature and the amount of free surfactant present, dependent 
on the total concentration and the CMC in the conditions under which the cells are 
exposed (Maurer et al., 1997; Vives et al., 1997). The proportion of surfactant 
molecules present at the plasma membrane or as micelles in the bulk of the liquid 
depends on the surfactant concentration. At low concentrations (A; Figure 6.01). 
surfactants will be monomeric and thus target the charged cell surface particularly if 
they are ionic. As the surfactant becomes more concentrated, i.e. molecules 
increasing in number micelles begin to be formed (8) and the number of monomeric 
molecules decline. Thus the number of surfactant molecules available to bind to the 
cell membrane decreases. At a specific concentration (dependent upon temperature, 
pressure, ionic concentration of other salts and liquid phase) the surfactant will be 
predominantly arrange as micelles but with few monomeric molecules (C), such that 
the plasma membrane can now become completely loaded with surfactant. 
Figure 6.01 : Physiochemical data concemmg representative critical micelle 
concentrations of the test surfactants in growth medium (adapted from Ward et al., 
1998). 
266 
Surfactant 
Sodium dodecyl sulphate 
Tween 20 
Cocamidopropylbetaine 
Benzalkonium chloride 
CMC (mM) 
6.2 - 6.8 
0.07 - 0.1 
0.2 - 0.24 
3.2 - 3.7 
Thus the toxicity of a surfactant depends upon its CMC and the avidity with which 
it binds to the cell membrane, which is dependent in part on its charge. Thus the 
manifest toxicity is due to a set of interactions and the environment in which the 
surfactant is presented. 
Figure 6.02 : A generic graph of surface tension versus the log of surfactant 
concentration. 
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Surfactants have the ability to induce phospholipid emulsification contributing to the 
cellular damage, which can result in cytolysis, the release of proteins, lysosomal and 
cytoplasmic enzymes and inflammatory mediators (Lee et al., 2000). The sequence 
of events when membranes are exposed to increasing concentrations of surfactant is : 
increased permeability; lysis; solubilisation of lipid-protein-detergent associations ; 
the appearance of lipid-detergent mixed micelles and solubilised protein; the 
appearance of detergent-only micelles or extensive denaturation and total 
solubilisation of proteins (Coleman, 1974; Vives et al., 1997). Surfactants can thus 
induce cellular damage in a number of ways. At low concentrations «CMC), 
surfactant monomers incorporate into the plasma membrane, as the concentration 
increases pores are formed within the plasma membrane allowing the uncontrolled 
passage of molecules between the cytosol and the external environment, impairing 
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homeostasis. In addition, with epithelial cells the adhesion molecules can be affected 
and thus paracellular pathways opened. Once the surfactant concentration reaches 
the CMC, the main mode by which surfactants induce cellular damage is through 
phospholipid emulsification and protein denaturation. The effects of acute exposure 
to such compounds is well documented (ECETOC, 1997). Grant and Acosta (1996) 
evaluated the effects of acute benzalkonium chloride and sodium dodecyl sulphate on 
the long term recovery of primary rabbit corneal cells. The two surfactants have 
distinctly different prolonged effects on corneal epithelial cells. It was observed that 
whilst BAK induced an increase in intracellular calcium levels, SDS decreased 
calcium levels 1-3 hours after the removal of the surfactants suggesting that BAK 
and SDS could differentially affect cellular recovery in vitro (Grant and Acosta, 
1996). However, the effects of chronic surfactant exposure on the corneal epithelium 
remain largely unknown, and need to be further examined (Clothier and Samson, 
1996). Interactions between surfactants (exposure to SDS alleviates the effect of 
BAK and SDS) have been demonstrated to occur in vivo in skin (Grant and Acosta, 
1996; McFadden et al., 2001) although that this occurs at the ocular surface remains 
to be shown. 
6.3.2 Rationale for the selection of a 21 day chronic-, and 60 second 
acute- exposure period 
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A chronic sub cytotoxic exposure period of 21 days was selected, as it has been 
demonstrated that prolonged chemical exposure allows both morphological and 
biochemical alterations to develop in vitro without loss of cell viability (Clemedson 
et al., 1996; Clothier and Samson, 1996; Clothier et al., 1997). In addition, when 
utilising the Draize test, the total effects due to initial exposure and the subsequent 21 
days post inoculation are taken (Draize et al., 1994). In one of the prescribed timolol 
preparations benzalkonium chloride is used as the preservative, thus accumulation in 
the accessory structures of eye e.g. accumulation of timolol maleate or benzalkonium 
chloride in the conjunctiva could occur (Liu et al., 2004). When determining an 
acute exposure period that would be representative of such an in vivo system, careful 
consideration needs to be made as to the associated structures of the eye and cornea 
which afford some protection or enhancement of the irritating effect of exogenous 
chemicals. In vivo the cornea's first line of defence against chemical insult, apart 
from the upper and lower palpebrae (prabhasawat and Tseng, 1998), is the tear film. 
Chemical irritants dissolved in a solution representative of the tear fluid proteins 
have less affect on cell viability, than when dissolved in phosphate buffered solution 
alone (Cheng et al., 1995), highlighting the importance of the tear film as a defence 
against chemical insult. A J-HeET monolayer is more susceptible to irritant 
exposure than either a stratified skin model (Ward et al., 1998) or the cornea in vivo. 
It has been suggested that these defensive systems clear 80% of the exogenous 
chemical from the ocular surface within 60 seconds of the initial exposure (Shaw et 
ai, 1990). The J-HCET monolayer model, used in this study does, not possess these 
defence mechanisms but nevertheless, an acute exposure time must be selected that is 
representative of the in vivo system, (Shaw et al., 1990) and thus 60 seconds is 
chosen, with thorough post washing to mimic tearing and blinking. The washing of 
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the test material is vital especially with viscous material such as T20 as it has been 
demonstrated (Ward et al., 1997b) that ineffective washing can lead to a longer 
exposure period than intended. 
6.3.3 Effects of chronic surfactant exposure on J-HCET cultures 
It was probable that the subcytotoxic concentration of surfactants required for 
continued viability over a 21 day period will fall well below that of the CMC as 
above this level, surfactants tend to emulsify phospholipids bilayers (Rhein et al., 
1990). Rhein et al., 1990; McFadden, 2001 suggested that, at lower concentrations, 
below the CMC, surfactants tend to be incorporate into the plasma membrane and 
bind to integral membrane proteins, including adhesion molecules. The 
concentrations of surfactants in growth medium that would allow sustained J-HCET 
viability over a 21 day period, ranked as T20, SDS, CAPB and BAK, from highest to 
lowest there being a 10,000 time difference between the non-ionic T20 and the 
cationic BAK. The medium supplement employed (HKGS or HKGS-V2) did not 
affect this response. Suggesting that the measured decreases in the ability of the J-
HCET monolayers to internalise neutral red (Borenfreund and Puerner, 1985) was 
due to cellular loss, and not, alterations in plasma membrane transport mechanisms 
as a consequence of surfactant assimilation (Rhein et al., 1990; McFadden, 2001). 
These results only concern the viability in terms of neutral red uptake and protein 
content of a static (none or limited replicative ability) J-HCET monolayer. The 
critical issue was the effects that these sub cytotoxic surfactant concentrations had not 
only on the growth rate, but also barrier integrity and redox potential of J-HCET cells 
over a 21 day exposure period. 
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Previous measurements of the population doubling time have demonstrated that the 
supplement employed (HKGS or HKGS-V2) can have a significant effect on the 
growth rate of the J-HCET cell line if the coating matrix was omitted with the 
HKGS-V2 supplements. The population doubling time of J-HCET cultured in 
medium containing HKGS supplements or HKGS-V2 supplements without the use 
of the recommended attachment factor was unaffected by chronic SDS; 4J,1gmrl, 
T20; 25J,1gmrl, CAPS; 3J,1gmr1 or BAK; 0.0025J,1gmr1 exposure. However, when 
the J-HCET population doubling time was determine for J-HCET cultured in 
medium containing HKGS-V2 supplements in the presence of the attachment matrix, 
it was observed that the growth rates were comparable to those expected if the 
attachment matrix was omitted. Thus the surfactants appear to affect or degrade the 
matrix. Whilst the matrix coating was not required when the cells are grown on the 
inserts, and hence the chronic exposure may not disrupt differentially the cells grown 
in the HKGS-V2, the potential effects on direct culturing on a 96 well plates does 
need to be taken into account. 
The resazurin reduction assay has been widely used to assess bacterial or yeast 
contamination in biological fluids and milk (Erb and Ehlers, 1950), to measure the 
viability of sperm by colorimetry (0 'Brien et al., 2000) for cytotoxicity studies, in 
the form of Alamar Blue™, and the effects of drugs on specific mammalian cell lines 
(page et al., 1993;Suggs et al., 1999; Lee et al., 2000). The assay has been 
compared to other viability assays and demonstrated a good correlation in predicting 
cytotoxicity, e.g. with the trypan blue exclusion-(Gazzano-Santoro et al., 1997), and 
the 3-( 4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide salt (MTT) assay 
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(Black et al., 1999) whilst allowing for repeated or continuous measurements 
(Goegan et al., 1994; Vian et al., 1994; Clothier and Sansom, 1996; O'Brien et al., 
2000). This cannot be achieved with assays that require fixation or destruction of the 
cells to determine the endpoint e.g. the MTT, NRU, NRR and total protein assays. 
Chronic surfactant exposure was not associated with a significant change in the 
ability of J-HCET monolayers to convert resazurin to resorufin when compared with 
unexposed cultures. This suggests that chronic surfactant exposure at the 
concentrations investigated (SDS: 4J,lgmrl; BAK: 0.0025J,lgmr1; T20: 25J,lgmr1 or 
CAPB: 2.99J,lgmr1) do not significantly interfere with the J-HCET respiratory 
pathways involved with resazurin reduction. 
6.3.4 Effect of chronic exposure on J·HCET monolayer barrier function 
Ward et al., (1997a) reported that a cationic surfactants i.e. benzalkonium chloride 
appeared to adsorb to particular types of membrane material and cause sodium 
fluorescein to bind to it on the membrane producing erroneous leakage results, and a 
yellow insert. Ward et al., (1997a) did not evaluate polycarbonate inserts and with 
no literature information on benzalkonium chloride interacting with polycarbonate 
membranes, preliminary studies were run that demonstrated that exposing the no-cell 
insert to this surfactant did not result in erroneous leakage data. Utilising the 
combined fluorescein leakage- resazurin reduction assay to measure the permeability 
and activity of the J-HCET monolayer the sub cytotoxic surfactant (SDS; 4J,lgmr1, 
T20; 25J.lgmr1, CAPB 2.99J.lgmr1 or BAK; 0.0025J.lgmr1) exposure had no 
detectable effects on barrier function or cell activity over the whole 21 day exposure 
period regardless of supplement (HKGS or HKGS-V2) employed. Morphological 
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analysis of the essentials components of the tight junction (f-actin, ZO-1 and 
occludin) revealed that between days 19 and 21 of continuous BAI< exposure the 
localisation of ZO-l to the membrane of abutting I-HCET is significantly disrupted 
even in the presence of 1000JlM calcium. This did not result in an increase in 
fluorescein leakage. This does not preclude the possibility that a reaction to a 
subsequent higher acute exposure would not modulate the barrier function. It is 
possible that detoxification or repair pathways had been augmented by the chronic 
exposure, or that the ZO-l associated with non TI's e.g. adherens junctions, was 
what was affected. This requires further investigation. 
A number of variants of the fluorescein leakage assay exist. A prevalidation trial of 
one standardised method has recently been completed (Southee and Curren, 1997). 
Sadly this was not successful in that the Protocol was not sufficiently defined and 
those conducting the assay did not follow the protocol or meet to discuss and resolve 
protocol problems. To improve the predictive capacity of the fluorescein leakage 
assay the resazurin assay as added. The rational for this was that it may help to 
distinguish between those chemicals that cause significant fluoresce in leakage via 
damaging all the adhesion molecules but not killing cells from those which kill a few 
cells but do not affect adhesion molecules expression significantly. Both could result 
in say 60% leakage with a no cell insert giving 100% and a confluent layer 6 %. In 
the former case, where adhesion molecules alone were affected, recovery could be 
rapid since upon the removal of the surfactant the cell adhesion molecules could be 
re-expressed. In the later case cell division would be required to restore the cell 
numbers and hence would take over 24 hours. It was upon this basis that this kind of 
approach was taken to predict mild from more aggressive ingredients and 
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formulations for cosmetic use (Hubbard et al., 1994) and for predicting human skin 
patch test data for hand wash solutions (Clothier et al., 2002). It was determined 
that, in correlation with the present study, in vitro, T20 was less damaging than SDS 
which was less damaging than CAPB and BAK as was also noted in the Draize 
scores (1944) from historical data (ECETOC, 1992). The MMAS scores (ECETOC. 
1998) are 4, 16, and 56.3 respectively with concentration of 100%,3%, 1% for T20, 
SLS andBAK. 
When compared with the model developed during the current study, results of the 
same order of magnitude were observed and thus the same irritancy potential would 
be predicted, The concentration of chemicals required to damage this monolayer 
system were greater, possibly as a consequence of the shorter exposure period (60 
seconds). Hence, the prediction of ocular irritancy potential from this combined in 
vitro assay system is based not only on the immediate effects but, as for the Draize 
score, also on the rate of recovery of cell-junction integrity and cell viability. The 
recovery profiles demonstrated that at high concentrations of T20 the change in 
resazurin reduction capacity of the cells was directly related to the change in cell-
junction integrity. A distinction between the effects on tight junctions and resazurin 
reduction was observed at the highest BAK concentration. Fluorescein leakage was 
increased but no significant modulation of resazurin reduction occurred. Therefore, 
impairment of generalised membrane function would be required to result in a 
decrease in resazurin reduction and overall viability (Larson et al., 1997). Recovery 
occurred with all test materials, in the present study, at concentrations that only 
depress both the resazurin reduction and barrier function integrity. At the highest 
concentration of T20, extensive damage to the monolayer was observed along with a 
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significant loss of ability to recovery. This was in correlation with the study of 
Clothier et al., (1999) who reported extensive damage to the MDCK monolayer was 
associated with a significant loss in the ability of the cells to recover over the 96 hour 
period. In addition, although the irritancy potential of the test materials was of the 
same order as when J-HCET were cultured on tissue culture plasticware, the 
concentration required to achieve a similar decrease in resazurin reduction on a 
polycarbonate membrane was higher. This confirms the hypothesis of Ward et al., 
( 1 9 9 7 a ~ ~ 1998) that culture conditions significantly affect the irritancy potential of 
chemical concentrations in vitro. 
As reported (Hubbard et al., 1994) the initial effects and the rate of recovery 
combined allow for discrimination between irritancy potential of chemicals and 
concentrations of the same test agent. Results concerning the effects on mono layers 
cultured in either HKGS or HKGS-V2 supplemented medium were comparable i.e. 
HKGS-V2 supplements do not modulate the toxicity of surfactants to molecules of 
the tight junction. 
6.3.5 Chronic and acute surfactant exposure 
Numerous methods are available for the determination of in vitro cytotoxicity 
resulting from a single acute exposure to a chemical (Clothier et al., 1 9 9 7 ~ ~ Eskes and 
Zuang, 2005). Evaluation of toxic insult to confluent layers of cells using high 
concentrations combined with short exposure times e.g. Neutral Red Release assay 
(Reader et al., 1990), through to low concentrations with longer exposure during 
exponential cell growth (e.g. the Kenacid Blue a s s a y ~ ~ Knox et al., 1986) are in 
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routine use. In the MEIC scheme a whole range of acute assay methods are reviewed 
and compared (Clemedson et al., 1996). However, many chemicals present 
significant toxicity in vivo on repeat exposure and hence methods are being 
developed in vitro to facilitate the evaluation of effects following repeat exposure 
(Clothier et al., 1997). In vitro chronic exposure assays need to be designed with the 
ability to monitor changing responses during the exposure period. Techniques should 
be adaptable, since the mechanisms of toxicity could change with the dose, cell target 
and number of exposures. Assays could adopt different treatment regimens, for 
example ranging from daily re-exposure for a fixed time, as is adopted in vivo with 
human patch testing of cosmetics, to repeat exposure once recovery has occurred 
from the previous insult as described for the evaluation of repeat exposure to mild 
surfactants (Clothier and Samson, 1996). In this study, two different approaches 
were employed. Initially, cells were seeded and specific parameters were measured 
(resazurin reduction, neutral red uptake, population doubling time, total protein 
content and fluorescein leakage) during continuous exposure to subcytotoxic 
concentrations of the test materials for 21 days. Secondly, I-HCET where cultured in 
medium containing the test materials and subsequently seeded out to determine the 
effects that the chronic exposure had upon the acute toxicity of the test materials. 
Previous acute exposures to these chemicals gave a ranking of: T20, SDS, CAPB and 
BAK in increasing order of toxicity as observed with human keratinocytes (Ward et 
al., 1998). 
However, when J-HCET were continuously exposed to concentrations, that are 
below the detectable cytotoxic range, a sub-acute assay, result in cumulative effects 
that alter the toxicity and recovery profiles to a subsequent single acute challenge 
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(Clothier et al., 1999). An analysis of the parameters measured during these studies 
reveal that the ratio of both neutral red uptake and resorufin production to protein 
content are constant regardless of chronic - acute exposure history. This suggests 
that the modulation of toxic response as a consequence of previous exposure history 
is related to cell loss from the culture surface and not perturbations in cellular 
metabolism. However, the precise mechanism involved is unclear. This illustrates 
that while such an approach can be used to evaluate chronic toxicity, more extensive 
assay methods to identify the precise changes that have occurred within the cells are 
required. Not only are enzymes and receptor assays required but also assays 
examining specific detoxification pathways which allows for the repeat assaying of 
the same cell population (Clothier and Samson, 1996). The advent of 3T3 cells with 
specific cytochrome P-450 enzyme capacities inserted opens a further facet to in 
vitro models to examine chronic chemical toxicity resulting from specific 
metabolism (DeGroene et ai., 1995). Bull et al., (1999) showed that the various 
pathways of Imipramine metabolism can be investigated using this approach. 
Extending the use of use of such cell lines to chronic/repeat evaluation was beyond 
the scope of this project. 
6.4 Prolonged use of timolol maleate in the treatment of glaucoma 
The reduction-oxidation (redox) state of the cell is a consequence of the balance 
between the levels of oxidising reactive oxygen species (ROS) and reducing 
equivalents. Although the total antioxidant status of cells may appear sufficient to 
protect them from oxidative stress, the necessary defence mechanisms may not be 
sufficiently functional. Particularly large numbers of a certain radical species, and 
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the type of antioxidants needed to deal with these species where in short supply, 
excess ROS where free to strip electrons from molecules in cell walls and genetic 
material and also to oxidise dietary fats in the blood, a chain reaction yielding more 
free radicals and, therefore, more extensive oxidative stress would occur. 
Glutathione is the principle non-protein thiol involved in the antioxidant cellular 
defence (Pastore et al., 2003). Glutathione is a ubiquitous molecule that is produced 
in all organs, especially the liver. Intracellularly, it is found in millimolar 
concentrations and the level of glutathione is much greater than that of cysteine and 
seems to serve as a storage form of cysteine moieties (Pastore et al., 2003). In cells. 
total glutathione can be free or bound to proteins, free glutathione is present mainly 
in its reduced form. This may be converted to the oxidised form during oxidative 
stress, and can be reverted to the reduced form by the action of glutathione reductase 
(Pastore et al., 2003). Glutathione provides reducing capacity for several reactions, 
for example, the formation of deoxyribonucleotides by ribonucleotide reductase 
(Pastore et al., 2003) and the reduction of dehydroascorbate to ascorbate. 
Glutathione functions in the detoxification of hydrogen peroxide and free radicals. It 
also plays a role in the detoxification of a variety of xenobiotics, which interact with 
glutathione and are ultimately excreted (Pastore et al., 2003). The synthesis and 
degradation of glutathione takes place by reactions of the y-glutamyl cycle. Since 
this cycle leads to the synthesis of glutathione, its function is closely connected with 
the several metabolic and physiological functions that are performed by this 
ubiquitous tripeptide (Klatt and Lamas 2 0 0 0 ~ ~ Pastore et al., 2003). When an 
inhibitor of glutathione synthesis, such as buthionine sulphoxamine (BSO), is given, 
there is a decrease in the intracellular levels of glutathione (Pastore et al., 2003). 
Even a complete block does not stop the function of the y-glutamyl cycle, since 
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glutamate may be produced by other pathways, such as hydrolysis of glutamine and 
transamination or reductive amination of a-ketoglutarate (Griffith and Meister, 
1979). In has been established that an increase in the glutathione level of a cell 
makes it more resistant to certain xenobiotics, whilst exposures that reduce cellular 
glutathione levels usually promotes sensitivity to certain drugs, radiation and oxygen 
(Klatt and Lamas, 2000 Pastore et al., 2003). The prolonged use oftimolol maleate 
as a treatment for glaucoma has been associated with discontinuation of treatment as 
a result of ocular irritation (Uusitalo et al., 1999; Aggarwal and Kaur, 2005). Since 
timolol maleate is detoxified in vivo via conjugation with glutathione (GSH) 
(Megaw, 1984; Riley, 1990) a proposed mechanism for the irritancy associated with 
long term use may be alterations in the y-glutamyl cycle resulting in a net decrease in 
intracellular GSH available for timolol detoxification. This would result in an 
increased sensitivity to oxidising chemical insult to the corneal epithelium as redox 
status depends upon the relative amounts of the reduced and oxidised forms of 
glutathione (GSHlGSSH). J-HCET cultures exposed to BSO in vitro confirm that 
the toxicity of timolol to this human corneal cells line was enhanced by suppressing 
the activity of y-glutamylcysteine synthetase (Griffith and Meister, 1979) through 
irreversible inhibition resulting in a decrease in intracellular GSH levels. This 
clearly demonstrates that the J-HCET model may be employed to monitor 
detoxification pathways, specifically conjugation to GSH. It would be possible, in 
the future to use cell tracker green (Clothier et al., submitted for publication) to also 
visualise the detoxification through conjugation to GSH as has been recently 
examined with the photoproduct of Bithionol in this lab (Reid et al., submitted for 
publication). 
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It has been suggested (Sponsel et al., 1999) that timolol maleate accumulates in the 
conjunctival cul-de-sac by both capillary and gravitational force, thereby, remaining 
in sustained intimate contact with the ocular surface at concentrations significantly 
lower than the original exposure. Utilising the J-HCET model, a timolol maleate 
concentration was identified that that did not affect the viability, population doubling 
time or intracellular GSH levels over a 21 day incubation period. Although long 
term use of timolol containing pharmaceuticals have been reported to be associated 
with irritancy, a single exposure to clinically relevant concentrations (2.5mgmr1) has 
not be associated with aggravation of the ocular surface (Megaw, 1984; Riley, 1990; 
Pastore et al., 2003). The finding that in vitro acute exposures to levels below that 
found in pharmaceutical preparations may result in higher intracellular GSH 
concentrations. This is due to upregulation of the y-glutamyl cycle in order to 
detoxify timolol maleate, a xenobiotic conjugated to GSH for its removal from the 
cell (Griffith and Meister, 1979; Pastore et al., 2003). The specific enzyme pathway 
responsible for the upregulation of GSH is almost certainly the y-glutamylcysteine 
synthetase pathway as when cells are cultured in the presence of BSO and 
subsequently exposed to timolol, the upregulation of GSH was no longer observed. 
A similar effect was observed in J-HCET cultured in subcytotoxic timolol 
concentrations for 21 days and subsequently exposed to an acute level. Although the 
sub cytotoxic concentration determined demonstrates no overt toxicity with regard to 
viability or GSH concentration, upon a acute exposure, it was found that the toxicity 
of timolol was significantly increased. This suggests that the y-glutamyl cycle 
cannot upregulate GSH levels over a sustained period upon acute exposures as a 
consequence of chronic pre-exposure. 
281 
6.4.1 Timolol exposure and barrier function 
Measurements reveal that an acute timolol exposure significantly increased the 
leakage of fluorescein across the monolayer with no decrease in viability or protein 
content. In addition, morphological analysis reveal significant alterations in the 
localisation of both ZO-l and occludin immediately following exposure suggesting 
that the increase in leakage was due to disruption of tight junction integrity. It had 
been demonstrated that the expression and localisation of the components of the tight 
junction was dependent upon the correct calcium concentration (Wilkinson et al .. 
2005). Timolol maleate is known to influence cellular sodium and calcium channels 
in vivo (Aggarwal and Kaur, 2005) and these results suggest timolol maleate may 
modulate tight junctions in vitro. Complete recovery of the barrier function was 
observed in unexposed monolayers; however, those pre-exposed to timolol only 
demonstrated partial recovery. This suggests that the recovery of barrier function 
may be modulated by previous exposure history. 
6.5 Conclusion 
This study has shown that the development of such a reliable and reproducible in 
vitro assay for chronic/repeat ocular irritation it is vital. The mechanistic relevance 
of the endpoints chosen and monolayer or multilayer ultrastructure is considered to 
be a vital component. The development of cell based in vitro systems to predict 
human responses to chronic/repeat ocular irritation is required (Balls and Worth, 
2002). This assay does address the components of the validation process and not 
"invalidation" as outlined by Balls and Combes (2005). 
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6.6 Future Work 
6.6.1 Stratification of the J-HCET model 
In addition to provide a species specific model it is desirable that an in vitro model 
afford the potential to express mechanistically relevant responses that can be used for 
predicting human ocular toxicity and recovery potential. Although the model 
developed during the present study employs human corneal epithelial cells, the 
stratification observed in vivo is not present. In the future in may be possible to 
develop techniques which will enable the stratification of the J-HCET model to more 
accurately represent the in vivo structure of the human cornea. 
6.6.2 Monitor tight junction integrity using TEM 
Ward et al., (l997b) employed TEM to visualise the effects that surfactant challenge 
had upon the ultrastructure of the Gillette corneal cell line. This technique could be 
adapted to visualise any subtle alterations in ultrastructure as a consequence of 
chronic exposure, and subsequently following an acute exposure to the test 
surfactants and timolol maleate. 
6.6.3 Effects of benzalkonium chloride on timolol toxicity in vitro 
Ophthalmic liquid formulations such as timolol contain penetration enhancers and 
antimicrobial agents (Chetoni et al., 2003) e.g. BAK, which enhances trans-corneal 
drug delivery and suppresses bacterial growth. Chetoni et al., (2003) suggested that 
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the long term irritancy of timolol maleate is due to the presence of penetration 
enhancers such as benzalkonium chloride as part of the formulation. It has been 
demonstrated during the current study that prolonged exposure to benzalkonium 
chloride significantly alters the expression of ZO-l in vitro, without altering the flux 
of fluorescein or viability. In addition, the toxicity of benzalkonium chloride has 
been demonstrated to be modulated by previous exposure history. In the future, 
studies may be conducted concerning the effects that benzalkonium chloride pre-
exposure has upon the toxicity of timolol, and that of formulations of timolol 
containing benzalkonium chloride as a preservative. This may lead to a further 
understanding of the mechanisms involved in the irritancy of timolol over prolonged 
use. 
6.6.4 Visualisation of GSH conjugation to xenobiotics in vitro 
It has been demonstrated that intracellular levels of GSH may be measured in vitro 
utilising a simple colorimetric assay, and that the GSH levels may be modulated by 
xenobiotics e.g. timolol maleate and BSO. In addition to quantifying the intracellular 
GSH it would be possible in the future to use cell tracker green to visualise the 
cytoplasmic distribution of GSH and monitor xenobiotic detoxification through 
conjugation to GSH, as has been recently examined with the photoproduct of 
Bithionol in this laboratory (Reid et al., submitted for publication). 
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